text stringlengths 102 99.6k | url stringlengths 31 426 | crawl_date timestamp[us, tz=UTC]date 2022-04-01 00:29:49 2022-09-19 04:34:15 |
|---|---|---|
BENTONVILLE, Ark., Aug. 23, 2022 /PRNewswire/ -- BSM Partners, the leading full-service pet care research and consulting firm, announces 15-year-old Ava Dorsey as the first participant in their Young Entrepreneur Mentorship Program. Dorsey is the founder and Chief Pet Officer of Ava's Pet Palace, a line of USDA Organic-certified and all-natural dog and cat treats and pet accessories. All packaging for Ava's Pet Palace products is made from sustainable recycled products.
"Having already accomplished so much at such a young age, Ava is the perfect first mentee to kickstart our Young Entrepreneur Mentorship program," said Dr. Frank Niles, Principal of BSM's Business Transformation practice and startup services group lead. "Our startup services team has been thrilled to be guiding and assisting Ava through her company's growth, and we look forward to helping other young entrepreneurs break into and flourish in the industry."
BSM Partners' Young Entrepreneur Mentorship Program guides emerging young business leaders within the pet industry, providing advice and support on matters such as product innovation, formula development, marketing, business development, employee development, organizational development, executive coaching, and more.
"It's been a great and very productive relationship since meeting everyone on the BSM team," said Dorsey. "The team members are so caring and provide help and guidance that any startup could benefit from across all areas of business. I'm really looking forward to the future of the pet industry that includes the youth this program seeks to help. And I'm so happy they are being active change agents for the future of the industry. Growing and scaling a business can sometimes feel scary, but I now feel very confident and super excited about the future of Ava's Pet Palace!"
Ava's Pet Palace is a line of organic and all-natural dog and cat treats and pet accessories and are sold online at www.avaspetpalace.com, in independent retailers throughout the nation and in all PetPeople and Pet Food Express locations.
BSM Partners is the leading full-service pet care research, consulting, and strategy-to-shelf product innovation firm. BSM Partners collaborates with hundreds of clients, ranging from the largest companies to individual entrepreneurs, to provide both technical and business solutions. The firm's startup services group helps early-stage pet care entrepreneurs build the foundation necessary to scale their business. From ideation to execution and everything in-between, BSM accelerates the growth of promising new businesses in the pet food industry. To learn more, go to www.bsmpartners.net.
View original content to download multimedia:
SOURCE BSM Partners | https://www.kxii.com/prnewswire/2022/08/23/bsm-partners-young-entrepreneur-mentorship-program-announces-ava-dorsey-avas-pet-palace-first-participant/ | 2022-08-23T10:38:43Z |
CHICAGO, Sept. 1, 2022 /PRNewswire/ -- Ryerson Holding Corporation (NYSE: RYI), a leading value-added processor and distributor of industrial metals, announced today its acquisition of Howard Precision Metals, Inc. ("Howard"), one of the largest aluminum distributors in the Midwest. Based in Milwaukee, Wisconsin, Howard specializes in value-added processing services including high-quality precision cut aluminum plate and saw cut extruded aluminum bar distribution.
"Howard has cultivated a strong brand and a reputation for creating excellent customer experiences," said Mike Burbach, Ryerson's Chief Operating Officer. "Its processing capabilities complement Ryerson's existing non-ferrous franchise, and we are excited to recognize these synergies as we welcome them to the Ryerson Family of Companies."
"Building on our legacy of over 90 years in the industry, Howard is excited for this opportunity to grow our brand and business with a company that shares our values and commitment to customers," said Mark Howard, President of Howard. "We look forward to continuing to provide excellent service to our customers as a member of the Ryerson Family of Companies."
About Ryerson
Ryerson is a leading value-added processor and distributor of industrial metals, with operations in the United States, Canada, Mexico, and China. Founded in 1842, Ryerson has around 4,000 employees in approximately 100 locations. Visit Ryerson at www.ryerson.com.
Safe Harbor Provision
Certain statements made in this presentation and other written or oral statements made by or on behalf of the Company constitute "forward-looking statements" within the meaning of the federal securities laws, including statements regarding our future performance, as well as management's expectations, beliefs, intentions, plans, estimates, objectives, or projections relating to the future. Such statements can be identified by the use of forward-looking terminology such as "objectives," "goals," "preliminary," "range," "believes," "expects," "may," "estimates," "will," "should," "plans," or "anticipates" or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy. The Company cautions that any such forward-looking statements are not guarantees of future performance and may involve significant risks and uncertainties, and that actual results may vary materially from those in the forward-looking statements as a result of various factors. Among the factors that significantly impact our business are: the cyclicality of our business; the highly competitive, volatile, and fragmented metals industry in which we operate; fluctuating metal prices; our substantial indebtedness and the covenants in instruments governing such indebtedness; the integration of acquired operations; regulatory and other operational risks associated with our operations located inside and outside of the United States; impacts and implications of adverse health events, including the COVID-19 pandemic; work stoppages; obligations under certain employee retirement benefit plans; the ownership of a majority of our equity securities by a single investor group; currency fluctuations; and consolidation in the metals industry. Forward-looking statements should, therefore, be considered in light of various factors, including those set forth above and those set forth under "Risk Factors" in our annual report on Form 10-K for the year ended December 31, 2021, and in our other filings with the Securities and Exchange Commission. Moreover, we caution against placing undue reliance on these statements, which speak only as of the date they were made. The Company does not undertake any obligation to publicly update or revise any forward-looking statements to reflect future events or circumstances, new information or otherwise.
View original content to download multimedia:
SOURCE Ryerson Holding Corporation | https://www.wibw.com/prnewswire/2022/09/01/ryerson-acquires-howard-precision-metals/ | 2022-09-01T21:24:04Z |
Annual live conference will return to the Renaissance at SeaWorld Orlando April 30 to May 3.
INDIANAPOLIS, Sept. 13, 2022 /PRNewswire/ -- AOTMP® Engage 2023, the in-person annual conference for Telecom, Mobility, and IT Management professionals, will return to the Renaissance at SeaWorld Orlando. The main conference will feature thought-provoking IT procurement, IT expense management, and mobility management topics. The Industry Awards & Recognition and Association Member Meeting will take place on May 3. The first AOTMP® Women in Technology conference will follow with a celebration and reception on May 3 and mainstage presentations and panels on May 4. Early bird registration for Engage 2023 will begin October 3, 2022. Bookmark AOTMP® Engage 2023 for quick access to important conference information and updates.
Programming at the event will include
- Industry Awards Ceremony highlighting outstanding individuals and teams
- Mainstage Panels with Enterprise professionals including topics such as
- Mainstage sessions focused on thought leadership and strategies, covering topics such as
- Breakout sessions focused on best practices and success stories, covering topics such as
- Themed evening receptions
- Sponsors and exhibitors with the newest industry solutions
AOTMP® is proud to announce its top three sponsors for this event have been secured, with ProcureLogix taking the exclusive top spot as Premier Sponsor. Connectbase and Sakon hold the next two spots as the platinum sponsors. Their support helps make this exciting event possible.
Timothy C. Colwell, AOTMP® Executive Vice President, said, "We are excited to gather industry professionals at a face-to-face event where we will have the opportunity to collaborate and learn from one another. As an industry support organization, AOTMP® remains ever committed to helping telecom, mobility & technology professionals drive the entire industry forward, together."
AOTMP® is a global organization, empowering professionals in the dynamic $4+ trillion telecom, mobility and IT management industry. AOTMP® delivers value through training, certifications, association memberships, events & programs, best practices, publications, resources, and professional development.
Learn more at www.aotmp.com
View original content to download multimedia:
SOURCE AOTMP | https://www.wibw.com/prnewswire/2022/09/13/aotmp-hold-annual-engage-2023-conference-telecom-mobility-it-management-professionals/ | 2022-09-13T16:05:10Z |
Supported by the nation's largest privately held building materials supplier, 'The People's Tree' is embarking on its annual journey to Washington, D.C. for the 2022 holiday season
EIGHTY FOUR, Pa., June 14, 2022 /PRNewswire/ -- When the U.S. Capitol Christmas Tree makes its annual trip to Washington, D.C., it will do so with the support of 84 Lumber, the nation's largest privately held building materials supplier. For the first time, 84 Lumber is the proud presenting sponsor of what is known as 'The People's Tree' this holiday season.
"84 Lumber is thrilled to sponsor the tree that brings so many people joy throughout the holidays," said 84 Lumber President Maggie Hardy Knox. "We're excited to be working with the U.S. Forest Service and Choose Outdoors for the first time through this partnership as well."
Every year since 1964, a different national forest has been selected to provide a tree for the West Lawn of the U.S. Capitol for the holiday season. The name 'People's Tree' reflects the nickname for the U.S. House of Representatives, the People's House. The 2022 tree will come from the National Forests in North Carolina, and 84 Lumber will be among those tracking the tree's journey from North Carolina to Washington, D.C. Each year, the National Forest that provides the U.S. Capitol Christmas Tree, along with various partners from across the country, also provides thousands of homemade ornaments, many of which are created by children.
The tree lighting ceremony will take place late November and the tree will light up the West Lawn from nightfall until 11 p.m. each evening until Jan. 1, 2023.
"The annual journey is only possible with the help of sponsors from both the public and private sectors," said Bruce Ward, president of Choose Outdoors, the non-profit partner of the U.S. Forest Service. "We're grateful for the time and resources that 84 Lumber and all our invaluable partners are providing to help make this the best tour to date."
For related news, events and tour information, and to track the tree on the journey to D.C. visit www.uscapitolchristmastree.com. To learn more about 84 Lumber, visit www.84lumber.com.
About the U.S. Capitol Christmas Tree
The U.S. Capitol Christmas Tree initiative is a 50-year tradition in which one of our 155 national forests provides a tree for the West Lawn of the U.S. Capitol for the holiday season. The project is made possible with support from partners including non-profit Choose Outdoors along with cash and in-kind contributions from companies large and small as well as volunteers locally and across America. For a list of 2022 sponsors and to join in the Christmas spirit, visit uscapitolchristmastree.com and @uscapitolchristmastree on Facebook and Instagram.
ABOUT 84 LUMBER
Founded in 1956 and headquartered in Eighty Four, Pennsylvania, 84 Lumber Company is the nation's largest privately held supplier of building materials, manufactured components and industry-leading services for single- and multi-family residences and commercial buildings. The company operates more than 250 stores, component manufacturing plants, custom door shops, custom millwork shops and engineered wood product centers in over 30 states. 84 Lumber also offers turnkey installation services for a variety of products, including framing, insulation, siding, windows, roofing, decking and drywall. A certified national women's business enterprise owned by Maggie Hardy Knox, 84 Lumber has held a spot on the Inc. 5000 list of America's fastest growing companies for several years in a row. For more information, visit 84lumber.com or join the company on your favorite social media platform.
View original content to download multimedia:
SOURCE 84 Lumber | https://www.mysuncoast.com/prnewswire/2022/06/14/84-lumber-announces-premier-sponsorship-2022-us-capitol-christmas-tree/ | 2022-06-14T13:32:51Z |
Nine Million Immigrants are Eligible for US Citizenship Each Year, But 91% Never Apply, Citing Affordability as a Main Deterrent
BOSTON, June 1, 2022 /PRNewswire/ -- More than nine million immigrants who are eligible to apply for US citizenship each year – 91% of whom never apply– will for the first time have access to a flexible 1% interest rate loan to cover the cost of their application.
The loan is offered by One Percent for America (OPA), a new digital platform affiliated with the nonprofit community development financial institution BlueHub Capital.
In September 2021, OPA conducted a national blind survey of more than 1,200 immigrants in the United States that are either non-citizens or were naturalized within the last five years and found that application fees create a significant financial barrier to citizenship.
While citizenship fees, which can cost up to $1,200, are in place to support United States Citizenship and Immigration Services (USCIS) operations, some immigrants cannot afford them. Eighty-seven percent of survey respondents reported borrowing money in order to pay the fees, and two-thirds reported that they tapped high interest financing like credit cards, payday lenders and other sources of borrowed money to cover the costs.
OPA's 1% loan has no credit requirements, no late or hidden fees, and a flexible repayment schedule, and is being offered in conjunction with free financial education and dedicated community support. Once borrowers apply and are approved for the loan through OPA's website, OPA will issue borrowers a check for their loan funds made payable to USCIS on their behalf. Borrowers must pay back the loan within one year and can do so while they are applying for citizenship in order to ensure the longevity of the program.
"While the 'one percent' has traditionally symbolized wealth inequality and the inaccessibility of the American Dream, the One Percent for America program introduces a new 'one percent' that represents economic empowerment and provides new citizens with the resources they need to thrive. Our entire country benefits when immigrants are given a fair shot to become citizens and contribute to the national economy and character," said BlueHub Capital CEO Elyse Cherry. "Leveraging the lending experience of BlueHub Capital, One Percent for America is a technology-enabled platform that is self-sustaining and scalable, setting it apart from any other lending program for eligible citizens out there. We are calling on people from coast to coast to become part of the 'one percent' and help move our nation towards unity."
OPA's model brings borrowers and investors together on one platform. Money donated or lent by investors allows immigrants to borrow the funds to pay their fees, then funds are recycled to help additional immigrant borrowers. The loan's low 1% interest rate is in contrast with the 18-22% interest rates that commonly come with other options like payday lenders and credit cards.
Building on BlueHub's over 35 years of experience in community-centric lending, the OPA program will combine its power with that of investors and borrowers to create a unique lending system that allows immigrants across the country to apply for citizenship without facing significant financial barriers.
To apply for a straightforward, 1% interest loan through One Percent for America, click here.
To invest in One Percent for America through a loan, donation or corporate sponsorship, please click here or email investOPA@onepercentforamerica.org.
BlueHub Capital is a national, mission-driven, nonprofit community development finance organization focused on building healthy communities where low-income people live and work. BlueHub uses innovative financial tools and has deployed over $2.4 billion (and leveraged over $12 billion) in capital to support projects that make communities more vibrant places to live. BlueHub has four distinct programs: BlueHub Loan Fund (community development financing), BlueHub SUN (foreclosure relief), BlueHub Energy (clean energy access) and One Percent for America (citizenship financing).
Contact: Abigail Goldring, abigail.goldring@berlinrosen.com
View original content:
SOURCE BlueHub Capital | https://www.kxii.com/prnewswire/2022/06/01/groundbreaking-1-interest-loan-makes-american-citizenship-applications-affordable-millions-eligible-immigrants-unable-cover-required-fees/ | 2022-06-01T10:22:12Z |
Lake Wind Advisory issued May 14 at 2:20PM MDT until May 14 at 8:00PM MDT by NWS Pocatello ID
* WHAT…Southwest winds 20 to 25 mph with gusts around 30 to 35
mph expected.
* WHERE…American Falls Reservoir.
* WHEN…Until 8 PM MDT this evening.
* IMPACTS…Strong winds and rough waves on area lakes will
create hazardous conditions, especially for small craft.
Boaters on area lakes should use extra caution since strong winds
and rough waves can overturn small craft. | https://localnews8.com/weather/alerts-weather/2022/05/14/lake-wind-advisory-issued-may-14-at-220pm-mdt-until-may-14-at-800pm-mdt-by-nws-pocatello-id/ | 2022-05-14T23:24:46Z |
Movie lovers in Temple and around the country will get a chance to celebrate National Cinema Day Saturday with steep discounts.
featured
Temple, Belton movie theaters offer $3 tickets for Saturday
Tags
TDT Shane Monaco
Get email notifications on {{subject}} daily!
Your notification has been saved.
There was a problem saving your notification.
{{description}}
Email notifications are only sent once a day, and only if there are new matching items.
Followed notifications
Please log in to use this feature
Log In
Don't have an account? Sign Up Today
Most Popular
Articles
- Shawarma karma: New restaurants planned for Temple area
- ‘I want to discuss the truth:’ Temple woman recounts teen’s fatal shooting
- UPDATE: 2 dead in Nolanville crash; Temple man among victims
- Temple Police assist as FBI makes arrest
- Man attempts Temple jewelry store break-ins
- Belton’s Brown set for next chapter
- Gritty victory: Temple leans on defense, big plays to beat McKinney in opener
- ‘I know what she did': Witness: Temple teen tried to stop attacker before fatal shooting
- Four-year Wildcats: York, Harrison-Pilot stay committed to craft in pursuit of success
- Two Killeen women on trial in shooting death of Temple teen | https://www.tdtnews.com/news/business/article_541821e0-27e4-11ed-9240-43ff18b21331.html | 2022-08-29T23:40:12Z |
LOS ANGELES (AP) — Oscar Tshiebwe of Kentucky won the John R. Wooden Award as the men’s college basketball player of the year.
Tuesday’s announcement from the Los Angeles Athletic Club was made on ESPN’s “SportsCenter.”
Tshiebwe led the nation with 515 total rebounds and 15.1 rebounds per game. The 6-foot-9 center had the most rebounds in a season since 1973 and the highest per game average since 1980. Kentucky was beat in the first round of the NCAA Tournament by St. Peter’s.
Tshiebwe, who is from Congo, is the second Kentucky player to win the award, joining Anthony Davis in 2012. Tshiebwe also collected player of the year honors from The Associated Press, Naismith Memorial Hall of Fame, the National Association of Basketball Coaches, The Sporting News and the U.S. Basketball Writers Association.
The other finalists were Ochai Agbaji of national champion Kansas, Johnny Davis of Wisconsin, Iowa’s Keegan Murray and Drew Timme of Gonzaga.
Aliyah Boston with national champion South Carolina won the women’s Wooden Award on Monday. The 6-foot-5 forward averaged 16.8 points and had a Southeastern Conference record of 27 straight double-doubles.
Tshiebwe and Boston have been invited to Los Angeles for Friday’s 46th annual presentation.
Voting took place from March 14-21 during the early rounds of the NCAA Tournament by a national panel of voters who cover the sport and former winners.
___
More AP college basketball: https://apnews.com/hub/college-basketball and https://apnews.com/hub/ap-top-25-college-basketball-poll and https://twitter.com/AP_Top25 | https://cw33.com/sports/ap-sports/kentuckys-oscar-tshiebwe-wins-john-r-wooden-award/ | 2022-04-06T18:53:52Z |
The most transparent way to get your home on and off the market quickly
SANTA MONICA, Calif., April 18, 2022 /PRNewswire/ -- HomeLister, the online-based digital brokerage, unveils a new way for homeowners to sell their homes without the hassle of real estate agents and multiple fees.
HomeLister has a variety of flat-fee prices that cater to different budgets encompassed by three plans: Basic, Premium, and Platinum. Homeowners can also add à la carte services to customize their needs. On average, homeowners save $21,000.
The Basic plan allows homeowners to pay only $599 at closing and nothing upfront. This plan includes a local listing on the MLS, instant showing requests and feedback, and live or virtual video showings with the virtual tours app and a traditional post yard sign.
The most popular plan, the Premium, costs $1,599 with only $599 needed upfront and $1,000 at closing. This plan includes everything the Basic plan has, plus professional photography for your home. It also comes with two open house signs, seller's paperwork management, a custom marketing flier for an open house or email, offers review, and counteroffer preparation.
The Platinum plan is the top-tier plan provided by HomeLister at $2,699 with $699 needed upfront and $2,000 at closing. This plan includes everything the Basic and the Premium plans have, plus offer negotiation, appraisal comps, and professional photography, including aerial photography. It also features a home price report (CMA), staging consultation, a digital lockbox, real estate professionals guiding the homeowner throughout the sale, and email marketing to local agents.
HomeLister also offers à la carte services that can be added to the plan. This way, homeowners can customize their packages based on their needs, as every home is different. These services include a wooden frame yard sign, a 3D interactive video tour, and a two-week-long online advertising campaign on Google, Facebook, and other major websites.
To learn more about HomeLister and sign up to receive updates, special offers, and more, visit HomeLister.com.
About HomeLister
HomeLister offers homeowners an empowering new way to sell their home without hiring a traditional real estate agent. Homeowners get their listing added to the MLS and every major real estate website with the ability to choose how much assistance they would like from HomeLister, and add additional services - like offer negotiation and professional photography - along the way. The company never takes a percentage of the sale price, charging a low flat fee starting at $599 instead. Learn more at homelister.com.
Contacts: Tommy Chang, 310-717-5707, tchang@homelister.com
View original content:
SOURCE HomeLister | https://www.kxii.com/prnewswire/2022/04/18/homelister-removes-pesky-fees-associated-with-selling-your-home/ | 2022-04-18T18:44:41Z |
GUELPH, ON, June 15, 2022 /PRNewswire/ -- Canadian Solar Inc. ("Canadian Solar" or the "Company") (NASDAQ: CSIQ), today announced it has secured 136 million Brazilian reais (approximately US$28 million) non-recourse project financing from Banco do Nordeste do Brasil S.A. (BNB) to support construction and operation of its 79 MWp Lavras II solar power project in Brazil. BNB is the largest regional development bank in Latin America, supporting the economy of Brazil's Northeast Region.
Lavras II is expected to reach commercial operation in the second quarter of 2022 and will be powered by Canadian Solar high efficiency BiHiKu modules. Canadian Solar won the Lavras II solar project in a private auction held by COPEL Energia, which is part of COPEL Group, one of the top 10 energy trading companies in Brazil, in September 2019, with a 15-year, inflation-adjusted PPA.
This inflation-linked debt tied to the National Consumer Price Index (IPCA) will provide improved capital and resource alignment with the Brazilian economy.
Dr. Shawn Qu, Chairman and CEO of Canadian Solar Inc., commented, "We are pleased to extend our long-standing partnership with BNB. This financing once again demonstrates our capabilities and commitment to the Brazilian market, where we are a market leader with more than 2 GWp of backlog projects that have secured power purchase agreements," Dr. Qu continued, "Sustainable public sector commitment for clean and affordable solar energy infrastructure has cemented Brazil as the biggest and fastest growing renewable energy market in Latin America. As a leader in financing infrastructure projects, BNB's continuing participation in our solar portfolio reinforces our confidence in the long-term potential of Brazil's renewable energy sector."
About Canadian Solar Inc.
Canadian Solar was founded in 2001 in Canada and is one of the world's largest solar technology and renewable energy companies. It is a leading manufacturer of solar photovoltaic modules, provider of solar energy and battery storage solutions, and developer of utility-scale solar power and battery storage projects with a geographically diversified pipeline in various stages of development. Over the past 20 years, Canadian Solar has successfully delivered around 71 GW of premium-quality, solar photovoltaic modules to customers across the world. Likewise, since entering the project development business in 2010, Canadian Solar has developed, built and connected over 6.6 GWp in over 20 countries across the world. Currently, the Company has around 800 MWp of solar projects in operation, 5.3 GWp of projects under construction or in backlog (late-stage), and an additional 18.5 GWp of projects in pipeline (mid- to early- stage). Canadian Solar is one of the most bankable companies in the solar and renewable energy industry, having been publicly listed on the NASDAQ since 2006. For additional information about the Company, follow Canadian Solar on LinkedIn or visit www.canadiansolar.com.
Safe Harbor/Forward-Looking Statements
Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially. These statements are made under the "Safe Harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by such terms as "believes," "expects," "anticipates," "intends," "estimates," the negative of these terms, or other comparable terminology. Factors that could cause actual results to differ include general business, regulatory and economic conditions and the state of the solar and battery storage market and industry; geopolitical tensions and conflicts, including impasses, sanctions and export controls; volatility, uncertainty, delays and disruptions related to the COVID-19 pandemic; supply chain disruptions; governmental support for the deployment of solar power; future available supplies of high-purity silicon; demand for end-use products by consumers and inventory levels of such products in the supply chain; changes in demand from significant customers; changes in demand from major markets such as Japan, the U.S., China, Brazil and India; changes in effective tax rates; changes in customer order patterns; changes in product mix; changes in corporate responsibility, especially environmental, social and governance ("ESG") requirements; capacity utilization; level of competition; pricing pressure and declines in or failure to timely adjust average selling prices; delays in new product introduction; delays in utility-scale project approval process; delays in utility-scale project construction; delays in the completion of project sales; continued success in technological innovations and delivery of products with the features that customers demand; shortage in supply of materials or capacity requirements; availability of financing; exchange and inflation rate fluctuations; uncertainties related to the CSI Solar carve-out listing; litigation and other risks as described in the Company's filings with the Securities and Exchange Commission, including its annual report on Form 20-F filed on April 28, 2022. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee future results, level of activity, performance, or achievements. Investors should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today's date, unless otherwise stated, and Canadian Solar undertakes no duty to update such information, except as required under applicable law.
Canadian Solar Inc. Investor Relations Contacts
Isabel Zhang
Investor Relations
Canadian Solar Inc.
investor@canadiansolar.com
David Pasquale
Global IR Partners
Tel: +1-914-337-8801
csiq@globalirpartners.com
View original content:
SOURCE Canadian Solar Inc. | https://www.wibw.com/prnewswire/2022/06/15/canadian-solar-secures-136-million-brazilian-reais-financing-lavras-ii-project-brazil/ | 2022-06-15T12:09:14Z |
Colony of prairie dogs face possible extermination for being too close to humans
LAFAYETTE, Colo. (KMGH) - As cute as they may be, prairie dogs can be a nuisance. At one office park, they’re getting too close for comfort.
“I definitely think they need to be relocated. (They’re) just a little bit too close to office space,” said Dr. JJ Wellman, owner of Happy Paws Veterinary Hospital.
Her veterinary office is at an office park right next door to a bustling prairie dog colony.
“They don’t belong, you know, adjacent to office buildings but, thankfully, there is a place for them to go,” she said.
The roughly 150 prairie dogs have caused enough problems that there now are plans in place by the owners’ association to remove them.
But how Wellman’s been told that will be done doesn’t sit well with her.
“We’ve only reached out to one company. The one company quoted $15 to $30,000 to trap as many as they could and fumigate the rest,” she said.
Instead, she would like them all to be relocated, not just some, and find a way for a new colony to not pop up again.
She said she’s also concerned about how the fumigation would affect the animals in her practice just feet away.
“We love animals, and that’s why I’ve dedicated my life to this, so we’re all supposed to just watch as prairie dogs are being fumigated out back? Like, it’s just not right, " Wellman said.
A proponent of the relocation and possible fumigation is the Boulder County Housing Authority. It owns the preschool nearby and the five lots around it where these prairie dogs currently reside.
In a statement, a spokesperson said, “BCHA supports relocating the maximum number of prairie dogs possible to help protect the preschool children and minimize contact with adults whose health may be at risk.”
Wellman said she just wishes it wasn’t at the cost of the prairie dogs’ lives.
“I’ve already been outvoted, but I’m hoping some media attention will help others advocate and for everyone to be a little bit more thoughtful about this decision,” she said.
There’s an association meeting scheduled for Wednesday morning, where businesses and the housing authority will learn more about the plans to remove the prairie dogs.
Copyright 2022 KMGH via CNN Newsource. All rights reserved. | https://www.kxii.com/2022/08/23/colony-prairie-dogs-face-possible-extermination-being-too-close-humans/ | 2022-08-23T16:30:39Z |
Beloved Food Company Founded by Actor and Philanthropist Paul Newman Continues Its 40-Year History of Giving 100% of Profits to Help Kids
WESTPORT, Conn. , May 31, 2022 /PRNewswire/ -- Newman's Own Inc., the food and beverage company founded by actor and philanthropist Paul Newman, today announced the launch of not one, but two exciting new products perfectly timed for summer: Garlic Vinaigrette & Marinade and Stone-Fired Crust Pizzas. Whether you're hosting a barbeque or looking for a quick and easy dinner after a day at the beach, these new products bring taste, quality, and convenience to the table while improving the lives of children in need. As with all Newman's Own products, 100% of profits from the sale of the new dressing and pizzas will go to organizations that help kids.
Perfect for dressing salads, marinating meats, topping pasta and dipping bread, Newman's Own new Garlic Vinaigrette & Marinade is light and fresh, full of flavor, and incredibly versatile. Made with premium ingredients and a special blend of herbs and spices, the double-purpose vinaigrette and marinade sets itself apart by featuring four different forms of garlic – minced, powdered, granulated and chopped – delivering deliciously bold and zesty flavor with every bite. It is the latest addition to the brand's extensive offering of classic vinaigrettes and dressings.
Expanding beyond the brand's Thin and Crispy and Cauliflower Crust Pizzas for the first time, Newman's Own new Stone-Fired Crust Pizzas are authentic, Italian pizzas with lightly blistered crusts. To achieve the perfect crust, the pizzas are stone-fired at a very high temperature (900°F) for 60 seconds to lock in the flavors of the high-quality Italian toppings and maintain a light, airy, and slightly crispy texture until they're ready to be baked in the oven at home. Newman's Own Stone-Fired Crust Pizzas are imported from Italy and available in three authentic Italian flavors including classic Margherita, Quattro Formaggi (Four Cheese), and Spinaci & Formaggi (Spinach & Cheese). The Margherita pizza is topped with a traditional tomato sauce, buffalo mozzarella cheese, and basil leaves. The four-cheese pizza features fior di latte mozzarella, buffalo ricotta, buffalo mozzarella, Pecorino Romano cheese, and basil leaves. The spinach and cheese pizza is made with caciocavallo cheese, fior di mozzarella, Grana Padano, spinach, garlic, and a splash of lemon.
"Forty years after Newman's Own was founded with the launch of its first salad dressing, we remain committed to Paul Newman's vision of giving all profits away," said Nicole Malcolm-Manyara, Chief Marketing Officer of Newman's Own, Inc. "As we launch a bold and zesty new dressing this year, as well as a new Italian pizza line, I'm proud that our customers can still feel doubly good about reaching for convenient, tasty foods with high-quality ingredients while helping support organizations that improve the lives of children at the same time."
The Garlic Vinaigrette & Marinade is gluten-free and has no artificial flavors, preservatives, colors or high fructose corn syrup. Within the Stone-Fired Crust Pizza line, Margherita has no preservatives or artificial ingredients, Quattro Formaggi has no preservatives or artificial ingredients, and Spinaci & Formaggi has no artificial colors or flavors. Newman's Own Garlic Vinaigrette & Marinade and Stone-Fire Crust Pizza products are rolling out nationwide this summer with an SRP of $3.99 and $7.29, respectively. For additional information and to find products in a store near you, visit NewmansOwn.com or follow the brand on Instagram @NewmansOwn.
About Newman's Own Inc.
Newman's Own, Inc., founded by Paul Newman in 1982, offers great tasting, high-quality food and beverage products for people and pets. Products include salad dressings, pasta sauces, frozen pizza, salsa, refrigerated drinks, cookies, and popcorn as well as dog food, and dog treats. Newman's Own Inc. continues Paul Newman's founding commitment to "give it all away," with 100% of profits going to organizations that help children who face adversity through the Newman's Own Foundation.
View original content to download multimedia:
SOURCE Newman's Own, Inc. | https://www.mysuncoast.com/prnewswire/2022/05/31/newmans-own-inc-introduces-new-garlic-vinaigrette-amp-marinade-line-stone-fired-crust-pizzas-nationwide/ | 2022-05-31T15:15:05Z |
RadCrimp™ solar splice connector significantly improves crimp reliability in the field
ENDICOTT, N.Y., May 13, 2022 /PRNewswire/ -- Amphenol Industrial Sustainable Technologies, a global leader in interconnect systems, has partnered with Melni Technologies a global leader in electrical device design and manufacturing, to offer a "crimpless" butt splice solar connector that utilizes Melni's patented dual spiral technology to make secure, long-lasting connections. The RadCrimp™ solar splice connector was developed to significantly improve crimp reliability in the field while helping to reduce the amount of crimp related failures that are directly related to improper crimping, as well as incorrect mating issues between connector mismatched manufacturers.
Technical Specifications
- Uses Melni's dual spiral technology
- Used in new PV installations, field replacement and repairs, solar field retrofits
- No special crimp tools needed for field termination
- Eliminates the risk of cross mating different manufacturers connectors
- Certified to UL6703 for 1500V DC
- Current rating of 30A for 10AWG cable
- IP68 sealing protection
Reducing Failure in the Field
The RadCrimp is ideal for use in new solar PV installations, field retrofits and repairs, in solar installations and any other field terminations requiring a robust sealed power connection. The simple and fast termination eliminates the need for crimping and specialized crimp tools and can be safely installed by field technicians.
Melni's dual spiral technology, allows for a very quick, easy and long-lasting connection with a pull strength unparalleled by its competitors. The innovative RadCrimp connector is assembled by stripping the PV wires/cables, inserting them into the connector and tightening the connector end caps to the specified torque. Since the RadCrimp is a single connector, there is no risk of mating incompatible connectors from different manufacturers and violating UL 6703 requirements. The secure "crimpless" termination eliminates the risk of crimp related assembly failures in the field.
Certified to UL6703 for 1500V DC specifications, this robust solar connector has a current rating of 20A for 12AWG wire and 30A for 10AWG wire. There plans to release an approved product for 6 and 8 AWG sizes later this year.
For full news release and hi-res photo: https://bit.ly/RadCrimp_News
Contact: Joanna Puglisi-Barley
Phone: (215) 453-8700
E-mail: publicrelations@simongroup.com
View original content:
SOURCE Amphenol Industrial Sustainable Technologies | https://www.kxii.com/prnewswire/2022/05/13/amphenol-partners-with-melni-technologies-create-crimpless-solar-connector/ | 2022-05-13T19:50:30Z |
Passage Capital providing growing cash infusions to small events; Passage Digital NFT Collectibles announced
DETROIT, June 23, 2022 /PRNewswire/ -- Passage, a cutting-edge event ticketing company launched in Detroit in 2014, has reached 6 million ticket sales, serving more than 2 million customers, while tripling its revenue in the past three years. In 2019, Passage's revenue was $800,000 on ticket sales of $11.6 million rising to $2.4 million and $37.3 million in ticket sales by 2021; projected revenue for 2022 is at $4.5 million with $65 million in ticket sales. The company specializes in ticketing for small to medium-sized events, offering customized features to maximize sales for event organizers while keeping service fees low. Features include assigned seating, virtual queues, a 'pay what you want' price model, merchandise sales, season passes, subscriptions, concessions and NFT (non-fungible tokens) collectibles, allowing event organizers to use just one vendor instead of multiple vendors. This month also saw the launch of Digital NFT Collectibles, allowing event organizers to sell limited edition digital collectibles to their fans. Unlike other NFT collectibles, Passage Collectibles are focused on event experiences and can be redeemed for physical items, used for VIP access at events, and more. During the pandemic, the company launched Passage Capital, a program to provide cash-infusions to small events that were struggling with upfront costs. The program just reached $250K in cash-infusions and is on pace to make $500K capital-infusions in 2022. For company images and bios click here.
Much of Passage's success comes from the company's unique approach of building category-specific features, functionality and even branding for the event categories it works with. Passage is now the leading provider of haunted house tickets in the US, with over $80 million-worth of tickets sold under the brand HauntPay. Other client categories include sports, particularly semi-pro, minor leagues, and soccer league games; escape rooms; food and drink festivals; axe-throwing and Scottish Highland games. In March 2020, the company launched Passage Virtual Events allowing venues and fans to continue to connect, despite pandemic restrictions. The company has sold tickets for events in all 50 states and as far afield as Canada and Australia. Closer to home, Passage is the official ticketing partner of Detroit City FC. Earlier in 2022, the company partnered with FloSports, which provides live streaming for over 200,000 events every year.
"I am proud to have built a business with a global reach right here in Detroit. By helping thousands of events around the country, and even internationally, grow their own businesses, we're showing just how much of an impact Detroit can have on the world," said Passage CEO and Co-founder Alex Linebrink, a serial tech entrepreneur who has built multiple marketing and financial technology companies.
Passage was recently awarded one of the top 50 companies to watch in Michigan by Michigan Celebrates Small Businesses and the 89th fastest growing company in the Midwest by INC Magazine. Headquartered in Detroit's Hunt Street Station, home to one of the first police academies in the nation, Passage has 14 full time staff, up from four in 2019. Team members are located all around the US and overseas, including in Sri Lanka, the Philippines and Dubai.
Linebrink founded the company with Passage Chief Technical Officer Patrick Misch, a full stack engineer and mobile application developer. The success of Passage, according to Linebrink, is its ability to offer unique features to events so that they can grow their audience. "Through customized features they can't find anywhere else, we help our clients reach more fans and sell more tickets. On average a client that has been with us for two years or more doubles their sales," he explained.
The new Passage Digital NFT Collectibles have a variety of launch partners including Dangerous Pinups, created by a Hollywood actress and filmmaker, and a league-championship soccer team. Passage will also soon be introducing its own "Zombie Buddy" NFT Collectibles, which can be redeemed for a physical art piece or figurine commissioned from a horror artist.
For more information on Passage, go to gopassage.com.
Passage powers ticketing and payments for events and attractions. The all-in-one mobile box office technology allows owners and managers to take control of all their ticket, merchandise, and concession sales both online and at-the-door, all while reaching more fans and making more money. Since 2014, Passage, founded and headquartered in Downtown Detroit, has completed millions of dollars in ticket and product sales for thousands of events around the world. For more information about Passage, please visit gopassage.com.
Contact: Alison Schwartz
alison@ckcagency.com
M: (248) 214-1205
View original content to download multimedia:
SOURCE Passage | https://www.wibw.com/prnewswire/2022/06/23/passage-detroit-based-event-ticketing-company-triples-revenue-three-years-reaches-6-million-ticket-sales/ | 2022-06-23T13:24:57Z |
Asia's biggest celebrities put PITERA™ Essence to its boldest stress test yet
In the late hours of the night to capture Crystal Clear Skin, even when it's meant to be at its worst
TOKYO, July 13, 2022 /PRNewswire/ -- Would you dare to be photographed at your worst moment? With PITERA™ Essence, you will. Witness the living proof of Crystal Clear Skin, even when it's meant to be your worst moment, through SK-II's boldest PITERA™ stress test yet.
"Late Night Portraits" is SK-II's latest feat to showcase the power of its exclusive and iconic PITERA™ and PITERA™ Essence.
At the heart of SK-II, PITERA™ is a naturally derived skincare ingredient crafted from a proprietary yeast fermentation process that is exclusive to SK-II. PITERA™ Essence is SK-II's signature and most awarded best-seller globally. Containing over 90% PITERA™, it is nicknamed "Miracle Water" by millions of women from around the world for transforming skin to Crystal Clear Skin. Every 3 seconds, 1 bottle of PITERA™ Essence is sold in the world[1].
The "Late Night Portraits" campaign features a series of stunning photographs starring SK-II's beloved brand ambassadors including MINA of global girl group TWICE, Japanese actress Ayaka Miyoshi, Japanese comedian Naomi Watanabe as well as SK-II's longest-standing brand ambassador, Japanese actress Kaori Momoi, all courageously captured at their worst moment.
In this bold stress-test, celebrities had their skin prepped with nothing but PITERA™ for the shoot and were photographed bare skinned.
Unveiled at the first-ever World PITERA™ Day in Tokyo on July 13, 2022, SK-II's "Late Night Portraits" campaign is inspired by SK-II's latest first-in-the-world PITERA™ 24/7 Skin Fluctuation Study on the skin of young women. The breakthrough studies, conducted 24/7 for over six weeks, goes beyond SK-II's pioneering longitudinal skin research to uncover how women's skin condition-texture, pores, redness, dullness, hydration and barrier function fluctuates greatly within a day, even looking up to almost 10 years older due to multiple daily stressors.
The time of the day she's at her worst? Late at night. If daily skin fluctuations are not tackled, visible skin problems in the long-term will be accelerated due to an accumulation of these daily fluctuating skin concerns.
In SK-II's PITERA™ 24/7 Skin Fluctuation Study, SK-II discovered that after regular use of PITERA™ and a bottle of PITERA™ Essence as her skincare essential, her skin fluctuations are dramatically stabilized, and her skin transforms to Crystal Clear Skin. How is this possible?
PITERA™ by SK-II is welcomed in by skin like its own because PITERA™ has a unique composition that resembles skin's Natural Moisturizing Factors. This allows PITERA™ to be absorbed quickly and deeply* into skin delivering all its goodness of over 50 micronutrients. PITERA™ is the essential skincare ingredient proven to stabilize skin fluctuations and provide visible transformation to Crystal Clear Skin. Skin is transformed to Crystal Clear Skin even when it's meant to be her worst moment.
"It was an unusual experience to be photographed at night without makeup. But when the cameras started clicking, I felt at ease knowing that my skin fluctuations have been stabilized by PITERA™. I'm happy and impressed at how well my skin turned out, as even late at night, my skin remained Crystal Clear," said MINA.
"I was eager to participate in Late Night Portraits because I was curious about how well my skin would stand up to the test. My skin turned out radiant and truly looked its best even at my worst moment. I hope my Late Night Portrait will convince everyone to be more conscious of starting a skincare routine early," said Ayaka Miyoshi.
"What a bold and cool idea it was to do a bare skinned late night photoshoot. My skin fluctuates frequently during the day and I have noticed before that late night is my worst moment. However, with PITERA™, my skin stayed Crystal Clear and looked amazing," said Naomi Watanabe.
"I really like how SK-II is unafraid to push boundaries. The idea of putting our skin to the test with Late Night Portraits intrigued me and, as a long-time user of PITERA™ Essence, I felt confident about the condition of my skin even late at night," said Kaori Momoi.
"Late Night Portraits" builds on SK-II's growing collection of stories about its iconic PITERA™ and PITERA™ Essence. Through the years, SK-II has been on a journey to bring to life the legend of PITERA™ as well as stories of PITERA™ Essence and transformation to Crystal Clear Skin in new and meaningful ways for its consumers over generations. This started from authentic celebrity testimonials in its early days to bold challenges with 2017's "Face The Wild Face the Camera" with National Geographic, 2018's "Bare Skin Project" with Magnum Photos, an industry-first beauty entertainment web-series with 2019's "Bare Skin Chat" and "PITERA Masterclass", an iconic skincare campaign remake with 2021's "My Pitera™ Story", as well as 2022's "PITERA™ & Me", SK-II's first-ever self-directed film series by its newest Gen Z brand ambassadors.
"Our latest SK-II campaign "Late Night Portraits" builds on our iconic PITERA™'s legacy of miraculous skin transformation and is underpinned by our desire to solve one of the greatest skin frustrations and problems of our consumers—young women of today." shared Sue Kyung Lee, CEO, Global SK-II. "Based on our latest breakthrough study about the phenomenon of daily skin fluctuations in young women and the discovery of how she can look up to almost 10 years older within a day, we embarked on this bold stress-test to uncover the condition of PITERA™-powered skin in her worst moment. Inspired by our celebrity ambassadors' courage in stepping up to do a bare skinned photoshoot late at night, I did my own "Late Night Portrait" during World PITERA™ Day. With PITERA™ as the essential, I can personally testify that late-night Crystal Clear Skin is indeed possible."
"Late Night Portraits" by SK-II can be viewed here.
About SK-II
For more than 40 years, SK-II has touched the lives of millions of women around the world through skin and life transformation. The fascinating story behind SK-II began with a quest to understand why elderly sake brewers had wrinkled faces, but extraordinarily soft and youthful-looking hands. These hands were in constant contact with the sake fermentation process. It took years of research for scientists to isolate SK-II's iconic ingredient PITERA™, a naturally-derived skincare ingredient crafted from a proprietary yeast fermentation process exclusive to SK-II. Since then, SK-II with PITERA™ has become a special secret shared by celebrities all over the world such as Chloe Grace Moretz, Simone Biles, Tangwei, Chun Xia, Haruka Ayase and Kasumi Arimura and Naomi Watanabe. For the latest news and in-depth information, please visit http://www.sk-ii.com.
About PITERA™
Iconic and exclusive to SK-II, PITERA™ is a naturally derived "miracle" skincare ingredient crafted from a proprietary yeast fermentation process that only SK-II owns. Packed with over 50 micro-nutrients – vitamins, amino acids, minerals and organic acids – the unique composition of PITERA™ harnesses the vital force of nature and is one that can't be achieved artificially or synthetically. PITERA™ resembles skin's Natural Moisturizing Factors. Skin recognizes and welcomes it, allowing it to be absorbed quickly and deeply into your skin delivering all goodness.
[1] Based on past 12-month FTE sales data worldwide, as of 30-Jun-2021
View original content to download multimedia:
SOURCE SK-II | https://www.kxii.com/prnewswire/2022/07/13/sk-ii-premieres-late-night-portraits-powered-by-pitera/ | 2022-07-13T23:41:59Z |
Area actors are ready to break a leg as events coming up this weekend include the “Salado Legends” outdoor musical and “Guys and Dolls” in Temple. Other upcoming events include an Elvis tribute show in Belton, a “Luck of the Lake” poker run fundraiser on Lake Belton, live music and more.
‘Salado Legends’
The Tablerock Festival of Salado will present performances of its annual “Salado Legends” outdoor musical starting this Saturday.
Performances will be offered at 8:15 p.m. on July 23, July 30 and Aug. 6.
Tickets may be purchased on www.centraltexastickets.com and cost $25 for adults, $10 for students and $5 for children age 12 and younger. Tickets for a meal served before the show at 7:15 p.m. are available for an additional $13.
Written by Salado resident playwright Jackie Mills, the musical blends accounts of Salado’s history and fictional storytelling to depict life in Texas in the 1850s.
The amphitheater is located at 409 Table Rock Road in Salado.
‘Guys and Dolls’
The Temple Civic Theatre, 2413 S. 13th St. in Temple, will present performances of “Guys and Dolls” this weekend. Shows will be offered at 7:30 p.m. Saturday and Sunday and 2:30 p.m. on Sunday.
Set in Damon Runyon’s mythical New York City, “Guys and Dolls” is an oddball romantic comedy. The plot follows Nathan Detroit, a gambler, as he tries to find the cash to set up the biggest craps game in town while the authorities breathe down his neck. Meanwhile, his girlfriend and nightclub performer, Adelaide, laments that they’ve been engaged for 14 years. Nathan turns to fellow gambler, Sky Masterson, for the dough, and Sky ends up chasing the straight-laced missionary, Sarah Brown, as a result. “Guys and Dolls” takes us from the heart of Times Square to the cafes of Havana, Cuba, and even into the sewers of New York City, but eventually everyone ends up right where they belong.
Tickets are $20 for adults and $12 for students and may be purchased online at templecivictheatre.com. The show also will be offered July 28-30 and the final showings will be Aug. 5-7.
Gospel event
First Cedar Valley Baptist Church, 12237 FM 2843 in Salado, is once again holding its fourth Friday gospel singing event at 7 p.m. on Friday.
The public is invited to worship and sing with the church.
The event will take place in the church’s temporary building. “The acoustics aren’t the best, but God knows our hearts and our voices are to be used for Him,” Linda Jackson, event organizer, said.
Those who attend are encouraged to bring a dish to share. The church will provide water and soda.
Lecture series
Barrow Brewing Company, 108 Royal St. in Salado, is hosting a free summer lecture series at 2 p.m. on Sundays.
This Sunday’s guest speaker will be Chris Coffey and the topic will be the pre-1840 Rocky Mountain fur trade.
Minority mental health awareness workshop
July is minority mental health awareness month and the Temple Unit NAACP is sponsoring a minority mental health awareness workshop 1-3 p.m. on Saturday at the Wheatley Alternative Education Center, 515 E. Ave. D in Temple.
The event will include a discussion on mental health topics such as post-traumatic stress disorder, anxiety, depression, and substance abuse.
Panelists will include Vincent Robinson, a licensed master social worker; Melee Munoz, a licensed professional counselor; and Dr. Kerry-Ann Zamore Byrd, who holds a doctorate of social work and is a licensed clinical social worker. A Spanish translator will be on site.
The event is free and open to the public. For information email Caleeah Curley at caleeahrn@yahoo.com.
Comedy show
The “PG-13 Backyard Comedy Show” will take place 8 p.m. Friday at FoxDog beer garden and coffee shop, 209 N. Seventh St. in Temple.
Alex Cunningham will host the show, which will feature performances from Tania Morales, James Garibay, Justin Moreno, and Connor King II.
The show is free and open to the public.
‘Eras of Elvis’
The Beltonian Theatre, 219 E. Central Ave. in Belton, will host “Eras of Elvis,” a show highlighting three eras of the King of rock n’ roll, at 6 p.m. on Saturday. Three award-winning Elvis tribute artists, Hunter Cole, Travis Hudson, and John Cobb, will perform live on stage.
“‘Eras of Elvis’ will take you on a journey from Elvis early hits of the 1950s, to the leather wearing ‘68 comeback special, and all the way to the later iconic jumpsuit wearing days of the 1970s” the Beltonian Theater said in a post on social media.
The three tribute artists also will perform at the theater again at 3 p.m. on Sunday. The show, titled “For the Love of Gospel,” will feature love songs and gospel favorites of Elvis.
Tickets to both performances are $20 each and may be purchased online at thebeltoniantheatre.com.
Morgan’s Point Resort summer reading program
The city of Morgan’s Point Resort is now registering children for its annual summer reading program.
The theme will be “Serving Your Community” and the program will take place from 10 a.m. to noon July 23, July 30, Aug. 6 and Aug. 13 at the Mary Ruth Briggs Library, 8 Morgan’s Point Boulevard.
The free summer reading program will offer free backpacks and school supplies to participants. Registration may be completed in person at the City Hall lobby or online at morganspointresorttx.com.
‘Through My Eyes’ art show
Nonprofit Feed My Sheep is hosting “Through My Eyes,” an art exhibit showcasing the diverse population of the Temple area, 6-8 p.m. Wednesday, July 27, and Thursday, July 28, at The Loft event center, 7 S. Second St. in Temple.
The art show will feature artists of all ages and mediums.
Organizer Jeff Stegall, executive director of Feed My Sheep, said he hopes the artwork submitted for the show lets attendees get to know another side of the city that they might not normally see.
Live music
The Temple Parks and Recreation Department will continue its “Hot Summer Sounds” free outdoor concert series with a performance by the Hair Metal Giants at 7:30 p.m. Friday at the Santa Fe Plaza, 301 W. Ave. A in downtown Temple. Those who attend are advised to bring their own lawn chairs.
Out of the Blue will perform at a country and western dance 6:30 p.m. Thursday at the Belton Senior Activity Center, 842 Mitchell St. in Belton. Cost is $5 per person and attendees are encouraged to bring a covered dish to share.
Emanuel J and DJ Oz will perform 8 p.m. Saturday at VFW Post No. 3892, 201 VFW Drive in Harker Heights.
Martian Folk will perform 8 p.m. Friday, Smokin Maxx will perform 8 p.m. Saturday and Ryan Youmans will perform 4 p.m. Sunday at Barrow Brewing Company, 108 Royal St. in Salado.
Jon Austin and Mojo Filter will perform 6 p.m. Friday and Martian Folk will perform 6 p.m. Saturday at Fire Street Pizza, 10310 FM 439 in Belton.
Fundraisers
Luck of the Lake Poker Run
Luck of the Lake Poker Run, an event benefitting the Central Texas Children’s Center, will take place Saturday on Lake Belton.
The event will kick off with a party Friday night at Schoepf’s BBQ, 702 E. Central Ave. in Belton, with live music featuring The Great Divide and special guest Joey Green.
The “poker run” will start at 10 a.m. on Saturday at North Point Yacht Club on Lake Belton. During the event, participants will travel to different locations around the lake to obtain a poker chip at each stop. While out on the lake, participants will need to keep a lookout for rubber duckies floating on the loose for extra chances at prizes. Participants will tie up at North Point Yacht Club at the end of the run for live music by Fenix Theory, and for food, fun and prizes.
Registration and information is available on eventbrite.com.
Salado Golf Tournament
The Salado Chamber of Commerce announced the annual Salado Golf Tournament, which benefits community projects and charities, will take place on Oct. 18 at Mill Creek Country Club
The event will start at 9:30 a.m. with registration at the Mill Creek Clubhouse. Activities will include a $50,000 putting challenge at 10:30 a.m. and a helicopter ball drop at 11:30 a.m. Participants may enter the drawing for the helicopter ball drop with the purchase of tickets (one ticket for $10 or five for $20). The tournament will begin with a shotgun start at noon.
Registration costs $125 for single players or $400 for four players. Participants may register in advance online at www.salado.com/signature-events.
Submission guidelines: Weekend events and fundraisers may be submitted by emailing living@tdtnews.com. All items are due by noon Monday. | https://www.tdtnews.com/entertainment/article_1b8148d2-0838-11ed-8caf-bf0ed41262c2.html | 2022-07-21T09:42:38Z |
NEW YORK, July 27, 2022 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Silverback Therapeutics, Inc. (SBTX), relating to its proposed merger with ARS Pharmaceuticals, Inc. Under the terms of the agreement, SBTX equity holders are expected to own approximately 37% of the combined company. Click here for more information: https://www.monteverdelaw.com/case/silverback-therapeutics-inc. It is free and there is no cost or obligation to you.
We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing. We were listed in the Top 50 in the 2018-2021 ISS Securities Class Action Services Report. Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions. Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2021 Top Rated Lawyer. Our firm's recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases.
If you own common stock in SBTX and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.
Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341
Attorney Advertising. (C) 2022 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.
View original content to download multimedia:
SOURCE Monteverde & Associates PC | https://www.wibw.com/prnewswire/2022/07/27/shareholder-alert-mampa-class-action-firm-announces-investigation-silverback-therapeutics-inc-sbtx/ | 2022-07-27T23:12:13Z |
A North American leading city builder further demonstrates its commitment to enhancing neighbourhoods across the GTA with the introduction of a new collection of housing development projects
TORONTO, Sept. 14, 2022 /PRNewswire/ - Vandyk Properties, a North American leading city builder in real estate development and investments, unveils today The Legacy CollectionTM. Paying homage to the company's roots and commitment to constant evolution, The Legacy Collection consists of carefully curated communities, with a mix of townhomes, semi-detached, and single-family homes with design-forward thinking and life-inspiring interiors in prime GTA locations. Three projects under this collection are anticipated to be unveiled this fall through 2023, further supporting the company's commitment to creating interconnected, family oriented, sustainable and forward-thinking communities.
"Vandyk Properties' roots are in creating ground-related premium communities; it's where we began," says John Vandyk, President & CEO of Vandyk Properties. "Our Legacy Collection pays respect to just that - our beginnings and an exciting development offering that we're bringing back with the goal of re-inspiring neighbourhoods across the GTA."
The Legacy Collection offers new housing opportunities to a growing GTA population. All developments within this collection are optimally situated and located in already established neighbourhoods, allowing the opportunity for families to set their roots by investing in a community for years to come. The first project within the collection, The Ravine is set to be unveiled in Mississauga this fall, a residential development located in the picturesque neighbourhood of Meadowvale Village.
The Ravine is a community comprised of 37 luxury detached homes, on permit-ready freehold lots backing onto Fletcher's Creek. The detached homes will feature up to five bedrooms and up to 4,000 square feet of living space as well as finished ground level spaces with separate entrances offering flexibility to a variety of families lifestyles. This exclusive enclave community will be located south of Derry Road West, between McLaughlin Road and Hurontario Street, in the highly desirable Meadowvale Village Neighborhood. This affluent residential community will be in close proximity to prime amenities, including excellent academic schools, modern conveniences and major highways and roads.
Having already established a track record of success in being one of the best-in-class real estate operators in North America, Vandyk Properties seeks to continue to be a leader within the category of residential property development.
For further information about The Ravine, register for updates and launch details at www.vandyk.com/theravine.
If you would like to be notified about future communities under The Legacy CollectionTM register at www.vandyk.com/legacycollection.
Vandyk Properties is a privately owned real estate development and investment management company with over 40 years of expertise in the North American real estate property sector. As real estate development experts, Vandyk is committed to creating sustainable neighbourhoods, comprehensively considering each project as a reinvestment within the community. As an investment management company, the company's diversified real estate operations are focussed on strategic growth; building long-term relationships with investors while carefully curating a first-class real estate portfolio representing $1 billion in completed value creation and $4.5 billion in owned assets under development.
For more information about Vandyk Properties, visit vandyk.com
View original content to download multimedia:
SOURCE VANDYK Properties | https://www.kxii.com/prnewswire/2022/09/14/vandyk-properties-unveils-legacy-collection/ | 2022-09-14T13:08:21Z |
Acquisition provides Company with new platform that complements existing ready-to-drink alcohol portfolio and non-alcohol business in Canada
BURLINGTON, Mass. and FRISCO, Texas, June 23, 2022 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ: KDP) announced today a definitive agreement to acquire the global rights to the non-alcoholic, ready-to-drink cocktail brand Atypique from Station Agro-Biotech, a Quebec-based company that specializes in the manufacturing and marketing of alcoholic and non-alcoholic beverages. Terms of the deal, which is expected to close in early Q4, were not disclosed.
Atypique is a highly unique offering in the emerging and fast-growing non-alcohol cocktail segment, providing a range of ready-to-drink cocktails, such as margaritas, gin & tonic and mojitos. In Canada, non-alcoholic cocktails grew more than 30 percent in retail dollar sales during the last year, and Atypique now has a 42 percent market share of that segment, where it is distributed.
The agreement includes a multi-year collaboration between the two companies to fuel accelerated growth for Atypique, leveraging Station Agro-Biotech's R&D expertise in the category and KDP's robust sales and distribution network.
"At Keurig Dr Pepper, we strongly believe in innovation to drive growth to meet the evolving beverage needs of consumers," said Ozan Dokmecioglu, CFO & President of International. "We are excited to add this new platform to our powerful portfolio in Canada, and the global rights to Atypique provides optionality to further expand the brand's growth potential." Olivier Lemire, President of Keurig Dr Pepper Canada, added, "Atypique is a great complement to our successful ready-to-drink alcohol portfolio, and we look forward to continue innovating around this brand to drive accelerated growth."
"We were looking for the best way to bring Atypique to the next level. This agreement represents an exceptional opportunity to work with a beverage industry leader, and Keurig Dr Pepper will bring market knowledge and strength to the Atypique brand," said Jonathan Robin, President, Station Agro-Biotech. "At the same time, we are delighted to have the opportunity to keep growing and innovating within a category in full effervescence and have more time to spend doing R&D in the broader beverage space."
Étienne Boulay, cofounder of Atypique, ex-Canadian star football player, TV and radio host added, "Atypique is meant to push the limits of the ready-to-drink industry by offering outside-the-box, beyond-the-normal-standard products, and this collaboration will allow the brand to continue to do just that. I can't wait to see where this will take Atypique."
About Keurig Dr Pepper
Keurig Dr Pepper (KDP) is a leading beverage company in North America, with annual revenue approaching $13 billion and approximately 27,000 employees. KDP holds leadership positions in soft drinks, specialty coffee and tea, water, juice and juice drinks and mixers, and markets the #1 single serve coffee brewing system in the U.S. and Canada. The Company's portfolio of more than 125 owned, licensed and partner brands is designed to satisfy virtually any consumer need, any time, and includes Keurig®, Dr Pepper®, Green Mountain Coffee Roasters®, Canada Dry®, Snapple®, Bai®, Mott's®, CORE® and The Original Donut Shop®. Through its powerful sales and distribution network, KDP can deliver its portfolio of hot and cold beverages to nearly every point of purchase for consumers. The Company is committed to sourcing, producing and distributing its beverages responsibly through its Drink Well. Do Good. corporate responsibility platform, including efforts around circular packaging, efficient natural resource use and supply chain sustainability. For more information, visit www.keurigdrpepper.com.
About Station Agro-Biotech
Located in the heart of the Saint-Hyacinthe Agri-Food Technopole, Station Agro-Biotech specializes in the manufacturing and marketing of alcoholic and non-alcoholic beverages. It has its own laboratory dedicated to research and development and focuses on innovation during the creation process.
The Station Agro-Biotech brings together several companies under one roof, including the Noroi distillery, the Le Bilboquet microbrewery and Atypique non-alcoholic beverages.
Distributed in more than 3,000 food stores across Quebec, the various products can be found on the shelves of grocery stores, specialty stores, convenience stores and at the SAQ. The company founded in 2019 is also developing its marketing outside Quebec. To learn more about Station Agro-Biotech: stationabt.com
Learn more about Atypique here: lesbreuvagesatypique.com | Instagram | Facebook | YouTube
CONTACT:
Katie Gilroy
Keurig Dr Pepper
781-418-3345
katie.gilroy@kdrp.com
View original content to download multimedia:
SOURCE Keurig Dr Pepper Inc. | https://www.mysuncoast.com/prnewswire/2022/06/23/keurig-dr-pepper-acquire-global-rights-non-alcoholic-brand-atypique/ | 2022-06-23T19:00:50Z |
Award recognizes the most ambitious leaders who are building and sustaining successful, dynamic businesses around the world.
PHILADELPHIA, June 27, 2022 /PRNewswire/ -- Carisma Therapeutics, a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that Steven Kelly, President and CEO, has been named Ernst & Young (EY) Entrepreneur of the Year® 2022 Greater Philadelphia Award Winner.
Steven was selected by a panel of independent judges for his work leading Carisma Therapeutics and joins an esteemed multi-industry community of likeminded entrepreneurs who have driven their companies' success, transformed their industries, and made a positive impact on their employees and communities.
"I am honored to be selected for this illustrious award and am proud of the entire Carisma team's incredible efforts towards meaningful scientific innovations in immunotherapy that made this possible," said Steven Kelly, President and CEO. "The opportunity to deliver potentially game changing cell therapies to patients with hard-to-treat cancers and other serious illnesses is what drives us, and we continue to dedicate ourselves to improving the lives of patients and their families."
For over 35 years, EY US has celebrated the unstoppable entrepreneurs who are building a more equitable, sustainable and prosperous world for all. The Entrepreneur of the Year program has recognized more than 10,000 US executives since its inception in 1986. Entrepreneur of the Year Award winners have exclusive, ongoing access to the experience, insight and wisdom of fellow alumni and other members of the entrepreneurial community in over 60 countries — all supported by vast EY resources.
As a Greater Philadelphia award winner, Kelly is now eligible for consideration for the Entrepreneur of the Year® 2022 National Awards.
Carisma Therapeutics Inc. is a biopharmaceutical company dedicated to developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania, are autologous chimeric antigen receptor (CAR)-macrophages for the treatment of solid tumors. Carisma Therapeutics is headquartered in Philadelphia, PA.
For more information, please visit www.carismatx.com
Entrepreneur Of The Year is the world's most prestigious business awards program for unstoppable entrepreneurs. These visionary leaders deliver innovation, growth and prosperity that transform our world. The program engages entrepreneurs with insights and experiences that foster growth. It connects them with their peers to strengthen entrepreneurship around the world. Entrepreneur Of The Year is the first and only truly global awards program of its kind.
Carisma Media Contact:
Julia Stern
(763) 350-5223
jstern@realchemistry.com
View original content to download multimedia:
SOURCE Carisma Therapeutics Inc. | https://www.wibw.com/prnewswire/2022/06/27/steven-kelly-president-ceo-carisma-therapeutics-named-ernst-amp-young-entrepreneur-year-2022-greater-philadelphia/ | 2022-06-27T18:35:43Z |
FARMINGTON, Conn., July 11, 2022 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries, announced today it closed a $45 million venture loan facility to Swift Health Systems, Inc. (dba InBrace) ("InBrace"), of which Horizon funded $7 million of the initial $10 million draw, and a private investment vehicle managed by Horizon Technology Finance Management LLC, Horizon's advisor, funded $3 million.
InBrace is the orthodontic company behind the Smartwire®, transforming the teeth straightening process and markedly improving the patient experience. The InBrace Smartwire is fit behind teeth by an orthodontist, making treatment completely hidden so that patients can share their improving smile as teeth are straightening in real time. The InBrace Smartwire is created from shape memory alloy that continually moves teeth into place using Gentleforce® technology. InBrace works like autopilot and doesn't require the painful monthly tightenings of braces or the tray changes and lifestyle inconvenience of plastic aligners. InBrace is backed by a consortium of well-known investors including: Vivo Capital, Endeavour Vision Ltd, Farallon Capital Management, Marshall Wace, MVM, Novo Holdings, RTW Investments, L.P., Soleus Capital, and venBio Partners LLC. The company will use the loan proceeds for general growth and working capital purposes.
"InBrace is disrupting the $40+ billion orthodontic market, offering completely hidden teeth straightening treatment that significantly reduces treatment time while allowing patients to eat, drink, brush and floss like they can when not in treatment," said Gerald A. Michaud, President of Horizon. "We are excited to work with InBrace as the company expands its offerings and uses its technology to grow and revolutionize the orthodontics industry."
"We welcome Horizon's support as we continue to change the way people think about teeth straightening," said Clint Carnell, Chief Executive Officer of InBrace. "InBrace patients get expert orthodontic care with just a few check-in appointments and without the lifestyle compromises of dated offerings. Best of all, with InBrace, patients don't have to look worse before they look better. The process is simple, InBrace takes the Toothprint™ of a patient who then co-designs their ideal smile with an InBrace provider. Then InBrace programs the Smartwire that's fitted behind teeth. It's a win-win for both providers and patients and we are excited to expand throughout North America."
Horizon Technology Finance Corporation (NASDAQ: HRZN) is a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries. The investment objective of HRZN is to maximize its investment portfolio's return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. Horizon Technology Finance Management LLC is headquartered in Farmington, Connecticut, with a regional office in Pleasanton, California, and investment professionals located in Portland, Maine, Austin, Texas, and Reston, Virginia. To learn more, please visit horizontechfinance.com.
InBrace was invented and founded by Drs. John Pham and Hongsheng Tong who set out to find a healthier and more efficient teeth straightening system to treat children with severe cleft lip and palate, which led them to partner with USC and Children's Hospital Los Angeles. InBrace filed the first application patent of its extensive patent portfolio in 2012.
InBrace is revolutionizing teeth straightening with a personalized Smartwire® that is designed using each patient's unique Toothprint™. The set it and forget it technology puts the orthodontic experience on autopilot; with treatment that's completely hidden from the world and which requires less work for patients and clinicians. Designed for you. Made for real life ™. InBrace is headquartered in Irvine, CA. For more information visit InBrace.com, LinkedIn, Instagram, or Facebook.
Statements included herein may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in the Company's filings with the Securities and Exchange Commission. Horizon undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.
Investor Relations:
ICR
Garrett Edson
ir@horizontechfinance.com
(860) 284-6450
Media Relations:
ICR
Chris Gillick
HorizonPR@icrinc.com
(646) 677-1819
View original content:
SOURCE Horizon Technology Finance Corporation | https://www.mysuncoast.com/prnewswire/2022/07/11/horizon-technology-finance-leads-45-million-venture-loan-facility-inbrace/ | 2022-07-11T22:22:12Z |
DeSantis vows Florida will allow people to carry firearms without permits ‘before I am done as governor’
By Steve Contorno, CNN
Gov. Ron DeSantis vowed on Friday that he would make Florida a so-called constitutional carry state, which would allow people to publicly carry firearms without permits.
“The legislature will get it done,” DeSantis said during a news conference in north Florida. “I can’t tell you if it’s going to be next week or six months, but I can tell you that before I am done as governor, we will have a signature on that.”
In Florida, people must obtain concealed weapon permits in order to carry hidden guns in public. About 2.5 million people have permits, more than any other state where they are required. The permit can be obtained by taking a gun training course and submitting proof of competency. In most cases, gun owners in Florida cannot openly carry firearms without permits, either, except in certain circumstances, like while hunting.
For DeSantis, successfully ushering a constitutional carry measure into law would be another conservative victory as he builds a resume that could appeal to Republican primary voters if he decides to run for president. He has already taken on several other issues of importance to his base, including a 15-week abortion ban and championing several measures the LGBTQ community has called anti-transgender, such as a prohibition on transgender girls and women competing in female scholastic sports.
“We used to be a leader on the Second Amendment,” said DeSantis, who is up for reelection in November.
Gun rights advocates have long pushed to make Florida, already one of the most gun-friendly states in the country, a constitutional carry state. But they have been unsuccessful in convincing Republican leaders who have held power in Tallahassee for two decades to lift one of the few limitations on gun ownership here. Earlier this year, a bill to allow for the constitutional carry of weapons died without any committee hearings.
DeSantis laid the urgency to pass a constitutional carry provision at the feet of state Agriculture Commissioner Nikki Fried, a Democrat and the head of the office that manages weapons permits in Florida. DeSantis asserted that Fried “doesn’t support Second Amendment rights.”
“So why would you want to subcontract out your constitutional rights to a public official that rejects the very existence of those rights,” DeSantis said.
The Department of Agriculture and Consumer Services’ stewardship of gun permits is a unique arrangement once championed by the National Rifle Association. At the time, the office was controlled by a Republican.
Fried, who is not running for reelection and is instead seeking her party’s nomination to take on DeSantis in November, has supported lawful gun ownership and has sued the Biden administration for denying federal firearm permits to those who use medical marijuana. Since she took office in 2019, her office has approved nearly 500,000 new permits to carry concealed weapons.
“I’m a gun owner and concealed weapons license holder,” Fried declared in a 2019 op-ed.
Fried has also called on DeSantis to lift a state ban on local governments passing gun ordinances, which would allow communities to decide if they wanted to limit ownership of assault-style weapons and high-capacity magazines. She has suspended the licenses of people charged with crimes related to the January 6, 2021, attack on the US Capitol, a move she noted Friday on Twitter: “I just suspended seven more Florida licenses held by January 6th insurrectionists.”
Responding to DeSantis’ announcement on Twitter, US Rep. Charlie Crist, also running for governor as a Democrat, said, “The last thing Florida needs during a gun violence epidemic is a governor who wants dangerous people carrying guns on the street without so much as a background check.”
Republican lawmakers have broached gun issues cautiously of late in Florida, the site of a deadly 2018 mass shooting at a high school in Parkland. After the massacre, which left 17 students and staff dead, Republicans and Democrats united to raise the age requirement to purchase a rifle or shotgun to 21 and to enact a so-called red flag law, which allows a court to temporarily remove firearms from someone perceived as a threat. The combined measures were signed into law by then-Gov. Rick Scott, a Republican.
But DeSantis criticized the law as a candidate in 2018, saying he would have vetoed it if it had reached his desk. Calling himself a “big Second Amendment guy,” he also backed allowing firearms on college campuses.
Gun politics loomed large that year in DeSantis’ primary, where he faced Agriculture Commissioner Adam Putnam, who campaigned as a self-described “Proud NRA sellout.” Putnam’s oversight of concealed weapons permits became a dominating issue in the race after reports emerged that his office had failed for more than a year to conduct background checks on some permit applications. Putnam’s office improperly gave gun licenses to hundreds of people that later had to be revoked.
Though DeSantis has voiced support for constitutional carry in the past, Friday’s declaration was his most vocal assurance to gun rights groups that he intends to make it a priority. If it’s approved, Florida would become the second-largest state to allow permitless concealed carry of guns. Texas Gov. Greg Abbot signed a bill last year that allows people to carry guns most places without licenses or safety training.
A permit is not required to carry a handgun in 23 states, according to the National Conference of State Legislatures.
DeSantis has already called for lawmakers to return to the state Capitol in May for a special session focused on a property insurance crisis, and he could force the Legislature to consider constitutional carry legislation then.
The-CNN-Wire
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved. | https://localnews8.com/politics/cnn-us-politics/2022/04/29/desantis-vows-florida-will-allow-people-to-carry-firearms-without-permits-before-i-am-done-as-governor/ | 2022-04-29T22:43:21Z |
Sarasota County School District thriving even with a shortage
SARASOTA, Fla. (WWSB) - With teacher shortages plaguing Florida, Districts like Sarasota County Schools are also feeling that strain. However, some of that was by design.
According to Superintendent Brennan Asplen, the district decided to add positions to help with reading, intervention services, and to decrease the teacher to student ratio. Even though the additions were for the better, he says if they hadn’t have added those positions, they wouldn’t be in a shortage.
“In an effort to have more teachers in front of students to reduce the class size ratio, we have 150 positions we included in our budget to be hired,” Asplen said. “With that, even though we’ve hired 700, and we still have around 80 to fill, if we hadn’t added those on we’d be full right now.”
In the meantime, the district has been utilizing substitute teachers to fill those gaps until the positions are filled. He said, they have over 1,200 substitutes and have a fill rate between 90 and 97%.
However, not just anybody can sign up to be a sub. In years past they required at least a bachelors degree. Now, they’ve lowered it to an associates to allow more opportunities.
“You would sign up with us if you wanted to be a substitute teacher,” said Asplen. “We put you on the list, we do background checks and everything, and then train you as far as what we want done.”
But it isn’t just teachers they’re looking to hire. They’re currently looking to hire 30 custodians, 20 food and service workers, and a few more bus drivers.
The Sarasota County School District will be having a job fair to fill all of their openings on September, 16th at the Landings location.
Copyright 2022 WWSB. All rights reserved. | https://www.mysuncoast.com/2022/08/31/sarasota-county-school-district-thriving-even-with-shortage/ | 2022-08-31T23:34:50Z |
Which bed tray is best?
A bed tray often evokes the image of bringing someone breakfast in bed on a special day, but a bed tray can have a place in everyday life. Bed trays are useful when you are feeling under the weather, when you’re injured or when you just want to relax in comfort.
A bed tray needs to be sturdy to avoid unnecessary spills and function to keep everything organized while you are lying in bed. Bed trays are good for holding television remotes, books, pen and paper, glasses and other small objects. You also can use a bed tray to hold up a laptop, tablet or book to a comfortable reading angle while in bed.
If you’re looking for a versatile bed tray, our top choice is the SONGMICS Bamboo Bed Tray, for its aesthetically pleasing design and ventilation holes.
What to know before you buy a bed tray
Stability
Stability is a big consideration. You don’t want everything on top of the tray to go flying across your bed and possibly spill if a leg collapses. The ideal bed tray has legs that lock in place with a sturdy latching mechanism if they are foldable.
Finding the right size bed tray is important. If it’s too big, it might be unwieldy and hard to use. Figuring out the best size for your bed tray needs is key. Decide what the bed tray will hold most frequently to determine the best bed tray size.
Portability
Bed trays are not exclusively meant to be used in bed. You can use one while sitting on the couch, on the floor or even while traveling. A lighter weight correlates to better portability.
What to look for in a quality bed tray
Flip-up top
A flip-up top is a useful feature. The tilting function can enable someone whose range of motion is limited to get more use out of the bed tray. This helps for books or tablets to be visible when the user is not able to sit up completely or move their body. Flip-up tops can be useful for anyone and are an optional feature on a bed tray.
Storage
Whether it’s a built-in cup holder or a small drawer underneath the bed tray, storage can be a necessity or a nice additional feature. Small drawers are mostly equipped to hold items like a pen, a small pad of paper and perhaps a charger cord. A cup holder is ideal for someone using electronics on the bed tray because it will keep any liquids from sloshing around.
Foldability
If the bed tray has legs you can’t fold, it’s harder to find a place to store it. Legs that can fold up or down make the bed tray more functional when it is in use, depending on how the person using the bed tray is situated.
Materials
A bed tray can be made from wood, metal, plastic or a combination of any of these materials. What the bed tray is made of will determine the cost of the tray.
How much you can expect to spend on a bed tray
Bed trays range from $20 to $60, depending on the material and features. The more features, the more the cost may be. Most bed trays are in the $30 range, making them an affordable way to incorporate better ergonomics into your life.
Bed tray FAQ
Does a bed tray need ventilation holes to keep your laptop cool?
A. Ventilation holes help but are not necessary to keep most laptops cool enough to operate.
How do bed trays hold up to spills?
A. Depending on the bed tray’s finish, it can handle being spilled on occasionally. Use a wet rag to wipe it clean, and use a dry cloth to remove any residual moisture to keep your bed tray in good condition.
What’s the best bed tray to buy?
Top bed tray
What you need to know: This lightweight tray with a tilting top and ventilation holes is perfect for holding laptops, books and more.
What you’ll love: The ventilation holes improve airflow for a laptop.
What you should consider: Small items can fall through the ventilation holes.
Where to buy: Sold by Amazon
Top bed tray for the money
Winsome Wood Breakfast Bed Tray
What you need to know: This no-frills bed tray has foldable legs, a wide lip to keep items from falling off the edges and a plain but pleasing design.
What you’ll love: This is one of the least expensive bed trays available, but it is sturdy.
What you should consider: The lip around the perimeter of the tray may limit the size of items you can place on it.
Where to buy: Sold by Amazon
Worth checking out
SAIJI Adjustable Laptop Stand for Bed
What you need to know: This space-age-looking bed tray has all the bells and whistles, such as a small drawer, tilting top and ergonomic armrest.
What you’ll love: This bed tray was designed for the laptop user, with ergonomics and convenience in mind.
What you should consider: This is one of the priciest bed trays available, and it is quite large.
Where to buy: Sold by Amazon
Want to shop the best products at the best prices? Check out Daily Deals from BestReviews.
Sign up here to receive the BestReviews weekly newsletter for useful advice on new products and noteworthy deals.
April Blake writes for BestReviews. BestReviews has helped millions of consumers simplify their purchasing decisions, saving them time and money.
Copyright 2022 BestReviews, a Nexstar company. All rights reserved. | https://cw33.com/reviews/br/home-br/storage-organization-br/best-bed-tray/ | 2022-06-26T12:28:40Z |
Flight passenger fined nearly $1,900 after McMuffins found in luggage
Published: Aug. 1, 2022 at 3:47 PM CDT|Updated: 5 minutes ago
(CNN) – A hungry traveler may have just paid for the most expensive McDonald’s breakfast ever.
The passenger traveling from Indonesia to Australia is being fined $1,874 for leaving two undeclared egg and beef sausage McMuffins and a ham croissant in their luggage.
A biosecurity dog sniffed out the sandwiches, which were then sent to be tested for foot and mouth disease.
Before this incident, Australian authorities introduced new biosecurity rules after a foot and mouth disease outbreak in Indonesia spread to Bali.
Copyright 2022 CNN Newsource. All rights reserved. | https://www.kxii.com/2022/08/01/flight-passenger-fined-nearly-1900-after-mcmuffins-found-luggage/ | 2022-08-01T20:54:42Z |
GOLETA, Calif., July 13, 2022 /PRNewswire/ -- Teva®, a division of Deckers Brands (NYSE: DECK), is thrilled to announce the release of its collaboration with eyewear designers and DJ twins, Coco and Breezy, consisting of sandals and sunglasses made with earth-conscious materials and available in all-gender sizing. The collection of outdoor fashion essentials makes its debut just in time for summer and celebrates self-expression and the freedom to explore.
The Teva x Coco and Breezy capsule collection features a reimagined Hurricane XLT2 sandal made with premium materials. This silhouette is elevated with design details like transparent outsoles and gold buckles to take wearers from the streets to the trails. Available in earth tones with inclusive sizing for adults and kids, the footwear is made with full grain leather in the heel and anchor points with premium leather Coco and Breezy patches, breathable mesh footstraps, and luxe suede details that seamlessly blend fashion and function.
"Teva was built on a foundation of creativity and freedom to explore. We inspire those who crave experiences and connections, in whatever form they take. Through our collaboration with Coco and Breezy, and as brands who value inclusion in the outdoors and celebrate expression through personal style, we wanted to design a collection of summer essentials that elevate your adventures, no matter where they bring you," Anders Bergstrom, Vice President, Global GM of Teva Footwear at Deckers Brands, stated.
The matching exclusive sunglasses exude Coco and Breezy's signature laid-back style and are designed with love. The earth conscious acetate wayfarer shaped frames have premium finishes, gold metal accents and tinted lenses. The sunglasses come in transparent green and brown colorways in sizing for adults and kids, perfectly complementing the footwear.
"We're excited to partner with Teva on a collection that celebrates our shared love for the outdoors. Access to nature supports our physical and mental wellbeing – and we believe everyone should have the freedom to explore the outdoors fearlessly," said Coco and Breezy Dotson, founders of Coco and Breezy. "We wanted to create a summer look for anyone to wear and adventure confidently in."
The Hurricane XLT2 retails at $60 (kids) and $90 (adults) and are available in whole sizing up to 14 (adults) and 3 (kids). The sunglasses retail at $60 (kids) and $90 (adults). Styles in the collection will be available today on Teva.com, cocoandbreezy.com, and Nordstrom.com.
Additionally, to support the Teva commitment to increasing access for all, the brand is donating $25K to support Intersectional Environmentalist's Earth Sessions program: a climate justice concert series combining art, education, joy, and community-building with the goal of empowering and inspiring folks to support grassroots climate justice efforts in their own communities.
In 1984, Teva created the world's first sport sandal on the banks of the Grand Canyon. The brand outfits free-spirited adventure-seekers all over the world with versatile, modern outdoor footwear. In 2020, Teva committed to reducing the brand's environmental impact by ensuring 100% of its iconic straps are made with recycled plastic, so future generations can continue exploring the wild world around them. Learn more about Teva, a division of Deckers Brands, at teva.com or follow @Teva.
Coco and Breezy Eyewear was founded in 2009 by twin designers Coco and Breezy Dotson. The brand creates optical and sunglasses for the individualist and we pride ourselves on detailed designs. Coco and Breezy's designs have ranged from the "third-eye" sunglasses for the late Prince to many other brand collaborations. The founders Coco & Breezy are also DJs / Producers and Co-Founders of The Lorca.
View original content to download multimedia:
SOURCE Teva | https://www.kxii.com/prnewswire/2022/07/13/teva-collaborates-with-coco-breezy-capsule-collection-summer-essentials/ | 2022-07-13T11:35:29Z |
Sesame Software's Data Management Platform, Relational Junction, provides Hubspot users with the ability to connect and combine data with many other data sources to drive insights.
SANTA CLARA, Calif., Aug. 11, 2022 /PRNewswire/ -- Sesame Software, the innovative leader in Enterprise Data Management and creator of Relational Junction, today announced the addition of a new data source connector for HubSpot. With Relational Junction for HubSpot, you can easily connect HubSpot with cloud applications and relational databases to the data warehouse of your choice. This connector empowers data teams to improve data quality, eliminate silos, and uncover new insights to support data-driven decision-making.
HubSpot is a leading platform for inbound marketing, sales, and customer relationship management. With HubSpot, you can get exhaustive data on your marketing efforts and Relational Junction helps you take control of that data.
Relational Junction is a no-code data integration and replication platform able to easily connect HubSpot and a wide variety of other data sources to your various data destinations. Thanks to its scalable architecture and automation, you can easily grow your data without the need for labor-intensive processes, including manual data entry, data mapping, and maintenance. As a result, you have the data you need, continuously updated and all in one place, allowing for you to provide better customer experiences with more targeted and informed campaigns.
Relational Junction supports delivery to a wide range of cloud data storage and on-prem data warehouses, allowing you to consolidate all of your data into a single location for archiving, reporting, analytics, and more.
In a matter of minutes, you can connect your Hubspot marketing and sales data with other data sources. Send your Hubspot data to feed your BI, your data warehouse, or your custom analytics stack and see a full view of your leads, analytics, sales, and customer service information.
- Easily access, discover, and connect HubSpot data with adjacent enterprise systems — such as databases, ERP and CRM systems, and custom applications
- Replicate HubSpot data into your data warehouse quickly and with no coding necessary
- Move data at the fastest possible speed with hyper-threaded high-volume data connectors
- Keep data fresh with automated data syncs for timely insights and accurate reporting
To learn more about how Relational Junction allows you to seamlessly flow data across HubSpot and other data sources in your tech stack, request a demo.
Sesame Software is the Enterprise Data Management leader, delivering data rapidly for enhanced reporting and analytics. Sesame Software's patented Relational Junction data platform offers superior solutions for data warehousing, integration, backup, and compliance to fit your business needs. Quickly connect to SaaS, on-premise, and cloud applications for accelerated insights. Learn more today!
Crystal Duarte
Chief Sales and Marketing Officer
Sesame Software
crystal.duarte@sesamesoftware.com
View original content:
SOURCE Sesame Software, Inc. | https://www.wibw.com/prnewswire/2022/08/11/sesame-software-announces-new-data-connector-hubspot-empowering-users-simplify-data-access-accelerate-insights/ | 2022-08-11T21:34:12Z |
Rapper Fetty Wap pleads guilty to conspiracy drug charge
CENTRAL ISLIP, N.Y. (AP) — Rapper Fetty Wap pleaded guilty Monday to a conspiracy drug charge that carries a mandatory five-year prison sentence.
The plea in Central Islip on Long Island came before U.S. Magistrate Judge Steven Locke, who had revoked his bond and sent him to jail two weeks ago. No sentencing date was immediately set.
Locke took that step after prosecutors said that Wap, whose real name is Willie Maxwell, threatened to kill a man during a FaceTime call in 2021, violating the terms of his pretrial release in his drug case.
The “Trap Queen” rapper was initially arrested last October on charges alleging he participated in a conspiracy to smuggle large amounts of heroin, fentanyl and other drugs into the New York City area.
He pleaded guilty to conspiracy to distribute and possess controlled substances, the top charge in an indictment against him. It carries a mandatory minimum sentence of five years in prison while federal sentencing guidelines are likely to recommend additional years in prison.
Maxwell and five co-defendants were accused of conspiring to possess and distribute more than 100 kilograms (220 pounds) of heroin, fentanyl and crack cocaine between June 2019 and June 2020.
The scheme allegedly involved using the U.S. Postal Service and cars with hidden compartments to move drugs from the West Coast to Long Island, where they were stored for distribution to dealers on Long Island and in New Jersey, prosecutors said.
Maxwell rose to prominence after “Trap Queen,” his debut single, reached No. 2 on the U.S. Billboard Hot 100 chart in May 2015.
Copyright 2022 The Associated Press. All rights reserved. | https://www.mysuncoast.com/2022/08/22/rapper-fetty-wap-pleads-guilty-conspiracy-drug-charge/ | 2022-08-22T18:46:59Z |
Digital Health Veteran to Bring Strategic Vision and Long-Term Growth Focus
NEW YORK, Sept. 14, 2022 /PRNewswire/ -- Remedy Health Media ("Remedy" or "the Company"), a leading digital health platform serving patients, caregivers, and healthcare providers through a family of trusted digital brands, today announced the appointment of Steve Zatz, M.D., as Chairman and Chief Executive Officer. The Company will conduct a process within the coming year to identify an individual who will assume the role of Chief Executive Officer while Dr. Zatz continues in his role as Chairman of the Board.
Dr. Zatz succeeds Mike Cunnion, who has led the company for 14 years, during which Remedy has become one of the leading digital health and content platforms in the industry. Mr. Cunnion will continue to provide strategic guidance through his role on the Board of Directors.
"It has been a privilege to lead Remedy for the last 14 years, and I could not be prouder of the growth we have achieved, the team we have built and the countless patients, caregivers and healthcare professionals we have positively impacted, supported and empowered," said Mr. Cunnion. "Steve is a pioneer in the digital healthcare space, and I know that he will bring a unique perspective and tireless drive to expanding our audience and growing our commercial business."
Dr. Zatz is a long-time industry leader in the digital health sector. He spent more than 20 years at WebMD and held various senior positions, including President and CEO. Under his leadership, WebMD became the leading source of online information for consumers and healthcare professionals. Before joining WebMD, Dr. Zatz founded and ran US Quality Algorithms (USQA), a subsidiary of US Healthcare (now Aetna), and earlier served as CEO of Physicians' Online. He currently serves as a Director of Prognos Health.
"I've spent my career helping inform the decisions patients and healthcare professionals make in order to enhance patients' quality of life and outcomes. I greatly admire the impressive work that Mike has done to position Remedy for long-term success and am very excited to join a company that shares my mission and values," said Dr. Zatz. "Remedy has a unique portfolio of highly engaging brands that provide current, informative and inspiring content, and there are many exciting opportunities for continued growth across the business in today's digital health economy."
Dr. Zatz continued, "I look forward to working with the talented team at Remedy as we continue to expand the reach and impact of Remedy's leading digital brands."
Remedy Health Media board member Nick Amigone added, "Mike's efforts have provided the business with a remarkable foundation and numerous opportunities for continued growth, and I look forward to working with our Board of industry veterans and the Remedy leadership team to position the company to enter a new phase of growth."
About Remedy Health Media
Remedy Health Media is a leading digital platform that serves communities of patients, care partners and healthcare professionals through a family of trusted health brands that exist to remove barriers and inspire action towards better health. Remedy Health Media owns and operates HealthCentral, Patient Power, TheBody, PsyCom, EndocrineWeb, Practical Pain Management, Spine Universe, TheBodyPro, EndocrineWebPro, Oncology Business Review, PsycomPro, and SpineUniversePro.
Contact
Erik Carlson
Joele Frank, Wilkinson Brimmer Katcher
212-355-4449
View original content:
SOURCE Remedy Health Media | https://www.kxii.com/prnewswire/2022/09/14/remedy-health-media-appoints-steve-zatz-chairman-chief-executive-officer/ | 2022-09-14T17:37:26Z |
‘There is no safe city:’ Pastor sees escalation of war in second trip to Ukraine
By Anjali Patel
Click here for updates on this story
ASHEVILLE, North Carolina (WLOS) — An Asheville pastor has just returned home to the mountains after his second wartime trip to Ukraine with family and friends from his church.
Sergio Fesiuk, the lead pastor at AVL City Church, said the group was in Ukraine for about 12 days for this latest trip, staying for a longer time and taking more people.
Fesiuk said they took lots of medication and protective equipment on the trip to distribute there.
“We took over 2,000 pounds on the plane with us. That’s 27 oversized luggage with eight people,” he said. “Being able to take it with us and get it to the frontlines as quick as possible, that was kind of our goal.”
The group helped deliver supplies, transport evacuees and even just handed money out to residents.
“We reconnected with some of the organizations that are on the ground, that are doing work, that are saving lives, that are evacuating people,” Fesiuk said.
Additionally, they took lots of supplies for orphanages, from necessities to art supplies — helping kids be kids.
“One of the things that our hearts went out to is the kids. A lot of the times, the kids get left behind and people don’t pay attention to them,” Fesiuk said. “We were able to visit some of these orphanages and just bring smiles to the kids’ faces and to the teachers and adults, as well.”
Fesiuk said he noticed how things had escalated on his latest voyage to his home country. Russia’s assault on Ukraine has now gone on for more than 70 days.
“When you realize that a missile has hit about an hour away from where you are, you realize that no place in Ukraine is currently safe. You know where the armies are and the footsoldiers are, but the missiles, they just come out of nowhere,” he said. “You’re realizing there is no safe city.”
Fesiuk said they visited huge cities that were once bustling, like Dnipro, but are now pitch dark.
“We drove into a city that’s over a million population and it’s pitch black, like you’re in downtown and you can see the stars,” he said.
Fesiuk said they’d crossed a bridge to get in and out of a city, and days later it was destroyed by a missile.
Fesiuk said he and his group were acutely aware of the dangers as they traveled the country, delivering aid, transporting people, praying and distributing supplies.
He said many of the locals, though, were almost numb to what was going on, now having lived through it for months.
“They are not swayed by all the sirens anymore as they were when it first started,” Fesiuk said.
He said it’s heartbreaking that this is a reality they have no choice but to accept.
“It’s always sad when you have to accept something that you did not choose,” Fesiuk said.
He said fatigue is inevitable, especially for those with boots on the ground, fighting and delivering aid.
“At first, you have all this energy to fight, to evacuate, to do things and go on very little sleep, but, after a while, you’re doing the same thing every day and one week turns into three weeks, three weeks turns into a month and a half and it’s not getting better, it’s actually getting worse,” Fesiuk said.
He believes the motivation to maintain Ukrainian autonomy is pushing their brave soldiers through.
“The arrogance and pridefulness of a bully country like Russia fuels their energy and passion to see this thing through,” Fesiuk said.
He said it’s only natural, though, for Ukrainians to get tired and even discouraged.
“They’re facing exhaustion, they’re facing anxiety and depression and trying to find truth within propaganda news,” Fesiuk said.
He said that’s why it’s important to have fresh people on the ground there, delivering aid and optimism, spreading the word that the world is behind Ukraine and its fight for freedom.
Fesiuk wonders, though, why allies haven’t done more to stop the atrocities there.
“How do you allow a country to plow through civilians without doing more than sending more military supplies?” he asked.
Fesiuk said massive graves are being found there and people lack the basic resources to survive.
“People don’t have water in these cities. It’s a crisis,” Fesiuk said.
He said it’s even more heartbreaking, because it’s a war and a humanitarian crisis happening simultaneously.
“Every day it’s not stopped is another day that children and women and grandparents are dying and cities are being destroyed,” Fesiuk said.
For information on how to donate to Ukrainians through the efforts of AVL City Church and its partners continuously on the ground in Ukraine, visit: avlcitycenter.com/crisis.
Please note: This content carries a strict local market embargo. If you share the same market as the contributor of this article, you may not use it on any platform. | https://localnews8.com/cnn-regional/2022/05/07/there-is-no-safe-city-pastor-sees-escalation-of-war-in-second-trip-to-ukraine/ | 2022-05-07T18:58:41Z |
- Scemblix® (asciminib) continues to show superior efficacy with more-than-two-fold improvement in major molecular response rate vs. Bosulif®* (bosutinib) at 96 weeks (37.6% vs. 15.8%), building on 24-week results1,2
- Long-term safety remains consistent, with discontinuation rates due to adverse events more than three times lower in the Scemblix vs. Bosulif arm (7.7% vs. 26.3%)1,2
- Updated results continue to support the use of Scemblix in patients with Philadelphia chromosome-positive CML in chronic phase previously treated with two or more TKIs, and its potential to transform the standard of care with a differentiated mechanism of action1,2
- Clinical development program continues, evaluating Scemblix across multiple lines of treatment in CML, with additional data being presented at the European Hematology Association 2022 Hybrid Congress
EAST HANOVER, N.J., June 7, 2022 /PRNewswire/ -- Novartis today announced longer-term follow-up data from the Phase III ASCEMBL trial for patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+ CML-CP) previously treated with two or more tyrosine kinase inhibitors (TKIs), presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting. In this analysis, the proportion of patients in the Scemblix® (asciminib) arm (n=157) who achieved a major molecular response (MMR) at 96 weeks was more than double that in the Bosulif®* (bosutinib) arm (n=76) (37.6% vs. 15.8% [P=.001]), substantially increasing from previous analyses1,2. Additionally, the probability of maintaining MMR for at least 72 weeks for patients treated with Scemblix was 96.7% (95% CI, 87.4%–99.2%), reflecting long-term durability of efficacy1.
Despite longer duration of exposure for patients in the Scemblix arm – with a median of 23.7 months vs. 7.0 months for patients in the Bosulif arm – the updated 96-week analysis showed the proportion of patients treated with Scemblix who discontinued treatment due to adverse events (AEs) continued to be more than three times lower than those treated with Bosulif (7.7% vs. 26.3%). No new on-treatment deaths were reported since the primary analysis at 24 weeks1,2.
"In a chronic cancer where resistance can develop to many of the existing therapies, or where patients can have their quality of life negatively impacted by treatment side effects over time, it's encouraging to see sustained and increasing efficacy with consistent adequate tolerability for patients treated with Scemblix in the longer term," said Jorge E. Cortes, MD, Director, Georgia Cancer Center, Augusta University. "This 96-week data shows the potential of Scemblix and its unique mechanism of action to help change the treatment paradigm in CML."
Scemblix is the first FDA-approved CML treatment that works by binding to the ABL myristoyl pocket3. With this novel mechanism of action, it is also known in scientific literature as STAMP inhibitor, Scemblix can help address resistance to TKI therapy in patients with Ph+ CML-CP and overcome mutations at the defective BCR-ABL1 gene, which is associated with the over-production of leukemic cells2,4-10. Scemblix continues to be studied across multiple lines of treatment for CML-CP11-18.
In addition to durable responses consistent with the primary analysis, more patients treated with Scemblix than Bosulif had BCR::ABL1≤1% (45.1% vs 19.4%) at 96 weeks. The most frequent (>10% in any treatment arm) grade ≥3 AEs on Scemblix vs. Bosulif, respectively, were thrombocytopenia (22.4%, 9.2%), neutropenia (18.6%, 14.5%), diarrhea (0%, 10.5%), and increased alanine aminotransferase (0.6%, 14.5%)1. The values for these AEs were similar to the values reported at the 24 and 48 week analyses1,2,19.
"These longer-term results offer a more robust view of the promising potential of Scemblix, and will help support ongoing regulatory filings as we seek to bring this therapy to more patients across the globe," said Jeff Legos, Executive Vice President, Global Head of Oncology & Hematology Development, Novartis. "As leaders in CML treatment innovation, we believe that with Scemblix, we have the potential to once again transform the standard of care for people affected by this disease."
Visit https://www.hcp.novartis.com/virtual-congress/a-2022/ for the latest information from Novartis at ASCO, including our bold approach to reimagining cancer care, and access to our ASCO data presentations. Additional updates on trials evaluating Scemblix in earlier lines of therapy – as well as for patients with the T315I mutation – will be presented at the upcoming European Hematology Association 2022 Hybrid Congress, with more information available at https://www.hcp.novartis.com/virtual-congress/eha-2022/.
Scemblix (asciminib) is FDA-approved for the treatment of adult patients with Ph+ CML-CP pre-treated with two or more TKIs, as well as adult patients with Ph+ CML-CP with the T315I mutation. The first indication is approved under the US FDA Accelerated Approval Program based on MMR rate at 24 weeks; continued approval for the first indication may be contingent upon verification and description of clinical benefit from confirmatory evidence3.
Scemblix represents an important development for patients who experience resistance and/or intolerance to currently available TKI therapies, and it is being studied across multiple treatment lines for CML-CP, both as monotherapy and in combination2,11-18. Specifically, the ASC4FIRST Phase III study (NCT04971226) evaluates Scemblix in newly-diagnosed adult patients with Ph+ CML-CP vs. an investigator-selected TKI, with recruitment proceeding ahead of plan12.
Regulatory reviews for Scemblix in multiple countries and regions across the globe are ongoing. These updated 96-week ASCEMBL results are being shared with regulatory authorities, as we seek to bring Scemblix to more patients in more countries across the globe.
Novartis has a long-standing scientific commitment to patients living with CML. For more than 20 years, our bold science has helped transform CML into a chronic disease for many patients. Despite these advancements, we're not standing still. We continue to research ways to target the disease, seeking to address the challenges with treatment resistance and/or intolerance that many patients face. Novartis also continues to reimagine CML care through its commitment to sustainable access for patients and collaboration with the global CML community.
SCEMBLIX® (asciminib) tablets is a prescription medicine used to treat adults with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP), previously treated with 2 or more tyrosine kinase inhibitor (TKI) medicines. The effectiveness of SCEMBLIX in these patients is based on a study that measured major molecular response (MMR) rates. No clinical information is available to show if these patients treated with SCEMBLIX live longer or if their symptoms improve. Ongoing studies exist to find out how SCEMBLIX works over a longer period of time.
SCEMBLIX is also approved for use in adults with Ph+ CML in CP with the T315I mutation.
It is not known if SCEMBLIX is safe and effective in children.
SCEMBLIX® (asciminib) tablets may cause low platelet counts (thrombocytopenia), low white blood cell counts (neutropenia), and low red blood cell counts (anemia). Patients should tell their doctor right away if they have unexpected bleeding or easy bruising; blood in their urine or stools; fever; or any signs of an infection. SCEMBLIX may increase enzymes in the patient's blood called amylase and lipase, which may be a sign of inflammation of the pancreas (pancreatitis). Patients should tell their doctor right away if they have sudden stomach-area pain or discomfort, nausea, or vomiting. During treatment with SCEMBLIX, doctors may check their patients' blood pressure and treat any high blood pressure as needed. Patients should tell their doctor if they develop elevated blood pressure or symptoms of high blood pressure including confusion, headaches, dizziness, chest pain, or shortness of breath.
If a patient has an allergic reaction while on SCEMBLIX, they should stop taking SCEMBLIX and get medical help right away. Signs or symptoms of an allergic reaction include trouble breathing or swallowing; feeling dizzy or faint; swelling of the face, lips, or tongue; fever; skin rash or flushing; or a fast heartbeat. SCEMBLIX may cause heart and blood vessel problems, including heart attack; stroke; blood clots or blockage of patient's arteries; heart failure; and abnormal heartbeat which can be serious and may sometimes lead to death. These heart and blood vessel problems can happen in people with risk factors or a history of these problems and/or previously treated with multiple TKI medicines. Patients should tell their doctor right away if they get shortness of breath; chest pain or pressure; a feeling like their heart is beating too fast or they feel abnormal heartbeats; swelling in their ankles or feet; dizziness; weight gain; numbness or weakness on one side of their body; decreased vision or loss of vision; trouble talking; pain in their arms, legs, back, neck, or jaw; headache; or severe stomach-area pain.
Before taking SCEMBLIX, patients should tell their doctor about all of their medical conditions, including if they have a history of pancreatitis; a history of heart problems; or blood clots in their arteries and veins (types of blood vessels). SCEMBLIX can harm an unborn baby. Women should tell their doctor right away if they become pregnant or think they may be pregnant during treatment with SCEMBLIX. Women who are able to become pregnant should have a pregnancy test before they start SCEMBLIX and should use effective birth control during treatment and for 1 week after the last dose of SCEMBLIX. Women should not breastfeed during treatment and for 1 week after their last dose of SCEMBLIX.
Patients should tell their doctor about all the medicines they take, including prescription medicines, over-the-counter medicines, vitamins, and herbal supplements. SCEMBLIX and other medicines may affect each other, causing side effects. The most common side effects of SCEMBLIX include nose, throat, or sinus (upper respiratory tract) infections; muscle, bone, or joint pain; rash; tiredness; nausea; and diarrhea. The most common blood test abnormalities include decreased blood counts of platelets, white blood cells, and red blood cells; and increased blood levels of triglycerides, creatine kinase, liver enzymes, or pancreas enzymes (amylase and lipase).
Please see full Prescribing Information for SCEMBLIX, available at https://www.novartis.us/sites/www.novartis.us/files/scemblix.pdf.
This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by words such as "potential," "can," "will," "plan," "may," "could," "would," "expect," "anticipate," "look forward," "believe," "committed," "investigational," "pipeline," "launch," or similar terms, or by express or implied discussions regarding potential marketing approvals, new indications or labeling for the investigational or approved products described in this press release, or regarding potential future revenues from such products. You should not place undue reliance on these statements. Such forward-looking statements are based on our current beliefs and expectations regarding future events, and are subject to significant known and unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those set forth in the forward-looking statements. There can be no guarantee that the investigational or approved products described in this press release will be submitted or approved for sale or for any additional indications or labeling in any market, or at any particular time. Nor can there be any guarantee that such products will be commercially successful in the future. In particular, our expectations regarding such products could be affected by, among other things, the uncertainties inherent in research and development, including clinical trial results and additional analysis of existing clinical data; regulatory actions or delays or government regulation generally; global trends toward health care cost containment, including government, payor and general public pricing and reimbursement pressures and requirements for increased pricing transparency; our ability to obtain or maintain proprietary intellectual property protection; the particular prescribing preferences of physicians and patients; general political, economic and business conditions, including the effects of and efforts to mitigate pandemic diseases such as COVID-19; safety, quality, data integrity or manufacturing issues; potential or actual data security and data privacy breaches, or disruptions of our information technology systems, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
Located in East Hanover, NJ Novartis Pharmaceuticals Corporation – an affiliate of Novartis – is reimagining medicine to improve and extend people's lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world's top companies investing in research and development. Novartis employs nearly 15,000 people in the United States. For more information, please visit https://www.novartis.us.
Novartis and Novartis US is on Twitter. Sign up to follow @Novartis at https://twitter.com/novartisnews and @NovartisUS at https://twitter.com/NovartisUS.
For Novartis multimedia content, please visit https://www.novartis.com/news/media-library.
For questions about the site or required registration, please contact media.relations@novartis.com.
*Bosulif is a registered trademark of Pfizer.
References
- Cortes JE, et al. Oral presentation at ASCO 2022; June 3-7, 2022. Chicago, IL and virtual. Abstract 7004.
- Rea D, et al. A Phase 3, Open-Label, Randomized Study of Asciminib, a STAMP Inhibitor, vs Bosutinib in CML After≥ 2 Prior TKIs. Blood. 2022. DOI: 10.1182/blood.2020009984. PMID: 34407542.
- Scemblix [prescribing information]. East Hanover, NJ: Novartis Pharmaceuticals Corp.
- Wylie AA, et al. The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1. Nature. 2017;543(7647):733-737. 4.
- Schoepfer J, et al. Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1. J Med Chem. 2018;61(18):8120-8135.
- Hughes TP, et al. Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure. N Engl J Med. 2019; 381(24):2315-2326.
- Hughes TP, et al. Expanded Phase 1 Study of ABL001, a Potent, Allosteric Inhibitor of BCR-ABL, Reveals Significant and Durable Responses in Patients with CML-Chronic Phase with Failure of Prior TKI Therapy. Poster presented at: ASH Annual Meeting & Exposition; Dec. 5, 2016.
- Ottmann OG, et al. ABL001, a Potent, Allosteric Inhibitor of BCR-ABL, Exhibits Safety and Promising Single- Agent Activity in a Phase I Study of Patients with CML with Failure of Prior TKI Therapy. Blood. 2015;126(23):138.
- Mauro MJ, et al. Combination of Asciminib Plus Nilotinib (NIL) or Dasatinib (DAS) in Patients (PTS) with Chronic Myeloid Leukemia (CML): Results from a Phase 1 Study. Poster presented at: EHA Annual Meeting; June 15, 2019.
- Cortes JE, et al. Combination Therapy Using Asciminib Plus Imatinib (IMA) in Patients (PTS) with Chronic Myeloid Leukemia (CML): Results from a Phase 1 Study. Poster presented at: EHA Annual Meeting; June 15, 2019.
- ClinicalTrials.gov. 2017. Study of Efficacy of CML-CP Patients Treated with ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs. [online] Available at: https://clinicaltrials.gov/ct2/show/NCT03106779.
- ClinicalTrials.gov. 2021. A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP. [online] Available at: https://clinicaltrials.gov/ct2/show/NCT04971226.
- ClinicalTrials.gov. 2020. Asciminib in Monotherapy for Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With and WithoutT315I Mutation (AIM4CML). [online] Available at: https://clinicaltrials.gov/ct2/show/NCT04666259.
- ClinicalTrials.gov. 2018. Study of Efficacy And Safety Of Asciminib In Combination With Imatinib In Patients With Chronic Myeloid Leukemia In Chronic Phase (CML-CP). [online] Available at: https://clinicaltrials.gov/ct2/show/NCT03578367.
- ClinicalTrials.gov. 2021. Study of Efficacy and Safety of CML-CP Patients Treated With Asciminib Versus Best Available Therapy, Previously Treated With 2 or More Tyrosine Kinase Inhibitors. [online] Available at: https://clinicaltrials.gov/ct2/show/NCT04795427.
- ClinicalTrials.gov. 2014. A Phase I Study of Oral ABL001 in Patients With CML or Ph+ ALL. [online] Available at: https://clinicaltrials.gov/ct2/show/NCT02081378.
- ClinicalTrials.gov. 2021 Asciminib Treatment Optimization in ≥ 3rd Line CML-CP. [online] Available at: https://clinicaltrials.gov/ct2/show/NCT04948333
- ClinicalTrials.gov. 2021. Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia [online] Available at: https://clinicaltrials.gov/ct2/show/NCT04925479
- Mauro, JM. Efficacy and Safety Results from ASCEMBL, a Multicenter, Open-Label, Phase 3 Study of Asciminib, a First-in-Class STAMP Inhibitor, Vs Bosutinib in Patients with Chronic Myeloid Leukemia in Chronic Phase after ≥2 Prior Tyrosine Kinase Inhibitors: Update after 48 Weeks. Oral presentation at: ASH Annual Meeting; Dec. 11, 2021. Abstract #310.
# # #
View original content:
SOURCE Novartis US | https://www.mysuncoast.com/prnewswire/2022/06/07/novartis-scemblix-with-novel-mechanism-action-shows-superior-long-term-efficacy-consistent-tolerability-96-week-follow-up-chronic-myeloid-leukemia-trial/ | 2022-06-07T16:18:51Z |
NEW YORK, June 20, 2022 /PRNewswire/ -- Attention Tupperware Brands Corporation ("Tupperware") (NYSE: TUP) shareholders:
The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between November 3, 2021 and May 3, 2022.
If you suffered a loss on your investment in Tupperware, contact us about potential recovery by using the link below. There is no cost or obligation to you.
ABOUT THE ACTION: The class action against Tupperware includes allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) Tupperware was facing significant challenges in maintaining its earnings and sales performance; (ii) accordingly, Tupperware's full-year 2022 guidance was unrealistic and/or unsustainable; (iii) all the foregoing, once revealed, was likely to have a material negative impact on Tupperware's financial condition; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.
DEADLINE: August 15, 2022
Aggrieved Tupperware investors only have until August 15, 2022 to request that the Court appoint you as lead plaintiff. You are not required to act as a lead plaintiff in order to share in any recovery.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
E-Mail: vw@wongesq.com
View original content:
SOURCE The Law Offices of Vincent Wong | https://www.mysuncoast.com/prnewswire/2022/06/20/class-action-alert-law-offices-vincent-wong-remind-tupperware-investors-lead-plaintiff-deadline-august-15-2022/ | 2022-06-20T11:11:45Z |
The Delfonics lead singer William ‘Poogie’ Hart dead at 77
NEW YORK (AP) — William “Poogie” Hart, a founder of the Grammy-winning trio The Delfonics who helped write and sang a soft lead tenor on such classic “Sound of Philadelphia” ballads as “La-La (Means I Love You)” and “Didn’t I (Blow Your Mind This Time),” has died. He was 77.
His son Hadi told The New York Times Wednesday that Hart died July 14 at Temple University Hospital in Philadelphia. The cause was complications during surgery.
From the late 1960s to the mid 1970s, The Delfonics had six top 40 pop hits and more than a dozen top 20 R&B hits. With Thom Bell serving as producer and co-writer, their sound was defined by the rich orchestral arrangements and layered harmonies — Hart at times rising to a falsetto — that made Philadelphia soul as essential to the ‘70s as Detroit’s Motown label had been in the previous decade.
The Delfonics, whose other songs included “Ready or Not Here I Come (Can’t Hide from Love)” and “Break Your Promise,” were among the first successes in a wave of Philadelphia vocal groups that included the Spinners, the O’Jays and the Stylistics. Their songs remained known well after they stopped having hits. The Delfonics were heard on soundtracks for movies by Quentin Tarantino and Spike Lee and were covered by Prince, Aretha Franklin and other artists. Nicki Minaj, the Fugees and many other performers sampled them.
In 1971, “Didn’t I (Blow Your Mind This Time)” brought The Delfonics a Grammy for best R&B performance by a duo or group. They were voted into the National Rhythm & Blues Hall of Fame in 2014.
Hart was a Washington, D.C. native, born in 1945. He later moved to Philadelphia and began singing in groups as a teenager, and with younger brother Wilbert Hart and Randy Cain (later replaced by Major Harris) formed the precursor to The Delfonics, The Orthonics, in 1965. They soon learned of a local writer-arranger, Bell, who eventually worked not just with The Delfonics but with the Spinners and Stylistics.
The Delfonics initially broke up in the 1970s, but later toured in various combinations. Hart’s outside projects included the 2007 album “Three Tenors of Soul” with two other stars from the ‘70s: Russell Thompkins Jr. of the Stylistics and Ted Mills from Blue Magic.
———
This story has been corrected to change William ‘Poogie’ Hart’s birth year to 1945 from 1947.
Copyright 2022 The Associated Press. All rights reserved. | https://www.mysuncoast.com/2022/07/21/delfonics-lead-singer-william-poogie-hart-dead-77/ | 2022-07-21T13:40:17Z |
WEST CONSHOHOCKEN, Pa. , June 10, 2022 /PRNewswire/ -- SAFARI Montage is excited to add four superstar edtech leaders to our team with the addition of Shannon Terry (Vice President of National Strategic Accounts), Kate Crawford (Vice President of Strategic Accounts), Tricia Kennedy (Consultant) and Nicole O'Brien (Manager of Customer Engagement). This quartet of forward-thinking female industry veterans brings a wealth of experience serving the K-12 community and using SAFARI Montage solutions as well as extensive expertise designing and implementing interoperable digital learning ecosystems.
In her new role as Vice President of National Strategic Accounts for SAFARI Montage, Shannon Terry will work closely with school districts to provide strategic vision and direction on implementing and effectively leveraging SAFARI Montage solutions in their digital ecosystems. Dr. Terry comes to the company from the Texas Education Agency (TEA) where she worked as the Division Director of Program Integration Strategy. Prior to TEA, Shannon served as the Executive Director of Professional and Digital Learning for Dallas Independent School District (TX).
Kate Crawford will be joining SAFARI Montage in August 2022 as the Vice President of Strategic Accounts. She most recently served as the Director, Digital Learning and Media Services at Fayette County Public Schools (GA) where she spent the last decade guiding the district on the effective use of technology and determined the applicability for educational settings and student achievement through actual implementation and progressive teaching and learning strategies. In her new role, Kate will work closely with the team at Chicago Public Schools (CPS) as they continue to leverage the SAFARI Montage Learning Object Repository as the interoperable foundation for their Skyline Digital Curriculum initiative along with other key K-12 partner school districts.
Tricia Kennedy is the former Executive Director, Instructional Development and Support for Gwinnett County Public Schools (GA). She is a nationally recognized leader in K-12 educational technology and recently retired after 30+ years of service at GCPS where she provided leadership on the design and implementation of the district's digital conversion initiative, including selection, procurement, and implementation of their learning management system; design of student and instructional staff portals and digital ecosystem; professional development for instructors and staff on use of technology to enhance effective instruction; preparation for district digital learning days. In her role as a Consultant for SAFARI Montage, Tricia will be working with SAFARI Montage K-12 partner districts to develop and implement effective digital curriculum, including facilitating leadership discussions of district needs, vision and requirements for digital curriculum; presenting districts with best practices and potential models for digital curriculum; connecting district with thought leaders in digital ecosystem and curriculum design; and more. Her first day with the company will be Monday, June 13, 2022.
Nicole O'Brien brings considerable experience and knowledge of K-12 public education as well as education technology to SAFARI Montage. In her most recent role, Nicole served as an Account Services Manager for Education Networks of America (ENA) and before that worked as the Technology Integration Coordinator for Sharon Public Schools (MA) and the Application Integration Support at Newton Public Schools (MA). As the Manager of Customer Engagement, Nicole will work with K-12 school districts throughout the Northeast United States to find the best ways to solve their digital instruction challenges using the SAFARI Montage platform.
"The addition of this fabulous foursome of edtech leaders will help SAFARI Montage strengthen our vision and commitment to advancing the possibilities for digital teaching and learning in K-12 classrooms," stated Tim Beekman, President & Co-Founder, SAFARI Montage.
SAFARI Montage is the leading K-12 Learning Object Repository, Video Streaming Library, IPTV & Live Media Streaming provider. This enterprise-level solution provides an interoperable foundation for teachers and students to have equitable access to procured, created and curated educational digital resources, create playlists and link them to their LMS. The platform is IMS certified in Learning Tools Interoperability (LTI), Common Cartridge, OneRoster, Competencies & Academic Standards Exchange (CASE), and Data Privacy.
SAFARI Montage comes preloaded with educational video titles tied to the curriculum from the industry's leading video publishers, which include Schlessinger Media, PBS, The History Channel, National Geographic, Scholastic, Disney Education, BBC and more.
SAFARI Montage LOR Cloud offers all of refined features of the Learning Object Repository without the need for hardware inside a school district. It is ideal for flexible in-person and remote instruction needs.
View original content to download multimedia:
SOURCE SAFARI Montage | https://www.mysuncoast.com/prnewswire/2022/06/10/safari-montage-adds-4-edtech-titans/ | 2022-06-10T19:12:41Z |
66% of organizations report spending more on SaaS apps than IaaS, yet SaaS security not yet a top three priority
NEW YORK, Aug. 31, 2022 /PRNewswire/ -- Axonius, the leader in cybersecurity asset management and SaaS management, today released the results of a new research study focused on SaaS usage among enterprises across the United States, United Kingdom, and Europe. The data highlights a striking difference between consumption and security of SaaS applications. In fact, the majority of respondents (74%) reported more than half of their applications are now SaaS-based, and 66% reported spending more on SaaS applications today than a year ago.
But amid rising adoption and increasing costs, most organizations reported SaaS security lagged in urgency and priority. Of those surveyed, 60% ranked SaaS security fourth or lower on their list of current security priorities, and only 34% cited being worried about the costs associated with rising SaaS-based app usage.
"The biggest concern with SaaS adoption right now is that most organizations are underestimating the number of SaaS applications that exist within their environment," said Dean Sysman, CEO and co-founder of Axonius. "SaaS offers numerous benefits, including more flexibility, accessibility, productivity gains, and more - anyone can register for a SaaS app and connect it to work data. But that also presents enormous risk. IT and security teams already struggle to identify the assets that exist within their organizations. SaaS apps further complicate their ability to gain visibility into data and interconnectivity, manage configurations, and close security gaps, as well as track licensing, usage, and spend."
66% of organizations surveyed did admit the increase in SaaS applications has resulted in more complexity and increased security risk in their organizations. But when asked why security isn't more of a concern, organizations pointed to limited time and resources (28%), pressure to focus on other issues from the C-Suite (23%), and staffing shortages (15%).
"The appetite for SaaS will only continue to grow, further exacerbating data sprawl and security implications," said Jerich Beason, Commercial Bank CISO and Axonius advisor. "These risks are no longer hypothetical, and without full visibility into the SaaS application landscape, organizations will continue to find themselves vulnerable to data loss from shadow SaaS, non-compliance with federal and industry regulators, and financial strain from lack of insight into organizational spend. Businesses can no longer wait to rein in SaaS complexity."
We're already witnessing the consequences of insecure SaaS environments. In March, identity and access management industry leader, Okta, announced that its platform has been the victim of a targeted security attack. In April, GitHub Security announced an investigation into abused stolen OAuth user tokens issued to two third-party OAuth integrators, Heroku and Travis-CI. To address SaaS security risks, organizations may need to rethink their priorities and adopt a different approach to SaaS security.
To learn more about the survey results and how to make SaaS security a bigger priority for your organization in the coming year, register for our upcoming webinar, "Why SaaS Security Is a Priority (Even If You Don't Know It Yet)." Taking place on October 3, 2022, Axonius will be joined by Jerich Beason to discuss how a modern, comprehensive approach to SaaS security, like Axonius SaaS Management, can help solve your SaaS challenges.
You can also see more of the survey results in our infographic by visiting the Axonius blog.
This survey was completed by Savanta in H1 2022. More than 500 senior decision makers from the US, the UK, and Europe were polled.
Axonius gives customers the confidence to control complexity by mitigating threats, navigating risk, automating response actions, and informing business-level strategy. With solutions for both cyber asset attack surface management (CAASM) and SaaS management, Axonius is deployed in minutes and integrates with hundreds of data sources to provide a comprehensive asset inventory, uncover gaps, and automatically validate and enforce policies. Cited as one of the fastest-growing cybersecurity startups, with accolades from CNBC, Forbes, and Fortune, Axonius covers millions of assets, including devices and cloud assets, user accounts, and SaaS applications, for customers around the world. For more, visit Axonius.com.
View original content to download multimedia:
SOURCE Axonius | https://www.wibw.com/prnewswire/2022/08/31/new-research-axonius-finds-despite-saas-spend-eclipsing-iaas-saas-security-not-priorityyet/ | 2022-08-31T13:26:49Z |
- Participated USD 4M in Series A round of Sabanto through Hico Capital
- Investment decision based on market growth and Sabanto's differentiated competitive edge… contributing to sustainability as well
- "Investing in a variety of promising business domains around the world, to build a foundation to upgrade our business portfolio"
SEOUL, South Korea, June 30, 2022 /PRNewswire/ -- Hico Capital, US based investment arm of SK networks, has invested in a US AgTech startup.
SK networks announced on June 30(CDT) that the company will invest USD 4 million, via Hico Capital, its US investment subsidiary, in the Series A round for tractor automation solution provider, Sabanto (based in Chicago, Illinois, USA). Total funding amount is USD 17 million which will be used to fund commercialization and continued development the technology.
Sabanto is a startup offering an automation solution for farming tractors and differentiates itself from competitors by delivering an automation solution deployable in conventional tractors currently in operation. In addition, as the solution is offered as an open platform, it is compatible with most of the tractor brands. The automation solution is attractive with this wide range of adaptability as it can enable customers to access autonomy-embedded tractor without replacing the existing tractors. Sabanto is on track for a commercial launch of its product to farmers in the third quarter of this year. In addition, Sabanto has been pilot testing with the US Air Force since last year, with the final phase of testing to be completed in the third quarter of this year.
Hico Capital has made its investment decision based on the considerable growth potential of AgTech industry as well as Sabanto's differentiated technologies. The US agriculture industry faces a series of challenges including aging farmers, shortage of labor, and rising costs, which have prompted the government and the market to consider automation technology as a possible solution. The global autonomous tractor market is estimated to grow at 20% per annum. Sabanto is expected to benefit from the industry tailwind, driven by the increasing demand for automation.
Samuel Kim, Managing Director at Hico Capital commented, "The AgTech industry is one of the fastest growing sectors in the United States, and Sabanto's automation tech offerings will not only boost the operational efficiency of tractors but also contribute to the sustainability in agriculture," and he added, "This investment will allow us to support startups with innovative technology and potentially forge partnership with SK networks' businesses in the future."
Founded in 2020, Hico Capital is a subsidiary of SK networks based in Silicon Valley to facilitate investments in frontier tech opportunities and to expand its local networks. Hico Capital has made a number of investments to date, including Standard Cognition and MycoWorks.
View original content to download multimedia:
SOURCE SK networks | https://www.wibw.com/prnewswire/2022/07/01/sk-networks-hico-capital-invests-us-tractor-automation-solution-provider/ | 2022-07-01T02:11:35Z |
TORONTO, May 2, 2022 /PRNewswire/ - Ikänik Farms, Inc. (CSE: IKNK.U) (FSE: DFMA) (the "Company" or "Ikänik Farms") announces that it will not be in a position to file its audited consolidated annual financial statements, the accompanying management's discussion and analysis and related CEO and CFO certifications for the year ended December 31, 2021 (the "Annual Financial Filings") by the May 2, 2022 filing deadline (the "Deadline") due to a combination of internal and external delays associated with the preparation and audit process as a result of a number of factors, including the recent downsizing of the Company in California where it maintains its corporate accounting, the departure of the Company's Controller, the onboarding and integration of the Company's new Controller into its corporate systems, the [capacity and limited availability of the Company's auditor and unanticipated complexities with the completion of the Annual Financial Filings.
The Company has been informed by the Ontario Securities Commission (the "OSC") that it is not eligible for a management cease trade order under National Policy 12-302 – Cease Trade Orders for Continuous Disclosure Defaults and, accordingly, the OSC will be issuing a failure-to-file cease trade order under National Policy 11-207 – Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions affecting all the Company's securities following the Deadline.
The Company's management and team members are moving expeditiously to complete the Annual Financial Filings which it anticipates will be filed prior to June 24, 2022. The Company is engaging a third-party service and advisory company to assist with the field work and audit evidence for its operations in Colombia and changes to the Company's corporate accounting processes, consolidation of systems and location.
"The timing of this cease trade order does not take away from the Company's momentum and recent results to transition operations away from its assets in California to the production and sale of certified pharmaceutical grade THC dry cannabis flower and derivatives from its indoor cultivation facility "Pideka" in Bogotá, Colombia, where Pideka has market leadership" said Mr. Sanz de Madrid, CEO.
Highlights of the Company's recent developments include the:
The Company will make further announcements with respect to the status of the Audited Financial Statements and changes to its accounting practices.
Ikänik Farms is multi-national operator with a medical grade indoor cultivation facility and laboratory (Pideka) in Colombia which holds GMP-PHARMA and (GACP) Good Agricultural and Collection Practice certifications, and a retail operation in California.
This news release includes "forward-looking information" and "forward-looking statements" within the meaning of Canadian securities laws and United States securities laws (together, "forward-looking information). All information, other than statements of historical facts, included in this news release that address activities, events or developments that the Company expects or anticipates will or may occur in the future is forward-looking information. When used in this news release, words such as "will", "could", "plan", "estimate", "expect", "intend", "may", "potential", "believe", "should", and similar expressions, are forward-looking information, including, but not limited to: statements with respect to the Audited Financial Statements, including the anticipated delay in filing the Audited Financial Statements and timing to complete the Company's audit and the anticipated closing of the proposed private placement financing.
Although the Company has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking information, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: changes in laws, a change in management and the inability to obtain additional financing.
There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in the forward-looking information may differ materially from actual results or events.
Accordingly, readers should not place undue reliance on forward-looking information. The forward-looking information in this news release is made as of the date of this release. The Company disclaims any intention or obligation to update or revise such information, except as required by applicable law, and the Company does not assume any liability for disclosure relating to any other company mentioned herein.
Related Links
https://ikanikfarms.com
View original content:
SOURCE Ikanik Farms Inc. | https://www.mysuncoast.com/prnewswire/2022/05/03/iknik-farms-announces-late-filing-2021-annual-financial-statements/ | 2022-05-03T06:53:58Z |
NEW YORK, April 5, 2022 /PRNewswire/ -- Lument has announced the launch of Leap to Loans, a new tool that provides quotes for multifamily housing loans. The platform, which will be available at leaptoloans.com, generates quotes for loans ranging from $1 million to $7.5 million.
"Leap to Loans will provide an essential service to seasoned and new real estate investors alike," said Joshua Orpin, Small Balance Loans (SBL) Director at Lument. "All users need to do is enter the property address to receive loan amounts, terms, and local market information. They will also get a call from a lending professional to provide detailed information and next steps."
Leap to Loans was built in-house by Lument's technology team and will be released on April 5. Each quote can include options from government-sponsored entities Fannie Mae and Freddie Mac, as well as balance sheet options. The tool also features educational resources to help newer investors learn more about the commercial real estate industry. Leap to Loans will grow and evolve through various phases as the firm's SBL lending offerings grow. This includes the planned addition of new loan product options and regular additions to education-related articles.
"This new, cutting-edge platform makes getting a multifamily quote easy," added Lument Senior Managing Director Rick Warren. "It combines efficient, streamlined design with leading technology that is sure to become a standard for the industry. We are excited to present this valuable and easy-to-use tool for anyone interested in multifamily investing."
About Lument
ORIX Real Estate Capital Holdings, LLC, d/b/a Lument, is a subsidiary of ORIX Corporation USA. Lument is a national leader in commercial real estate finance. As the combined organization of legacy industry experts Hunt Real Estate Capital, Lancaster Pollard, and RED Capital Group, Lument delivers a comprehensive set of capital solutions customized for investors in multifamily, affordable housing, and seniors housing and healthcare real estate. Lument is a Fannie Mae DUS®, Freddie Mac Optigo®, FHA, and USDA lender. In addition, Lument offers a suite of proprietary commercial lending, real estate investment sales, investment banking, and investment management solutions. Lument has approximately 600 employees in over 25 offices across the United States. Securities, investment banking, and advisory services are provided through OREC Securities, LLC, d/b/a Lument Securities, Member FINRA/SIPC. Investment advisory services are provided by OREC Investment Management, LLC, d/b/a Lument Investment Management. OREC Investment Management is registered as an investment adviser with the U.S. Securities and Exchange Commission. For more information, visit www.lument.com.
MEDIA CONTACT
Tyler Howard | Associate Director
513-403-1911 | tyler.howard@lument.com
View original content to download multimedia:
SOURCE Lument | https://www.wibw.com/prnewswire/2022/04/05/lument-launches-leap-loans-platform-multifamily-quotes/ | 2022-04-05T15:36:09Z |
METRO CHICAGO, Ill., Aug. 1, 2022 /PRNewswire/ -- Calamos Investments®* has announced monthly distributions and sources of distributions paid in August 2022 to shareholders of its seven closed-end funds (the Funds) pursuant to the Funds' respective distribution plans.
The following table provides estimates of Calamos Global Total Return Fund's and Calamos Global Dynamic Income Fund's distribution sources, reflecting YTD cumulative experience. The Funds attribute these estimates equally to each regular distribution throughout the year.
Regarding Calamos' remaining five closed-end funds, which operate under a managed distribution policy: The information below is required by an exemptive order granted to the Funds by the US Securities and Exchange Commission and includes the information sent to shareholders regarding the sources of the Funds' distributions.
The following table sets forth the estimated amount of the sources of distribution for purposes of Section 19 of the Investment Company Act of 1940, as amended, and the related rules adopted thereunder. The Funds estimate the following percentages, of their respective total distribution amount per common share, attributable to (i) current and prior fiscal year net investment income, (ii) net realized short-term capital gain, (iii) net realized long-term capital gain and (iv) return of capital or other capital source as a percentage of the total distribution amount. These percentages are disclosed for the current distribution as well as the fiscal YTD cumulative distribution amount per common share for the Funds. The following table provides estimates of each Fund's distribution sources, reflecting YTD cumulative experience. The Funds attribute these estimates equally to each regular distribution throughout the year.
Note: NAV returns are as of July 31, 2022, and Distribution Returns include the distribution announced today.
You should not draw any conclusions about the Fund's investment performance from the amount of this distribution or from the terms of the Fund's plan.
If the Fund(s) estimate(s) that it has distributed more than its income and capital gains, a portion of your distribution may be a return of capital. A return of capital may occur, for example, when some or all of the money that you invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Fund's investment performance and should not be confused with 'yield' or 'income'.
The amounts and sources of distributions reported in this 19(a) notice are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for accounting and tax purposes will depend upon the Fund's investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099 DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.
Return figures provided below are based on the change in the Fund's Net Asset Value per share ("NAV"), compared to the annualized distribution rate for this current distribution as a percentage of the NAV on the last day of the month prior to distribution record date.
1Since inception for CPZ
Note: NAV returns are as of July 31, 2022 and Distribution Returns include the distribution announced today.
While the NAV performance may be indicative of the Fund's investment performance, it does not measure the value of a shareholder's investment in the Fund. The value of a shareholder's investment in the Fund is determined by the Fund's market price, which is based on the supply and demand for the Fund's shares in the open market. Past performance does not guarantee future results.
Monthly distributions offer shareholders the opportunity to accumulate more shares in a fund via the automatic dividend reinvestment plan. For example, if a fund's shares are trading at a premium, distributions will be automatically reinvested through the plan at NAV or 95% of the market price, whichever is greater; if shares are trading at a discount, distributions will be reinvested at the market price through an open market purchase program. Thus, the plan offers current shareholders an efficient method of accumulating additional shares with a potential for cost savings. Please see the dividend reinvestment plan for more information.
Important Notes about Performance and Risk
Past performance is no guarantee of future results. As with other investments, market price will fluctuate with the market and upon sale, your shares may have a market price that is above or below net asset value and may be worth more or less than your original investment. Returns at NAV reflect the deduction of the Fund's management fee, debt leverage costs and other expenses. You can purchase or sell common shares daily. Like any other stock, market price will fluctuate with the market. Upon sale, your shares may have a market price that is above or below net asset value and may be worth more or less than your original investment. Shares of closed-end funds frequently trade at a discount which is a market price that is below their net asset value.
About Calamos
Calamos Investments is a diversified global investment firm offering innovative investment strategies including alternatives, multi-asset, convertible, fixed income, equity, and sustainable equity, currently managing approximately $39 billion in assets under management. The firm offers strategies through separately managed portfolios, mutual funds, closed-end funds, private funds, and UCITS funds. Clients include major corporations, pension funds, endowments, foundations, and individuals, as well as the financial advisors and consultants who serve them. Headquartered in the Chicago metropolitan area, the firm also has offices in New York, San Francisco, Milwaukee, Portland (Oregon), and the Miami area. For more information, please visit us on LinkedIn, on Twitter @Calamos or at www.calamos.com.
*Calamos Investments LLC, referred to herein as Calamos Investments®, is a financial services company offering such services through its subsidiaries: Calamos Advisors LLC, Calamos Wealth Management LLC, Calamos Investments LLP and Calamos Financial Services LLC.
View original content:
SOURCE Calamos Investments | https://www.kxii.com/prnewswire/2022/08/01/calamos-investments-closed-end-funds-nasdaq-chi-chy-csq-cgo-chw-ccd-cpz-announce-monthly-distributions-required-notifications-sources-distribution/ | 2022-08-01T20:34:24Z |
CANNES, France, May 20, 2022 /PRNewswire/ -- WeWay , the unique entertainment ecosystem powered by NFTs and blockchain technology, is delighted to announce that WeWay Brand Ambassador Ellen Sheidlin received "Best NFT Artist" award at the WIBA ceremony in Cannes.
This ceremony is a part of the fourth edition of the World Influencers and Bloggers Awards (WIBA) 2022. It took place on 18th May during the Cannes Film Festival at the famous Hotel Martinez.
At WIBA 2022, Ellen Sheidlin won an award in the nomination "Best NFT Artist". As a well-known fashion model and artist, Ellen works with both physical and digital art directions, using the unique style of survirtualism. Her artwork is in high demand in exhibitions in London, Florence, Palermo and also in Japan.
Following her outstanding achievements and the fact that she was among the first artists to join the non-fungible token market, the WeWay team decided to form a partnership with Ellen. As the project's official Brand Ambassador, she promotes WeWay's NFT-powered ecosystem as well as educates and raises the awareness of her audience about digital collectibles and the metaverse.
"I am really happy that this year I was honored to become the winner in the nomination 'Best NFT Artist'. This is especially important for me because, for many years, I have been creating works in which I try to convey my vision of the world and show life from a new angle. Recently, I discovered the field of NFTs, which fascinated me with its capabilities. And WeWay helped me to delve into the sphere of NFTs and metaverses, showed me what advantages these sectors can give with influencers," said Ellen Sheidlin.
"We are glad that such outstanding representatives of creative professions as Ellen realize the importance of new technologies and try to bring them into their work. In turn, we are always happy to help them master these technologies and explain the value of the products produced by celebrities to their audience in the metaverse. Ellen is an excellent example of how a creative person working in the field of art familiar to us can reach a new level of creativity using the metaverse and NFTs," Fuad Fatullaev, WeWay's Founder and CEO, stated.
View original content:
SOURCE WeWay | https://www.kxii.com/prnewswire/2022/05/20/weway-ambassador-ellen-sheidlin-wins-award-cannes/ | 2022-05-20T08:23:23Z |
Over the hum of jet engines, I could hear the flight attendant comforting a fellow passenger seated a couple of rows behind me. "You're out, and you're safe now," she said warmly.
Our plane had just taken off from Shanghai, a city of gleaming high-rises, home to 25 million people who are slowly being worn down by China's unrelenting zero-Covid regime.
As she approached my row, the flight attendant addressed me with the same concerned tone. You got out with this little guy, I see," she said, glancing at my rescue dog, Chairman, asleep in his carry case under the seat in front me. "How did you do it? And how are you feeling?" she asked.
It caught me off guard. As a journalist, I'm usually the one asking those types of questions. But on this flight, I was of the few who had managed to navigate the complex process of securing a one-way ticket out of Shanghai's oppressive Covid lockdown.
Right now, expats who want to escape Shanghai typically need consular assistance, approval from community leaders to get extra non-government Covid tests, a registered driver to take them to the airport, and a ticket on a rare flight out (and that's even harder to find with a pet).
But most of all, people leaving must promise their community leaders that once they step through the gates, they won't come back.
Deserted roads lead to an empty airport
After 50 days of being locked inside, I could feel my neighbors peering at me from their homes as I left my apartment. They likely assumed I was either being bused off to a government quarantine center like people who had tested positive, or had found a quick escape route like other expats trying to get out.
In fact, my trip had been planned for several months, well before the start of the maddening lockdown. After covering the initial outbreak in Wuhan in January 2020, I stayed in China as it shut itself off from the rest of the world. But after more than two-and-a-half years away from my close-knit Cuban-American family, I needed to get back.
The commute from Xuhui district in central Shanghai to Pudong International Airport to the east of downtown was nothing like I remembered. Tape lined near-desolate sidewalks, and most stores and restaurants were closed, their shutters down and doors secured with chains and locks.
The few people out on the streets were mostly dressed in hazmat suits, police included. Checkpoints lined the route to the airport, and when my driver was stopped, officers spent several minutes inspecting our documents: flight confirmation emails, negative Covid tests, even a letter from the US Embassy.
As we pulled up outside the terminal, I realized there were no other cars or passengers in sight -- and for a fleeting second I feared my flight had been canceled.
A different country
The China I'm leaving bears little resemblance to the one that welcomed me almost three years ago -- but it does remind me of the first major story I covered here.
Months after arriving, my team was sent to Wuhan in central China after word started spreading about a mystery illness. That was January 21, 2020, and within days the city went into an unprecedented citywide lockdown -- the first of many worldwide.
We, along with many others, scrambled to get out, but realizing we could potentially be exposed, we decided to self-isolate in a hotel for 14 days, before quarantining became mandatory.
In those early days, a brief window of unfiltered truth opened before Chinese censors shut it down. During that time, we spoke with victims' relatives, who risked their freedoms to express their anger toward government officials they say mishandled and covered up the initial outbreak.
Chinese officials maintain they were transparent from the start. And just this month, President Xi Jinping reaffirmed and praised his country's zero-Covid efforts, vowing to fight with any doubters and critics of the increasingly controversial policy.
China was one of the first countries to shut its borders, build field hospitals, roll out mass testing of millions of people, and create a sophisticated contact tracing system to track and contain cases -- providing a template for other countries as they fought their own outbreaks.
And for a time, it worked. Even as cases surged around the world, China remained relatively Covid-free, and this year took its pandemic measures to another level, hosting the Olympic Games under the tightest health security apparatus ever staged for a global event.
Reporting in China was notoriously difficult even before Covid, but pandemic restrictions meant that every assignment came with the threat of being trapped in a snap lockdown or forced into quarantine.
China's battle against Covid coincided with worsening international relations, particularly its ties with the US. American journalists, like me, were slapped with heavy visa restrictions -- visa periods were shorter and multi-entry access was scrapped. So rather than risk being locked out of China, many of us stayed.
Taking off from lockdown
Stepping into the airport's eerily quiet Terminal 2 was like advancing to the next level of a video game -- a moment of relief overshadowed by anxiety that some kind of unexpected hurdle could take me back to where I started.
The departures board listed only two destinations: Hong Kong and my destination, Amsterdam.
No shops or restaurants were open, even the vending machines had stopped working. In the far corners of the massive terminal building, departed travelers had left behind sleeping bags and piles of trash. Some were still there, waiting for what I had -- a flight out.
At the check-in desk, passengers left queues of trolleys piled high with luggage as they waited hours for attendants to appear in white hazmat suits to check them in.
By the time I passed customs and security, the sun was setting on the dimly-lit terminal. Other passengers, mostly expats, huddled nearby, waiting to board, sharing similar stories.
"We're leaving after 5 years," one woman said. "We've been here 7 (years)," another passenger responded, pointing out another couple: "They've lived here about a decade."
The folks I spoke with seemed to have reached the same conclusion: the time they had invested in China's financial hub no longer mattered. It was time to pull out, cut your losses.
From the window, I could see our plane at the gate and watched ground crew in hazmats spray each other with disinfectant, sanitizing from their heads to the soles of their shoes after loading the last of our luggage.
When I finally settled in my seat --- with entire rows around me empty -- weeks of built-up adrenaline, anxiety and stress began to ease. For the first time perhaps since the start of the outbreak in March, I felt a sense of relief and certainty, though it was tinged with survivor's guilt as the plane took off.
The flight attendants were seemingly fascinated by each passenger's "escape story" and remarked how they've never had a flight with so many grateful people on board.
Two of them approached my seat as we reached cruising altitude. One of them said, "You all have had a long few weeks, why don't you get some rest. We'll have you home soon."
The other nodded in agreement, and then pointing to her face mask said, "Oh, and just so you're not too shocked, once we land you'll hardly notice anyone wearing these anymore."
"You're about to enter a whole new world."
The-CNN-Wire
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved. | https://www.albanyherald.com/news/leaving-locked-down-shanghai-for-a-whole-new-world-outside-china/article_db6e57c1-c2fd-523f-8c9f-c208ab9e899e.html | 2022-05-13T04:29:06Z |
Nxivm founder alleges FBI tampered with key evidence in his case, asks conviction be vacated
By Sonia Moghe, CNN
An attorney for Nxivm founder Keith Raniere on Tuesday asked for his conviction to be vacated, alleging in a court filing the FBI tampered with key evidence in the case against him and gave false testimony in his 2019 trial.
Raniere was convicted on seven counts, including racketeering, racketeering conspiracy, wire fraud conspiracy, forced labor conspiracy, sex trafficking, sex trafficking conspiracy and attempted sex trafficking. Raniere was sentenced to the remainder of his life in prison.
In a motion filed Tuesday, Raniere’s attorney, Joseph Tully, asked for Raniere’s conviction to be vacated, because of “the government’s use of false testimony and evidence.”
A spokesperson for the FBI declined to comment.
Attorneys for Raniere are set to make oral arguments appealing his conviction Tuesday afternoon, as are attorneys for his co-defendant Clare Bronfman, who pleaded guilty to conspiracy to conceal and harbor people who were not in the US legally for financial gain, as well as fraudulent use of identification. Bronfman was sentenced to nearly seven years in prison.
Raniere was accused of creating, a sex cult within the self-help group Nxivm, with an all-female group known as DOS, whose members served as “slaves” and “masters.”
Multiple women testified at trial they were misled about joining the group and were told it was a “women’s empowerment” group. They later found out they would become “slaves” who would be expected to have sex with Raniere, send him nude photos and have his initials branded onto their bodies.
The allegations in Tuesday’s motion have been part of Raniere’s appeal, but the motion details evidence allegedly showing metadata of a file card was changed while in possession of the FBI to make it appear nude photographs of a female were taken in 2005, when the woman was a minor. The evidence was at the heart of a child pornography charge Raniere was convicted of.
In the filing, Tully asks for there to be an evidentiary hearing where attorneys can question multiple forensic examiners, FBI special agents involved in the case, two federal prosecutors, two witnesses and others. A spokesperson for the US Attorney’s Office for the Eastern District of New York had no comment.
In a timeline summarizing alleged evidence of tampering, Raniere’s attorneys said a camera, camera card and hard drive were found at a home linked to Raniere in March 2018, and authorities held onto the devices for 4.5 months. The summary alleges “an unknown person delinquently accessed the camera card” in September 2018.
A former FBI special agent submitted an expert report where he said he believed tampering “definitely” took place while the devices were in the custody of the FBI, and it was his expert opinion “the FBI must have been involved in such evidence tampering.”
The-CNN-Wire
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved. | https://localnews8.com/news/national-world/cnn-national/2022/05/03/nxivm-founder-alleges-fbi-tampered-with-key-evidence-in-his-case-asks-conviction-be-vacated/ | 2022-05-03T19:46:15Z |
WASHINGTON, June 13, 2022 /PRNewswire/ -- Scientists will discuss new research from NASA missions – on topics ranging from exoplanets to citizen science discoveries – at the 240th meeting of the American Astronomical Society (AAS). The meeting began Sunday, June 12, and continues through Thursday, June 16, at the Pasadena Convention Center in Pasadena, California.
Agency leaders and researchers will discuss the latest developments in astrophysics during various press conferences, scientific sessions, and town halls. News conferences, highlighting results enabled by NASA missions such as the Chandra X-ray Observatory and Hubble Space Telescope, as well as NASA's Stratospheric Observatory for Infrared Astronomy (SOFIA) and Transiting Exoplanet Survey Satellite (TESS), will stream live to the public on the AAS Press Office YouTube channel.
In addition to press conferences, NASA highlights for registered attendees include:
- NASA Town Hall: 12:45 p.m. PDT Monday, June 13
- Plenary lecture by Thomas Zurbuchen, associate administrator for NASA's Science Mission Directorate: 11:40 a.m. PDT Tuesday, June 14
- James Webb Space Telescope Town Hall: 6:30 p.m. PDT Tuesday, June 14
- SOFIA Town Hall: 6:30 p.m. PDT Wednesday, June 15
- Roman Space Telescope Town Hall: 12:45 p.m. PDT Thursday, June 16
The full of list of NASA meeting highlights is as follows:
Monday, June 13
10:15 a.m. PDT – AAS News Conference
Room 107, lower-level conference room
News from NASA's SOFIA mission will be highlighted with results from the following presentation:
- "Polarization and Dust Properties of the Supernova Remnant Cassiopeia A"
12:45 p.m. PDT – NASA Town Hall
Ballroom D
Paul Hertz, director of NASA's Astrophysics Division, will provide a status update on NASA's astrophysics programs.
2:15 p.m. PDT – AAS News Conference
Room 107, lower-level conference room
News from NASA's SOFIA mission will be highlighted with results from the following presentation:
- "Large- and Small-Scale Magnetic Fields in the Cygnus-X Star-Forming Region"
Tuesday, June 14
10:15 a.m. PDT – AAS News Conference
Room 107, lower-level conference room
News from NASA's Hubble Space Telescope and Disk Detective citizen science program will be highlighted with results from the following presentations:
- "Disks in Nearby Young Stellar Associations Found Via Citizen Science and Virtual Reality"
- "The Largest Ultraviolet Survey of Distant Galaxies by the Hubble Space Telescope"
11:40 a.m. PDT – Plenary lecture by Thomas Zurbuchen
Hall C
Thomas Zurbuchen, associate administrator for NASA's Science Mission Directorate, will present a plenary lecture: "Enabling a Decade of Great Astrophysics by Excellent Teams."
6:30 p.m. PDT – James Webb Space Telescope Town Hall
Hall C
Mission experts will provide a status update on NASA's James Webb Space Telescope. Webb is currently completing the months-long process of preparing for science operations, ahead of the release of its first full-color images and data, scheduled for Tuesday, July 12.
Wednesday, June 15
10:15 a.m. PDT – AAS News Conference
Room 107, lower-level conference room
News from NASA's TESS mission will be highlighted with results from the following presentation:
- "The HD 260655 System: Two Rocky Worlds Transiting a Bright M Dwarf at Just 32 Light-Years"
2:15 p.m. PDT – AAS News Conference
Room 107, lower-level conference room
News from NASA's Chandra X-ray Observatory and Hubble will be highlighted with results from the following presentations:
- "A High Velocity Pulsar in a Galactic Supernova Remnant Measured by the Chandra X-ray Observatory"
- "Strange Abundances in a White Dwarf: Evidence for Simultaneous Accretion of Rocky and Icy Bodies"
6:30 p.m. PDT – SOFIA Town Hall
Ballroom C
The SOFIA team will provide a report on the status of the airborne observatory, which will end operations by Sept. 30, 2022, after a successful eight years of science.
Thursday, June 16
10:15 a.m. PDT – AAS News Conference
Room 107, lower-level conference room
News from a variety of missions with NASA involvement will be highlighted with results from the following presentation:
- "New Images Combine Telescopes to Reveal the Growth and Destruction of Interstellar Dust in Nearby Galaxies"
12:45 p.m. PDT – Nancy Grace Roman Space Telescope Town Hall
Ballroom D
Mission experts will provide a status update on the development of the Roman Space Telescope, which is planned to launch no earlier than May 2027.
For more information on the meeting, including press registration and the complete meeting schedule, visit:
https://aas.org/meetings/aas240
View original content to download multimedia:
SOURCE NASA | https://www.wibw.com/prnewswire/2022/06/13/nasa-discoveries-highlighted-american-astronomical-society-meeting/ | 2022-06-13T15:48:56Z |
PHOENIX, July 20, 2022 /PRNewswire/ -- Universal Technical Institute, Inc. (NYSE: UTI), a leading provider of transportation and technical training programs, today announced that it plans to report results for the third quarter of fiscal year 2022 on Wednesday, August 3, 2022, after market close. Jerome Grant, chief executive officer, and Troy Anderson, chief financial officer, will host a conference call at 4:30 p.m. Eastern Time on the same day to discuss the financial results and operating performance.
To participate in the live call, investors are invited to dial (844) 881-0138 (domestic) or (412) 317-6790 (international). A live webcast of the call will be available via the Universal Technical Institute investor relations website at https://investor.uti.edu. Please go to the website at least 10 minutes early to register, download and install any necessary audio software. The conference call webcast will be archived for fourteen days at https://investor.uti.edu. Alternatively, the telephone replay can be accessed through August 17, 2022, by dialing (877) 344-7529 (domestic) or (412) 317-0088 (international) and entering passcode 8868532.
Founded in 1965 and headquartered in Phoenix, Universal Technical Institute's (NYSE: UTI) mission is to serve our students, partners, and communities by providing quality education and support services for in-demand careers. Approximately 250,000 students have graduated from one of UTI's 15 campuses located across Arizona, California, Florida, Illinois, Michigan, North Carolina, Pennsylvania, New Jersey, and Texas. UTI's campuses are accredited by the Accrediting Commission of Career Schools and Colleges (ACCSC), while its employer-aligned technical training programs are offered under four brands: Universal Technical Institute, Motorcycle Mechanics Institute / Marine Mechanics Institute, NASCAR Technical Institute, and MIAT College of Technology. For more information and a complete list of all programs offered, please visit www.uti.edu or follow on LinkedIn @UniversalTechnicalInstitute and on Twitter @news_UTI.
Media Contact:
Alanna Vitucci
Public Relations Director
Universal Technical Institute, Inc.
(480) 710-6843
Investor Relations Contact:
Robert Winters or Davis Snyder
Alpha IR Group
(312) 445-2870
UTI@alpha-ir.com
View original content to download multimedia:
SOURCE Universal Technical Institute, Inc. | https://www.wibw.com/prnewswire/2022/07/20/universal-technical-institute-release-third-quarter-fiscal-year-2022-results-august-3-2022/ | 2022-07-20T21:44:26Z |
SAN JUAN, Puerto Rico (AP) — Powerful lawmakers in Puerto Rico are joining conservatives in states across the U.S. mainland in attempting to set tighter restrictions on abortions, alarming feminist groups and others on the island.
A recently introduced bill would prohibit abortions starting at 22 weeks, or when a doctor determines that a fetus is viable, with the sole exception being if a woman’s life is in danger. That is roughly in line with most U.S. state laws, though more limiting than Puerto Rico’s current status, which sets no term limit.
The move comes at a time when a conservative majority on the U.S. Supreme Court has many speculating that it may reverse or weaken the constitutional right to abortion recognized under the landmark 1973 Roe v. Wade ruling.
A Puerto Rico Senate committee approved the bill last week in a 9-3 vote despite objections from the island’s health and justice departments. The health secretary said the measure interferes with the patient-doctor relationship and doesn’t take into account circumstances that affect women’s health and access to abortion services. The justice secretary objected to the bill’s call for a government registry of those who terminate pregnancies and the reasons behind it, which he said could endanger patients’ right to privacy.
Feminist groups and others also complained of a lack of public hearings before the bill was approved.
Some were further angered when José Luis Dalmau, president of Puerto Rico’s Senate and the opposition Popular Democratic Party, said last week that those who abort a viable fetus are “murderers.”
His speech brought criticism from former governors of his own party, which has long been considered more liberal than the New Progressive Party of Gov. Pedro Pierluisi.
While many polls show majority support for abortion rights in many or most cases on the U.S. mainland, there are signs the opposite is true in Puerto Rico: Recent polls are scarce, but a 2017 survey by Pew Research found that about three quarters of people in Puerto Rico opposed abortion in all or most cases — a far higher percentage than among Puerto Ricans living on the U.S. mainland.
Smaller, more recent surveys by local media organizations suggest public opinion hasn’t swayed much. And key politicians from Puerto Rico’s two main parties seem to see advantages in appealing to anti-abortion beliefs.
Raúl Cotto-Sierra, a political philosophy professor at the University of Puerto Rico, said both the Popular Democratic Party and the New Progressive Party are trying to regain conservative supporters they lost in the recent election to newer parties such as Project Dignity, which ran on a Christian platform and vowed to implement abortion restrictions.
Sen. Joanne Rodríguez Veve, a member of that party, is one of the authors of the current abortion bill. Joining her are Dalmau and Sen. Thomas Rivera Schatz, a former Senate president who is a member of the New Progressive Party.
If Puerto Rico lawmakers approve the bill, they would join a growing trend of U.S. states restricting abortions.
Forty-four U.S. states have imposed a threshold on abortions — many at fetal viability or in a range of 20 to 24 weeks. And last year, 19 states enacted more than 100 abortion restrictions, the highest total in any year since the Roe v. Wade ruling, according to the Guttmacher Institute, a New York-based research organization that supports abortion rights. The most recent occurred Tuesday, when the Republican-controlled House of Oklahoma approved a bill that makes performing an abortion in most circumstances a felony punishable by up to 10 years in prison.
Puerto Rico’s Senate had been expected to vote Monday on the bill, but instead kicked it back to the Committee on Life and Family Affairs following criticism about the lack of public hearings. Rodríguez, one of the senators who authored the bill, oversees that committee.
“This is a real threat that we’re facing,” said attorney Amárilis Pagán, executive director of Mother Project, a nonprofit group focused on helping women. “We have to align forces so we can fight this.”
The committee is expected to hold public hearings this month and send it to the Senate for a vote. If it passes, it would go to the House of Representatives.
Sens. Dalmau, Rivera and Rodríguez released a joint statement implying they don’t expect hearings to sway positions: “Some believe or imply that holding public hearings would change the minds of those who favor or those who oppose the measure. Time will tell.”
Their supporters include the activist group Women for Puerto Rico, which said the bill could help boost the island’s dwindling birth rate and argued that fetuses at 23 weeks have survived.
The territory of 3.2 million people recorded a total of more than 3,700 abortions in 2020, a drop from the 4,200 reported in 2018, according to the latest government statistics. Health officials say about 99% of abortions in Puerto Rico are done before 22 weeks.
Gov. Pedro Pierluisi has not joined the debate, saying only he favors public hearings “so that we can obtain input from all parties, including medical criteria. We must be careful in this matter, and it must depend on the greatest amount of analysis possible.” | https://cw33.com/health/ap-health/puerto-rico-steps-into-abortion-restriction-debate/ | 2022-04-07T23:51:24Z |
AUSTIN (KXAN) — Our investigation into medical debt lawsuits began when an email landed in our inbox last year. The tip referenced a civil court in Williamson County with a large number of lawsuits aiming to collect unpaid medical bills.
The tip offered a good starting point, leading us to discover a Central Texas hospital – and a law firm working on its behalf – behind hundreds of those suits. We wanted to know: how were people in Central Texas being affected by these cases?
Using online court databases, we discovered almost all the hospital’s cases were filed in one court – Williamson County Justice of the Peace Precinct 2. In 2020, the hospital’s cases accounted for over 70% of all small claims lawsuits in that court, according to records provided by court administration.
We didn’t find the hospital engaged in any illegal practice or process. Under current Texas law, the hospital is within its right to sue former patients for medical debt.
Find out how we connected with people who were sued, and what’s being done in the future.
Explore the ‘Medical Debt Lawsuits’ project
- Read the story: Hear from people facing lawsuits and lawmakers and explore interactive charts and multmedia
- Listen to the podcast: A special episode about medical debt challenges across Texas and the U.S.
- Explore behind the scenes: Watch a timeline of lawsuits in Central Texas and learn how this story came together
- Get help: Learn what you should do if you’re sued over medical debt
Catalyst is a specialty unit within the KXAN investigative team focused on “digital-first” storytelling that aims to make a positive change in society. The unit takes a multi-platform, innovative approach to each project and rotates among various investigators. | https://cw33.com/news/texas/how-a-texas-hospitals-debt-lawsuits-launched-a-statewide-investigation/ | 2022-09-12T16:09:46Z |
PASADENA, Calif., June 16, 2022 /PRNewswire/ -- OpenX Technologies, Inc., a leading global omnichannel advertising exchange, today announced the appointment of broadcast and advertising industry veteran Geoff Wolinetz as senior vice president of demand platforms. In this role, Wolinetz will oversee OpenX's relationships with demand-side platforms (DSPs) with a focus on emerging digital platforms and TV. His immediate priorities are building and expanding the strategic relationships with DSP partners and helping them "future-proof" their businesses as the industry moves into a cookie-less environment.
Most recently, Wolinetz led the expansion of the connected TV business at Chalice, a marketing and data science company that helps brands create custom algorithms for DSPs, as the company's senior vice president of growth.
"Geoff brings a robust supply-side perspective, most notably in broadcasting and TV advertising, that will be invaluable in growing our DSP business," said John Gentry, chief executive officer of OpenX. "As OpenX continues to take a more holistic approach within the digital advertising value chain – reducing the friction between supply and demand – Geoff's previous experience on both sides of the equation will help us connect those dots."
Wolinetz's career has focused on building relationships with inventory suppliers and helping them monetize their businesses. Prior to Chalice, he was the senior vice president of client relationships and head of revenue at Comcast Corp.'s FreeWheel, which enables all segments of the new TV ecosystem. Earlier, he spent 16 years at Turner Broadcasting, Inc. supporting advertising and operational services in various leadership positions.
"OpenX is at an exciting stage of its evolution as an industry-leading connector of supply and demand, and it is making serious commitments to sustainability within the industry," said Wolinetz. "I'm thrilled to join the company and help grow our demand partnerships in new and interesting ways. I'm inspired by the culture of inclusivity and eager to be a part of an organization that places such emphasis on making the ecosystem a better place for everyone involved."
OpenX is a pioneering leader in advertising technology, helping create a world where the open web thrives. The company powers advertising on web, mobile and connected TV formats, enabling marketers to reach their target audience across OpenX's global network of publishers. OpenX works with more than 130,000 premium publishers and receives more than 250 billion ad requests every day. OpenX has been certified as a CarbonNeutral® company and is on a path to becoming one of the first companies in the world to achieve Net-Zero status.
View original content to download multimedia:
SOURCE OpenX Technologies, Inc. | https://www.mysuncoast.com/prnewswire/2022/06/16/openx-names-industry-veteran-geoff-wolinetz-oversee-demand-side-platform-relationships/ | 2022-06-16T20:17:40Z |
Good Samaritans lift truck off trapped 10-year-old boy after accident
WICHITA FALLS, Texas (KAUZ/Gray News) - A 10-year-old boy trapped under a truck after an accident in Texas was saved by a group of community members who came together to lift the truck off him.
Porter Hulme is in the hospital with severe injuries, but his family said they’re still in awe that a dozen or so drivers saw the accident and got out of their cars to help, lifting the one-ton truck high enough to pull Porter to safety.
“When they told me that my sons were alive, my prayer was of gratitude,” Scott Hulme, Porter’s father, told KAUZ.
After a long day of roping cattle, Ethan and Porter Hulme were on their way back home when one of their tires blew out.
“And then my other tire blew, and that’s when it really shot us into the ditch and after which I tried to keep it as straight as I could, but it happened so quick,” Ethan said.
The attached horse trailer then detached, causing the truck to roll many times.
“I just remember waking up, and I got out of the seatbelt and crawled out of the truck, and right as I did that, the other fella that stopped, he came around and said, ‘Are you okay?’ I said, ‘I’m fine; I’ve got to find my little brother,’” Ethan said.
Porter was found unconscious under the truck. It took Ethan and 12 good Samaritans to lift the one-ton truck off the 10-year-old. Porter is currently in the hospital with severe injuries.
“It’s going to be a rough trip. He’s got a broken right arm, a broken collar bone, four or five broken ribs on the right side, and a broken shoulder blade,” Scott Hulme said.
Porter’s parents are looking at the silver lining: Porter will still be able to walk, a feat many describe as a miracle.
“The doctor asked my son Porter if he could move his legs if he could feel his toes, and he said he was moving them, but his feet and toes wouldn’t move,” Scott Hulme said. “I nearly threw up. About a half-hour later, I went over there in the room, prayed over my son again, and said, ‘Porter can you move your toes for me,’ and he moved his toes for me.”
The Hulme family has been getting an outpouring of support worldwide, from donations to kind words and prayers. They said they couldn’t be thankful enough for the help.
“The wonderful thoughts, if I could tell any of y’all thank you enough, it would be impossible,” Scott Hulme said.
A GoFundMe has been set up for Porter’s medical expenses.
Copyright 2022 KAUZ via Gray Media Group, Inc. All rights reserved. | https://www.kxii.com/2022/06/02/good-samaritans-lift-truck-off-trapped-10-year-old-boy-after-accident/ | 2022-06-02T22:01:28Z |
BEIJING, May 16, 2022 /PRNewswire/ -- A news report by China.org.cn on UNESCO's Man and the Biosphere Programme in China:
Since China joined UNESCO's Man and the Biosphere (MAB) Programme, especially the foundation of Chinese National Committee for MAB Programm (MAB China), MAB's implementation has played a positive role in the biodiversity conservation, sustainable use of natural resources, the building of ecological civilization and a beautiful China, and the development of ecological research in China, Wang Ding, secretary general of MAB China, lately states in an article published on Bulletin of Chinese Academy of Sciences.
In his article "To Harmonize Relationship Between Human and Nature and Achieve Sustainable Development: UNESCO's Man and the Biosphere Programme in China," Wang reviews the progress of the implementation of MAB in China, analyzes the problems and challenges, and makes proposals in regard of the rising needs of global environmental governance and building a community of shared future for all life on Earth by cooperation within international community.
During the 1950s and 1960s, environmental pollution and protection gradually attracted people's attention. In 1971, René Maheu, former director general of UNESCO, first launched MAB Programme to the world at UNESCO's General Assembly. China joined this program in 1973, and the Chinese National Committee for UNESCO's Man and the Biosphere Programme (MAB China) was founded in 1978, with the support of Chinese Academy of Sciences (CAS) in collaboration with other ministries engaged in the administration of environmental conservation, forestry, agriculture, education, ocean and atmosphere, and so on. Since then, MAB China has carried out diverse explorations combining the value of UNESCO-MAB and the needs of the natural reserves in China.
According to the article, China now has built, the only one in the world, its own national biosphere reserves network, and carried out rich natural protection and sustainable development practices based on the network. A total of 34 protected natural areas, such as Changbaishan Nature Reserve in Jilin, Dinghushan Nature Reserve in Guangdong and Wolong Nature Reserve in Sichuan have been designated as the world biosphere reserves by UNESCO, with the total number ranking the first in Asia. "These reserves feature active biodiversity and ecosystem conservation, sustainable use of natural resources, and frontier exploration and international cooperation in co-development of protected areas and surrounding communities," Wang says.
To make full use of the international exchange platform of MAB and further expand the influence of MAB in China, Chinese Biosphere Reserves Network (CBRN) was established in 1993. By the end of 2020, 185 protected natural areas had been included in this network, 80 percent of which were national nature reserves, accounting for 31 percent of the total nature reserves in China. This network covers almost all the major ecosystem types and biodiversity protected areas in the country. "The network holds training seminars and other exchange activities every year, becoming one of the key trans-departmental and inter-disciplinary exchange platforms for protected natural areas," Wang writes.
"It is noteworthy that CBRN is the first national network corresponding to the world biosphere reserves network (WBRN), and this pioneering work has been highly appraised by UNESCO. The initiative promoted UNESCO to build the regional network and thematic network of world biosphere reserves, which, to some extent, disseminated the Chinese wisdom to the world. In 1996, MAB China was granted the Fred M. Packard Award (one of the most important international awards in natural conservation) by International Union for Conservation of Nature (IUCN), and the primary reason for the award was the founding of CBRN to promote the wider practice of MAB," he continues.
Wang discloses that rich sustainable development practices have been carried out in biosphere reserves. For instance, relationship between biosphere reserves and surrounding communities has been improved to promote sustainable development, and standardized ecotourism has been advocated to promote sustainable development. As a global intergovernmental science programme, MAB has supported a large number of research projects, and organized and implemented a number of research and monitoring projects in collaboration with some authoritative organizations at home and abroad since the 1980s. The idea of harmony between human and nature has been transmitted by traditional and new media, and there are also a series of training activities to improve the capacity building of reserves.
In spite of the great achievements, Wang mentions, there are still some challenges in implementing the programme in China. "In particular, it will be a major task for China to give full play to the advantages and make up for deficiencies in the post-pandemic era and the construction of protected natural area system dominated by national parks," he indicates. "MAB China will make efforts to promote the better development of UNESCO-MAB in China from three aspects."
The first is to strengthen the leading role of sciences. "It is necessary to further play the leading and supporting role of science and technology as well as the advantages of organizational talent team of CAS." He also suggests to strengthen the international cooperation to promote the exchanges between China and the world. "On one hand, we will continue to transmit the international advanced idea on ecological management to China; on the other hand, we will disseminate China's experience in recent ecological civilization construction and Chinese wisdom to the world," he says. His third suggestion is to give more play to experts of related fields and gather wisdom to build a community of shared future for all life on the earth.
UNESCO's Man and the Biosphere Programme in China harmonizes relationship between human and nature
http://belt.china.org.cn/2022-05/16/content_78219495.htm
View original content:
SOURCE China.org.cn | https://www.mysuncoast.com/prnewswire/2022/05/16/unescos-man-biosphere-programme-china-harmonizes-relationship-between-human-nature/ | 2022-05-16T14:23:16Z |
The baby formula supply problem is getting worse
By Parija Kavilanz and Ramishah Maruf, CNN Business
For months stores nationwide have been struggling to stock enough baby formula. Manufacturers say they’re producing at full capacity and making as much formula as they can, but it’s still not enough to meet current demand.
The out-of-stock rate for baby formula hovered between 2% and 8% in the first half of 2021, but began rising sharply last July. Between November 2021 and early April 2022, the out-of-stock rate jumped to 31%, data from Datasembly showed.
That rate increased another 9 percentage points in just three weeks in April, and now stands at 40%, the statistics show. In six states — Iowa, South Dakota, North Dakota, Missouri, Texas and Tennessee — more than half of baby formula was completely sold out during the week starting April 24, Datasembly said.
And although seven states had between 40-50% of baby formula products out of stock as of early April, 26 states are now struggling with supply.
“This issue has been compounded by supply chain issues, product recalls and historic inflation,” Datasembly CEO Ben Reich said. “Unfortunately, given the unprecedented amount of volatility to the category, we anticipate baby formula to continue to be one of the most affected products in the market.”
CVS and Walgreens confirmed that it is limiting customers nationwide to three toddler and infant formulas per transaction. “We continue to work diligently with our supplier partners to best meet customer demands,” Walgreens said in a statement to CNN Business.
A Target spokesperson confirmed that the retailer has limited baby formula purchases to four units per customer for online purchases. There is no limit on the number of units that can be bought in person in Target stores, the company said.
Customers shared images on social media of Walmart imposing similar constraints on its sales of baby formula, though Walmart did not confirm if it was a nationwide policy. Images shared with CNN Business show empty shelves where baby formula should be, and a sign saying only five units were allowed per customer.
Walmart did not immediately respond to a request for comment from CNN Business.
The shortage has been exacerbated by the Food and Drug Administration’s shutdown of an Abbott Nutrition facility in Sturgis, Michigan. Abbott is a major producer of baby formula.
In February, the US Food and Drug Administration recalled three brands of powdered baby formulas made by the company due to potential bacterial infections, including Salmonella. The agency advised parents not to buy or use certain batches of Similac, Alimentum and EleCare powdered infant formulas, all Abbott brands.
A former employee of Abbott Nutrition filed a whistleblower complaint with the FDA months before the recall, documenting their concerns that the company was hiding safety problems at its Sturgis, Mich. plant. The formulas manufactured at the facility were recalled after four infants drinking it had fallen ill with rare infections caused by Cronobacter sakazakii bacteria. Two infants died, the complaint said.
The Abbott spokesperson noted that the recall affected only batches of formulas produced at and distributed from its Sturgis, Mich. facility, and said that no other products that Abbott distributes had so far tested positive for Salmonella or other pathogens.
Finding standard formula has become difficult for parents, many of whom described the extraordinary lengths they’ve gone to in order to score even a single can or bottle. Specialized formula is even harder to locate amid the widespread shortage. Parents are driving to neighboring states to try their luck, and many are pleading for help on social media, imploring strangers to share or even barter any extra supply they may have.
Abbott told CNN in a statement Saturday it is working closely with the FDA to resume operations in its Michigan plant.
“We continue to make progress on corrective actions and will be implementing additional actions as we work toward addressing items related to the recent recall. In the meantime, we are working to increase the supply of infant formula by prioritizing infant formula production at our facilities that provide product to the US market,” Abbott said in a statement to CNN Business.
The-CNN-Wire
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved. | https://localnews8.com/money/cnn-business-consumer/2022/05/08/the-baby-formula-supply-problem-is-getting-worse/ | 2022-05-08T22:15:28Z |
SANDPOINT, Idaho, May 23, 2022 /PRNewswire/ -- Litehouse Inc., a 100% employee-owned company and the No. 1 Refrigerated Salad Dressing (RSD) brand in the U.S.1, unveiled a new line of thick and creamy Litehouse Dips & Spreads which complements the brand's breadth of product offerings. The new dip and spreads line features bold flavors for every dip-worthy occasion and brings the delicious taste of Litehouse dressings to the dip and spread category.
Industry data shows that consumers are snacking more often and more frequently throughout the day2 and that 69% of consumers use sour cream-based and creamy-based dips as snacks3. These insights, combined with flavor trends and strong sales for Litehouse dressing flavors like Avocado Ranch and Homestyle Ranch, led to the development of the new line of flavor-forward dips and spreads.
The new dips and spreads are an evolution of Litehouse's popular 15 oz. Veggie Dips which historically were a leader in the creamy veggie dips category. Developed to satisfy consumers' evolving palettes, the new dips and spreads feature cleaner ingredient labels, bolder flavors, and better taste. Additionally, the packaging has been refreshed with new 12 oz. tubs featuring vibrant visuals that pop on-shelf and demonstrate product versatility.
"We are continually innovating to keep pace with flavor trends and consumer preferences," said Krystle Turnball, Brand Manager at Litehouse, Inc. "Our new dips and spreads enhance everyday meals and snacks, including expanded use cases like pizza, wings and sandwiches."
Litehouse Dips & Spreads are available in five delicious new flavors:
- Homestyle Ranch is the perfect blend of sour cream, buttermilk, garlic, and onion, giving this ranch dip a classic taste that pairs well with veggies and chips.
- Avocado Ranch combines real avocado, sour cream, lime juice, spices, and a kick of jalapeno that's delicious with chips and veggies or spread over a BLT.
- Southwest Ranch blends buttermilk, jalapenos, and a dash of chipotle, resulting in robust flavor that will add a zesty twist to any dish.
- Dilly Dip is a bright and flavorful mix of dill, sour cream, and spices that pairs perfectly with veggies and pita or spread on salmon.
- Spinach Parmesan is a rich and creamy dip that combines spinach with savory parmesan cheese. This dip is a delightful complement to pretzels, bread, and crackers.
Litehouse Dips & Spreads are available in the refrigerated produce department at grocery retailers nationwide, including Kroger and Walmart, and have an SRP of $3.99.
About Litehouse:
Litehouse Inc. started in the Hope, Idaho restaurant of the Hawkins family over 50 years ago. Since then, it has become a leader in refrigerated salad dressings, dips, sauces, cheese, and other innovative consumer packaged goods, manufacturing these delicious products at its five U.S. facilities based in Idaho, Michigan, Utah, and Virginia. Litehouse offers its diverse portfolio of products through general retail, e-commerce, foodservice, deli, member stores, and value-added goods, where Litehouse products are featured in meal and salad kits. Litehouse is proud to be 100% employee-owned, and each one of the employee-owners delivers on high standards of quality and innovation.
For more information, visit www.litehousefoods.com, Facebook, Instagram, Pinterest, and Twitter.
View original content to download multimedia:
SOURCE Litehouse Inc. | https://www.mysuncoast.com/prnewswire/2022/05/23/litehouse-launches-delicious-new-dips-amp-spreads/ | 2022-05-23T15:30:35Z |
MILAN (AP) — Denim, fringe and chunky rubber sliders. These are the elements of next year’s summer wardrobe emerging from the second day Saturday of Milan Fashion Week menswear previews.
Temperatures in Milan were unusually high and the fashion crowd scooted from show to show with the thermometer topping 34 C (93 F) and forecast to keep getting hotter in the coming days. That makes linen an easy sell, but less so for the leather and even fur making appearances on Milan’s Spring-Summer 2023 runways.
Milan designers Fendi, Armani and Dolce&Gabbana sought to invoke joy with collections that beckoned a return to leisure and some notes of nostalgia. Highlights from Saturday’s shows:
____
FRINGE AT FENDI
Silvia Venturini Fendi created earthy, grounded looks for a planet-conscious generation in shades that ranged from soothing chambray to hearty ochres, merging into a new motif created from images of swirling weather patterns of planet Earth.
The collection carried some nostalgia for more innocent times, from fraying hems on jeans to soft seams on denim bags, embroidery accents that recall beaded daisy chains and long, lush tassels on moccasins. Bucket hats are cut out for a visor feel, while knit cloches sport brims. Chunky rubber slip-ons were emblazoned with the inverted double-F logo.
For an easy day look, denim trousers were worn with knitwear in matching tones, accompanied by faded denim Fendi shoppers with a long, fringe crossbody strap. For the beach, there were short shorts in linen with soft zipped jackets and sturdy-soled slip-on loafers. On the more dressy end, roomy Bermuda’s shorts in cream paired with a camel jacket and ochre zipper back, with the cutout bucket hat.
The swirling patterns of Earth showed up on jacquard coats and intarsia knitwear and fur, and on a pair of ample coveralls. Bags included duffel-bucket combo shaped by the word FENDI cut out in leather; a denim Peekaboo incorporated as an external water bottle holder and bright shoppers were made out of recycled plastic.
“It’s about a balance of decoration and simplicity,” Venturini Fendi said in show notes. “An ageless sense of freedom to play, as we rediscover the luxury of free time.”
____
DOLCE&GABBANA REVISIT SEASONS PAST
Domenico Dolce and Stefano Gabbana reached back into their archives for a new collection dubbed “Re-edition” that takes inspiration from the past, but is updated for the moment.
As if cleaning the slate, designers opened the show with a barefoot model in a white tank and briefs.
Dolce&Gabbana mixed distressed elements with tailored pieces for a high-low fashion appeal. The fashion house’s traditional lace tops were updated with a grungily distressed back, giving the otherwise dressier piece some streetwear credibility. Fraying jeans were worn with a black jacket and white shirt unbuttoned to the waist — as with the entire Re-edition collection, each piece carried a label establishing the original year of issue and the 2023 season update, for a dose of now and then.
Patchwork denim became statement pieces, with knee-high boots that appeared fashioned from jean jackets paired with patchwork shorts, leaving just a peek of leg in between. A soft white terry track suit gave way to Dolce&Gabbana’s familiar bling: a crystal covered rose-pattern jacket, worn with torn white jeans and velvet rhinestone covered slippers. Footwear included furry slippers, canvas or macrame sneakers with rope laces.
“I love the freedom of expression that they have,” said stylist Apuje Kalu, who took in the show from the front row alongside NFL quarterback Tyrod Taylor and NBA players Rudy Gay, Jaren Jackson Jr. and Corey Kispert. “That use of color, texture and print, they are not afraid of doing that for men. You don’t always see that.”
____
EMPORIO ARMANI’S SEASCAPES
The Emporio Armani collection carried the carefree waft of summer, from light chambray tones to faded coral prints. The sense of the looks was that it’s time to return to the simple pleasures.
Soft shirts, gilets and jackets, with dramatic flaps, high necks or zipper accents, were paired with streamlined cargo shorts or pleated trousers, often with informal slits up the leg.
Beachier looks, including drawstring pants and sheer knitwear, were finished with chunky rubber slip-ons, while more urban sophisticated tailored looks — including a series of black-and-white combo suits — were grounded with thick-soled black shoes.
As if to underline the need for joy, a reggae dancer jaunted down center stage to close the show. | https://cw33.com/entertainment-news/ap-entertainment/milan-fashion-week-fendi-armani-dolcegabbana-invoke-joy/ | 2022-06-18T19:32:46Z |
NEW YORK, July 12, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Apyx Medical Corporation (NASDAQ: APYX) alleging that the Company violated federal securities laws.
Class Period: May 12, 2021 to March 11, 2022
Lead Plaintiff Deadline: August 5, 2022
No obligation or cost to you.
Learn more about your recoverable losses in APYX:
https://www.kleinstocklaw.com/pslra-1/apyx-medical-corporation-loss-submission-form-2?id=29701&from=4
Apyx Medical Corporation NEWS - APYX NEWS
CLASS ACTION CASE DETAILS: The filed complaint alleges that Apyx Medical Corporation made materially false and/or misleading statements and/or failed to disclose that: (1) a significant number of Apyx's Advanced Energy products were used for off-label indications; (2) such off-label uses led to an increase in the number of medical device reports filed by Apyx reporting serious adverse events; (3) as a result, the Company was reasonably likely to incur regulatory scrutiny; (4) as a result of the foregoing, the Company's financial results would be adversely impacted; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
WHAT THIS MEANS TO YOU AS A SHAREHOLDER: If you have suffered a loss in Apyx you have until August 5, 2022 to petition the court for lead plaintiff status. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
NO COST TO YOU: If you purchased Apyx securities during the relevant period, you may be entitled to compensation without payment of any out-of-pocket fees.
HOW TO PROTECT YOUR FINANCIAL INTERESTS: For additional information about the APYX lawsuit, please contact J. Klein, Esq. by telephone at 212-616-4899 or click this link: https://www.kleinstocklaw.com/pslra-1/apyx-medical-corporation-loss-submission-form-2?id=29701&from=4.
ABOUT KLEIN LAW FIRM
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. The Klein Law Firm is a boutique litigation firm with experience in a wide range of areas including securities law, corporate finance and commercial litigation. Since 2011, our experienced attorneys have achieved superior results for our clients with a personalized focus. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
www.kleinstocklaw.com
View original content:
SOURCE The Klein Law Firm | https://www.mysuncoast.com/prnewswire/2022/07/12/apyx-alert-klein-law-firm-announces-lead-plaintiff-deadline-august-5-2022-class-action-filed-behalf-apyx-medical-corporation-shareholders/ | 2022-07-12T11:23:59Z |
LOS ANGELES, June 9, 2022 /PRNewswire/ -- GEEKOM has continued to develop and expand the Mini PC product line since the release of the Mini IT8, and the MiniAir 11 is now available as a member of the new MiniAir series. Let's take a look at it.
The title is self-explanatory. For everyone, the MiniAir 11 is a must-have, everyday Mini PC. It combines reliable performance, extensive connectivity, great flexibility, and more features into an incredibly small form factor, giving you everything you need right at your fingertips.
What are the key features
Windows 11 Pro is pre-installed and ready to use right out of the box.
Ultra-slim, space-saving design with dimensions of only 117 x 112 x 34.2 mm.
11th Gen Intel® Celeron® CPU ensures smooth, stable computer and processing power.
For sharp visuals and more efficiency, Intel® UHD graphics power two 4K screens.
Fast performance is backed by up to 32GB dual-channel DDR4 memory support.
Your mass storage needs are met by M.2 SSD storage with expansion up to 1TB.
Multiple ports for connecting various devices; Bluetooth and Wi-Fi wireless connectivity.
Low-power, low-noise, and energy-efficient design.
Day-to-day solutions
Computers are an essential part of our day-to-day lives. I think everyone will love a PC with good solutions to meet our daily computing needs. MiniAir 11 seems like a great choice.
It is simple and flexible to deploy, with a thin, simplified overall design and many mounting choices. Using the included VESA mount, this Mini PC can be mounted on the back of a monitor, TV, or embedded inside furniture, a sales rack. For steady performance, its system features a quad-core Intel® Celeron® processor, up to 32 GB dual-channel memory, and up to ITB M.2 SSD storage. Quality and flexibility are included, as well as support for dual 4K displays, HDMI and Mini DisplayPort connectors, and several USB ports.
Overall, the GEEKOM MiniAir 11 is a budget-friendly PC with daily solutions for home media, small and medium business applications, kiosks, collaboration and streaming, digital signage, and more. Streamline daily tasks like web browsing, spreadsheet editing, streaming, and light gaming with this tiny PC. Create, learn, and excel; stay connected with friends and family around the world. Experience dependable, secure performance for the modern workplace; connect and collaborate from any location. What a fantastic PC to have!
Pricing and availability
GEEKOM MiniAir 11 Pricing will range from $239 to $279
It is available to order on Jun 8, 2022 on GEEKOMPC.COM
About GEEKOM
GEEKOM was founded in 2003. Over 18 painstaking years, GEEKOM put all its efforts into the research, design, production, and sales of quality computer products. We have always been committed to offering powerful, portable, popular Mini PCs and laptops and providing flexible and diversified support to people in different scenarios. We have also set up strategic partnerships with well-known global brands, including Intel and Kingston. With us, more people will learn, work, play, and do more efficiently and easily.
Follow GEEKOM and stay in the know
Web: www.geekompc.com
Email: support@geekompc.com
Instagram: @geekompc
Facebook: @GEEKOM
TikTok: @geekompc
YouTube: @GEEKOM PC
View original content to download multimedia:
SOURCE GEEKOM | https://www.kxii.com/prnewswire/2022/06/09/its-here-geekom-miniair-11-your-everyday-mini-pc/ | 2022-06-09T15:32:03Z |
LOS ANGELES, July 25, 2022 /PRNewswire/ -- Realsee has announced the launch of its new mobile app on iOS and Android making it easier for users to scan, transform and share unique spaces using virtual reality (VR) technology.
Realsee's new app will support a range of commercially available 360 cameras in addition to the Realsee G1 lightweight gimbal frame, and the newly added Realsee Galois, a best-in-class compact laser scanner designed for precision scanning of large spaces. The new app also benefits from being faster, more streamlined, while also adding new functionality.
In an increasingly digital world, VR is being adopted by leading businesses to integrate online and offline operations, providing consumers with a new way to interact with products and services which reaches across borders and time zones.
Realsee has been recognized by partners around the world being present in 27 countries and capturing over 1.89 billion square meters (equal to over 300,000 football fields) of digital space. The firm has enjoyed significant demand in the North America market, adding to a growing footprint in Japan, South America and Southeast Asia. Realsee's products and services are being used across a wide range of industries, from real estate and interior design, to accommodation, hospitality and facilities management – all sectors which rely on maximizing use of space.
With over four billion cumulative users and 200 brands taking advantage of Realsee's services, the firm is looking to accelerate its presence in major international markets. Seeking to offer more innovative spatial capture solutions and products to an increasingly global marketplace.
View original content:
SOURCE Realsee | https://www.mysuncoast.com/prnewswire/2022/07/25/realsee-major-provider-digital-space-solutions-launches-new-app-accelerates-overseas-expansion/ | 2022-07-25T07:55:14Z |
Survivors dig by hand after Afghanistan quake killing 1,000
GAYAN, Afghanistan (AP) — Survivors dug by hand Thursday through villages in eastern Afghanistan reduced to rubble by a powerful earthquake that killed at least 1,000 people, as the Taliban and the international community that fled their takeover struggled to aid the disaster’s victims.
In Paktika province’s hard-hit Gayan district, villagers stood atop the mud bricks that once was a home there. Others carefully walked through dirt alleyways, gripping onto damaged walls with exposed timber beams to make their way.
The quake was Afghanistan’s deadliest in two decades, and officials said the toll could rise. An estimated 1,500 others were reported injured, the state-run news agency said.
The disaster inflicted by the 6 magnitude quake heaps more misery on a country where millions face increasing hunger and poverty and the health system has been crumbling since the Taliban retook power nearly 10 months ago amid the U.S. and NATO withdrawal. The takeover led to a cutoff of vital international financing, and most of the world has shunned the Taliban government.
How — and whether the Taliban allow — the world to offer aid remains in question as rescuers without heavy equipment dug through rubble with their bare hands.
“We ask from the Islamic Emirate and the whole country to come forward and help us,” said a survivor who gave his name as Hakimullah. “We are with nothing and have nothing, not even a tent to live in.”
The full extent of the destruction among the villages tucked in the mountains was slow in coming to light. The roads, which are rutted and difficult to travel in the best of circumstances, may have been badly damaged, and landslides from recent rains made access even more difficult.
While modern buildings withstand magnitude 6 earthquakes elsewhere, Afghanistan’s mud-and-brick homes and landslide-prone mountains make such temblors even more dangerous.
Rescuers rushed in by helicopter, but the relief effort could be hindered by the exodus of many international aid agencies from Afghanistan after the Taliban takeover last August. Moreover, most governments are wary of dealing directly with the Taliban.
In a sign of the muddled workings between the Taliban and the rest of the world, the Taliban had not formally requested that the U.N. mobilize international search-and-rescue teams or obtain equipment from neighboring countries to supplement the few dozen ambulances and several helicopters sent in by Afghan authorities, said Ramiz Alakbarov, the U.N. deputy special representative to Afghanistan.
Still, officials from multiple U.N. agencies said the Taliban were giving them full access to the area.
Taliban spokesman Zabihullah Mujahid wrote on Twitter that eight trucks of food and other necessities from Pakistan arrived in Paktika. He also said Thursday that two planes of humanitarian aid from Iran and another from Qatar had arrived in the country.
Obtaining more direct international help may be more difficult: Many countries, including the U.S., funnel humanitarian aid to Afghanistan through the U.N. and other such organizations to avoid putting money in the Taliban’s hands.
The quake was centered in Paktika province, about 50 kilometers (31 miles) southwest of the city of Khost, according to neighboring Pakistan’s Meteorological Department. Experts put its depth at just 10 kilometers (6 miles). Shallow earthquakes tend to cause more damage.
The death toll reported by the Bakhtar news agency was equal to that of a quake in 2002 in northern Afghanistan. Those are the deadliest since 1998, when an earthquake that was also 6.1 in magnitude and subsequent tremors in the remote northeast killed at least 4,500 people.
Wednesday’s quake took place in a region prone to landslides, with many older, weaker buildings.
In neighboring Khost province’s Speray district, which also sustained serious damage, men stood atop what once was a mud home. The quake had ripped open its timber beams. People sat outside under a makeshift tent made of a blanket that blew in the breeze.
Survivors quickly prepared the district’s dead, including children and an infant, for burial. Officials fear more dead will be found in the coming days.
“It is hard to gather all the exact information because it is mountainous area,” said Sultan Mahmood, Speray district’s chief. “The information that we have is what we have gathered from the residents of these areas.”
___
Associated Press writers Jon Gambrell in Dubai, United Arab Emirates, and Rahim Faiez and Munir Ahmed in Islamabad contributed to this report.
Copyright 2022 The Associated Press. All rights reserved. | https://www.kxii.com/2022/06/23/survivors-dig-by-hand-after-afghanistan-quake-killing-1000/ | 2022-06-23T05:45:18Z |
Wells Beach Resort Campground to be renamed Sun Outdoors Wells Beach
OCEAN CITY, Md., May 4, 2022 /PRNewswire/ -- Maryland-based outdoor hospitality specialist Blue Water recently assisted in the transition of Wells Beach Resort Campground in Wells, Maine in partnership with Sun Outdoors. This top-rated campground – soon to be known as Sun Outdoors Wells Beach – is located in the heart of southern Maine and is surrounded by scenic beaches, perfect for any vacation getaway. Blue Water officially took over the operations of the property in November 2021 and will be assisting in this transition in partnership with Sun Outdoors.
"This is a wonderful opportunity for additional Blue Water presence in New England along with our KOA partnerships: Lebanon KOA Holiday on Salmon Falls River and Strafford / Lake Winnipesaukee South KOA Holiday," said Todd Burbage, Blue Water's CEO. "Wells Beach has amazing potential for waterfront adventures and an already established quality of service that we can't wait to take to the next level."
Guests can choose from seasonal sites, 29 tent sites, and 169 various RV sites. Amenities include 18-hole mini golf, a swimming pool, two playgrounds, a recreational field, sand volleyball, a fitness center, a camp store for camping supplies, groceries, souvenirs, and more. Returning guests can also expect to continue to see the same friendly faces of the staff at the park.
"Blue Water was instantly drawn to this property due to it being an immaculate family camping resort with a 10/10/10 Good Sam rating – the highest rating of all parks in Wells," Burbage said. "The best feature is that guests can use the Wells Trolley System to get to Wells Beach and area attractions without even having to drive! These qualities, paired with the coastal New England charm and an immersive 18-hole mini golf course, made it the perfect addition to our growing portfolio."
Sun Outdoors Wells Beach is open from May 13 to October 13. Online booking is now available to help guests conveniently plan their next Wells Beach trip. To learn more and book reservations, visit www.sunoutdoors.com/maine/sun-outdoors-wells-beach.
About Blue Water:
Founded in 2002, Blue Water specializes in investing, developing, and managing RV resorts, campgrounds, hotels, and attractions. Blue Water's integrated approach to marketing, revenue management, and operations has quickly established itself as a hospitality industry leader. With dozens of resort-area properties in East Coast states from Maine to Florida, and new additions out west in Texas, Montana, and Oregon, the Blue Water family is committed to creating elite assets, delivering exceptional guest experiences, and enhancing the communities we serve. To learn more, visit BWDC.com.
About Sun Outdoors:
Sun Outdoors is a leader in outdoor hospitality and is committed to its mission of offering guests exceptional and transformative outdoor experiences. With over 150 locations across the U.S. and Ontario, Canada, Sun Outdoors offers guest several ways to stay: from RV sites to vacation rentals, from tent camping to glamping, whether they stay for a weekend, season, or longer. Visit www.sunoutdoors.com to learn more.
View original content to download multimedia:
SOURCE Blue Water Development | https://www.mysuncoast.com/prnewswire/2022/05/04/blue-water-assumes-management-top-rated-maine-campground/ | 2022-05-04T18:32:27Z |
SAN JOSE, Calif., Aug. 1, 2022 /PRNewswire/ -- BridGene Biosciences, Inc., a biotechnology company using a proprietary chemoproteomics technology to discover and develop small molecules for high value, traditionally undruggable targets, today announced that David Sperandio, Ph.D., a medicinal chemist with more than 20 years' experience, has joined the company as the Head of Chemistry.
Dr. Sperandio, an inventor on 23 patents and author of 25 peer-reviewed publications, has extensive experience leading cross-functional teams from molecule discovery through IND filing. Dr. Sperandio will lead the BridGene chemistry team and supervise research into covalent chemistry, chemical proteomics and quantitative mass spectrometry as methods for identifying undruggable targets. Additionally, Dr. Sperandio will be responsible for advancing BridGene's internal pipeline of first-in-class drugs for hard-to-drug targets in oncology.
BridGene co-founder and CEO Ping Cao, Ph.D., commented, "David's addition to our leadership team and the recent Series B financing deepen BridGene's capabilities for using IMTAC™ to discover new drugs for novel and traditionally undruggable targets. David's leadership and experience will help expand BridGene's library of molecules to identify as potential drug candidates as we aim to advance a pipeline of first-in-class drugs for these new targets."
Dr. Sperandio most recently served as an Executive Director at Biomea Fusion, where he led the team that identified BMF-500, a potential best-in-class targeted covalent FLT-3 inhibitor for the treatment of acute myeloid leukemia. Prior to joining Biomea Fusion, Sperandio led a collaboration of R2M Pharma Inc. with Tenaya Therapeutics Inc., which discovered novel HDAC6 inhibitors for cardiovascular diseases and was key for the clinical development of TN-301, an experimental treatment for heart failure. Dr. Sperandio started his career at Celera Corp. and focused on the structure-guided discovery of covalent reversible serine-protease inhibitors. He later moved to Gilead Sciences Inc., where he led the chemistry team that discovered Alobresib (GS-5829), a novel BRD4 inhibitor for prostate cancer, and Presatorvir (GS-5806), the first small molecule RSV fusion inhibitor that reached the clinic and showed proof of concept in men.
Dr. Sperandio commented, "I am excited to join BridGene at such a dynamic time for the company. 2022 has been a remarkable year so far, and I look forward to working closely with the management team to continue to drive the success of IMTAC™."
Dr. Sperandio obtained his doctoral degree in Organic Chemistry from the University of Zurich and completed his postdoctoral research at Stanford University.
About BridGene Biosciences
BridGene is a biotechnology company focused on discovering and developing innovative small molecules that drug traditionally undruggable targets, providing new paths to treat diseases. By using its proprietary chemoproteomics platform, IMTAC™, BridGene can screen small molecules against proteins in live cells to discover drug candidates for high value and traditionally undruggable targets. For this purpose, BridGene takes advantage of its proprietary, diverse library of tagged, drug-like small molecules. The ultimate goal is to enable breakthrough small molecule drug discovery with expanded mechanisms to treat diseases with targets previously inaccessible to small molecules. The uniqueness of BridGene's technology allows it to perform IMTAC™ screening for both covalent and non-covalent molecules, target different amino acids and discover new targets for disease treatments by deconvoluting phenotypic screening hits. The company is advancing a diversified pipeline of first-in-class drugs for targets in multiple disease areas. For more information, visit https://www.bridgenebio.com.
Contact
Tiberend Strategic Advisors, Inc.
Investors
Jonathan Nugent
+1-205-566-3026
jnugent@tiberend.com
Media
Bill Borden
+1-732-910-1620
bborden@tiberend.com
Dave Schemelia
+1-609-468-9325
dschemelia@tiberend.com
View original content to download multimedia:
SOURCE BridGene Biosciences | https://www.kxii.com/prnewswire/2022/08/01/bridgene-biosciences-names-david-sperandio-phd-head-chemistry/ | 2022-08-01T12:58:20Z |
Coronavirus committee: Meat companies lied about impending shortage and put workers at risk
By Parija Kavilanz and Danielle Wiener-Bronner, CNN Business
At the height of the pandemic, as the coronavirus infected tens of thousands of meat industry workers and caused hundreds to die, executives at the nation’s largest meat producers were aware of the transmission risk in their plants and successfully lobbied the Trump White House and the USDA to circumvent coronavirus prevention measures and regulations, according to the latest findings of a congressional investigation.
The House Select Subcommittee on the Coronavirus Crisis, which launched its probe in February 2021 into meatpackers’ Covid response, also found that meat processors’ warnings about the nation being on the brink of a meat shortage were not based in fact, and that industry experts at the time believed them to be intentionally misleading.
“The Select Subcommittee’s investigation has revealed that former President Trump’s political appointees at USDA collaborated with large meatpacking companies to lead an Administration-wide effort to force workers to remain on the job during the coronavirus crisis despite dangerous conditions, and even to prevent the imposition of commonsense mitigation measures,” committee chairman, US Rep. James Clyburn, said in a statement Thursday.
The North American Meat Institute, an industry trade group, criticized the committee’s report as “partisan” and said it “distorts the truth about the meat and poultry industry’s work to protect employees during the Covid-19 pandemic.”
“The House Select Committee has done the nation a disservice. The Committee could have tried to learn what the industry did to stop the spread of Covid among meat and poultry workers, reducing positive cases associated with the industry while cases were surging across the country. Instead, the Committee uses 20/20 hindsight and cherry picks data to support a narrative that is completely unrepresentative of the early days of an unprecedented national emergency,” Julie Anna Potts, president and CEO of the North American Meat Institute, said in a statement.
Ignoring the risk
The investigation centered on meat producers Tyson, Smithfield, JBS USA, Cargill and National Beef along with the Occupational Safety and Health Administration and its response to worker illnesses. Meat plants became a hotbed for Covid outbreaks in the first year of the pandemic as workers grappled with long hours in crowded work spaces.
The initial results of the probe, released last October, showed infections and deaths among workers in plants owned by those five companies in the first year of the pandemic were significantly higher than previously estimated, with over 59,000 workers infected and at least 269 deaths.
The report cited examples, based on Internal meatpacking industry documents, of at least one company ignoring warnings by a doctor of the risk of rapid transmission of the virus in their facilities.
For example, the report found that a JBS executive received an April 2020 email from a doctor in a hospital near JBS’ Cactus, Texas, facility saying, “100% of all Covid-19 patients we have in the hospital are either direct employees or family member[s] of your employees.” The doctor warned: “Your employees will get sick and may die if this factory continues to be open.”
The emails prompted Texas Governor Greg Abbott’s chief of staff to reach out to JBS, but it remains unclear whether JBS ever responded to the email, the report said.
“This coordinated campaign prioritized industry production over the health of workers and communities and contributed to tens of thousands of workers becoming ill, hundreds of workers dying, and the virus spreading throughout surrounding areas,” said Rep. Clyburn.
“The shameful conduct of corporate executives pursuing profit at any cost during a crisis and government officials eager to do their bidding regardless of resulting harm to the public must never be repeated,” he said.
In a response to CNN’s request for comment, JBS, in an email, did not address the doctors warning, highlighted by the committee.
“In 2020, as the world faced the challenge of navigating Covid-19, many lessons were learned, and the health and safety of our team members guided all our actions and decisions. During that critical time, we did everything possible to ensure the safety of our people who kept our critical food supply chain running,” said Nikki Richardson, a spokeswoman for JBS USA & Pilgrim’s.
The investigation surfaced examples of some meatpacking industry executives acknowledging that being transparent about the lax mitigation measures and high infections rates in plants would cause alarm.
The report, citing a company email, said on April 7, 2020, managers at National Beef discussed avoiding explicitly notifying workers when an infected plant worker returned to work with physician clearance, saying they should instead “announce line meeting style,” likely referring to announcements made during informal in-person huddles of production line workers, “hoping it doesn’t incite additional panic.”
Meatpacking companies and the United States Department of Agriculture “jointly lobbied the White House to dissuade workers from staying home or quitting,” according to the report.
Further, meatpacking companies successfully lobbied USDA officials to advocate for Department of Labor policies that deprived their employees of benefits if they chose to stay home or quit, while also seeking insulation from legal liability if their workers fell ill or died on the job, according to the report.
The probe found that in April 2020, the CEOs of JBS, Smithfield, Tyson and other meatpacking companies asked Trump cabinet member and then Secretary of Agriculture Sonny Perdue to “elevate the need for messaging about the importance of our workforce staying at work to the POTUS or VP level,” and to make clear that “being afraid of Covid-19 is not a reason to quit your job and you are not eligible for unemployment compensation if you do.”
On April 28th, 2020, President Trump signed an executive order directing meat packing plants to follow guidance being issued by the CDC and OSHA on how to keep workers safe, so processing plants could stay open.
Sec. Perdue would later send a letter to governors and to the leaders of meat processing companies.
“Meat processing facilities are critical infrastructure and are essential to the national security of our nation. Keeping these facilities operational is critical to the food supply chain and we expect our partners across the country to work with us on this issue.”
The Committee report said meatpacking companies and lobbyists worked with USDA and the White House in an attempt to prevent state and local health departments from regulating coronavirus precautions in plants.
A spokesman for Perdue, who is currently Chancellor of the University of Georgia, said Perdue “is focused on his new position serving the students of Georgia” and did not provide a comment on the committee report.
Former President Trump has not responded to CNN Business’s request for comment.
False claims of impending meat shortage
As their workers fell ill with the virus, several meat suppliers were forced to temporarily shut plants in 2020 and their companies’ executives warned the situation would put the US meat supply at risk.
The report slammed those warnings as “flimsy if not outright false.”
“Just three days after Smithfield CEO Ken Sullivan publicly warned that the closure of a Smithfield plant was ‘pushing our country perilously close to the edge in terms of our nation’s meat supply,” he asked industry representatives to issue a statement that ‘there was plenty of meat, enough . . . to export,” while Smithfield told meat importers the same, the report said.
The investigation found industry representatives thought Smithfield’s statements about a meat supply crunch were “intentionally scaring people.”
At the time, food experts told CNN Business that while there were meat shortages, at times, various cuts of meat might not be available.
Tyson said via an email response that it was reviewing the report.
Smithfield said it took “every appropriate measure to keep our workers safe” when it encountered a “first-of-its-kind challenge” two years ago.
“To date, we have invested more than $900 million to support worker safety, including paying workers to stay home, and have exceeded CDC and OSHA guidelines,” Smithfield spokesman Jim Monroe, said in an email to CNN Business.
“The meat production system is a modern wonder, but it is not one that can be re-directed at the flip of a switch. That is the challenge we faced as restaurants closed, consumption patterns changed and hogs backed-up on farms with nowhere to go. The concerns we expressed were very real and we are thankful that a true food crisis was averted and that we are starting to return to normal…. Did we make every effort to share with government officials our perspective on the pandemic and how it was impacting the food production system? Absolutely,” he said.
Cargill and National Beef could not immediately be reached for comment.
The committee said its report was based on more than 151,000 pages of documents collected from meatpacking companies and interest groups, calls with meatpacking workers, union representatives, and former USDA and OSHA officials, among others.
— CNN Business’ Jennifer Korn contributed to this report
The-CNN-Wire
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved. | https://localnews8.com/money/cnn-business-consumer/2022/05/12/coronavirus-committee-meat-companies-lied-about-impending-shortage-and-put-workers-at-risk/ | 2022-05-12T19:38:52Z |
NEW YORK, May 23, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AbbVie Inc. ("AbbVie" or the "Company") (NYSE: ABBV). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.
The investigation concerns whether AbbVie and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
On September 1, 2021, the United States Food and Drug Administration ("FDA") announced that final results from the safety trial of Xeljanz, an anti-inflammatory drug manufactured Pfizer Inc., established an increased risk of serious adverse events, even with low doses of Xeljanz. As a result, the FDA determined that it would require new and updated warnings for Xeljanz and Rinvoq, an anti-inflammatory drug manufactured by AbbVie, because Rinvoq "share[s] similar mechanisms of action with Xeljanz" and "may have similar risks as seen in the Xeljanz safety trial." The FDA also indicated that it would further limit approved indications for Rinvoq as a result of these safety concerns.
On this news, AbbVie's stock price fell $8.51 per share, or 7.04%, to close at $112.27 per share on September 1, 2021.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com
888-476-6529 ext. 7980
View original content to download multimedia:
SOURCE Pomerantz LLP | https://www.mysuncoast.com/prnewswire/2022/05/24/shareholder-alert-pomerantz-law-firm-investigates-claims-behalf-investors-abbvie-inc-abbv/ | 2022-05-24T02:01:38Z |
High Visibility Enforcement initiative in Manatee and Sarasota Counties following high number of serious and deadly crashes
SARASOTA, Fla. (WWSB) - Serious and fatal crashes involving pedestrians and bicyclists continues to be a big issue in Sarasota and Manatee Counties.
Both counties now implementing a High Visibility Enforcement campaign. The focus is mainly in areas that see many of these crashes.
“What we do is target a section or different multiple sections within the county,” said Matt Binkley with the Sarasota County Sheriff’s Office. “We’ll go into that area, we’ll target that area and we’ll educate. We’ll enforce in order to eliminate the amount of incidents that are occurring.”
Many drivers ABC7 talked with say a lot of the roads are very dangerous, especially in high traffic areas.
“Bad, really bad, everyone is in a big hurry,” said Michael Richards, a Sarasota resident.
One pedestrian who walks on Bee Ridge Road everyday near Village Green Drive in Sarasota says it makes him nervous to walk around here. That is one of the target areas.
“There’s no respect, a lot of blind spots,” said Steve, a Sarasota pedestrian. “Drivers really just don’t care, that’s the way it is.”
This campaign is already underway in Manatee County. It will get started in Sarasota County on Monday.
Law enforcement says the end goal of all this is awareness, education, and to keep people safe.
“We really want people to see us there for that presence,” said Randy Warren, a spokesperson for the Manatee County Sheriff’s Office. “We’re going to be able to write citations, it’s not that we want to but it’s going to be necessary, we want people to understand that there’s a reason there have been a lot of unfortunate crashes.”
This High Visibility Enforcement campaign will run until May.
Here are the locations in Manatee County that will be targeted.
- 14th St. W. (63rd Ave. W. to 60th Ave. W.)
- 14th St. W. (69th Ave. W. to 900 ft. north of 66th Ave. W.)
- 14th St. W. (57th Ave. W. to 55th Ave. W.)
- Cortez Rd. W. (28th St. W. to 17th St. W.)
- 14th St. W. (53rd Ave. W. to Cortez Rd. W.)
- 14th St. W. (Cortez Rd. W. to 28th Ave. W.)
- 15th St. E. (63rd Ave. E. to 41 Ave. E.)
- 15th St. E. (30th Ave. E. to 22nd Ave. E.)
- Cortez Rd. W. (66th St. W. to Timber Lane)
- 301 Blvd. E. (1st St. to 9th St. E.)
- Lockwood Ridge Rd. (University Pkwy. to Glenbrooke Dr.)
- 5th St. E. (61st Ave. E. to 59th Ave. E.)
- 53rd Ave. E. (24th St. E. to 37th St. E.)
- US 301 (60th Ave. E. to 100th Dr. E.)
- US 301 (25th Dr. E. to 45 Ave. E.)
- US 41 N. (20th St. E. to 27th Ave. E.)
- US 19 (45th St. Ct. W. to Bayshore Dr.)
- US 41 N. (33rd St. W. to 45 St. E.)
These are the locations in Sarasota County:
• Bee Ridge Road from Village Green Drive to Maceachen Boulevard, Sawyer Road to Bond Place, and Maxfield Drive to I-75.
• Fruitville Road from Houle Avenue to Paramount Drive.
• South Tamiami Trail from Park Place to Jacaranda Boulevard, E. Seminole Drive to Sunset Beach Drive, Beneva Road to N. Lakepointe Boulevard, and Blackburn Point Road to E. Bay Street.
Copyright 2022 WWSB. All rights reserved. | https://www.mysuncoast.com/2022/08/04/high-visibility-enforcement-initiative-manatee-sarasota-counties-following-high-number-serious-deadly-crashes/ | 2022-08-04T01:15:19Z |
City celebrates EPL title with Manchester parade
MANCHESTER, England (AP) — Manchester City has celebrated its fourth English Premier League title in five seasons after a parade through the streets of the northern city. Three open-top buses carrying City players and staff navigated a short route through Manchester center after starting at the National Football Museum. The parade came a day after City added another incredible comeback story to its history, scoring three goals in about five minutes to beat Aston Villa 3-2 and edge out Liverpool to the title by a single point. Kevin De Bruyne was far from alone in sporting dark glasses, admitting to being a “little bit drunk.” | https://localnews8.com/sports/ap-national-sports/2022/05/23/city-celebrates-epl-title-with-manchester-parade/ | 2022-05-23T22:39:54Z |
– Hans Lindeberg, Previously Head of ALK's Nordic Region, Has Been Named as the New Senior Vice President of ALK North America, Effective Immediately –
– His Predecessor Jorge Alderete Retires from the Company at the End of June –
ROUND ROCK, Texas, May 19, 2022 /PRNewswire/ -- ALK (ALKB:DC / OMX:ALK B / AKABY / AKBLF) has appointed Hans Lindeberg as its new Senior Vice President of Commercial Operations in North America. He succeeds Jorge Alderete, who will retire from ALK on June 30, 2022.
Lindeberg joined ALK in 2005, following 10 years at GSK in various sales and marketing roles. After joining the company, he was appointed to sales and marketing roles of increasing seniority, until being named General Manager for ALK's Nordic sales region in 2014. In this role, Lindeberg doubled the size of the Nordic sales region and was named ALK's 'General Manager of the Year' twice.
"Hans Lindeberg has a reputation for mobilizing and motivating his teams to deliver outstanding results and a proven track record of using digital engagement to motivate people with allergy to take action on their allergic condition," said Executive Vice President of Commercial Operations Søren Niegel. "By adding his leadership and skills to our already highly capable North American management team, Hans will further advance our ambitions in the region and our ability to deliver on our strategic aspirations."
Lindeberg will be based in Bedminster, New Jersey, and will report directly to Søren Niegel, also becoming a member of ALK's Global Commercial Operations Management Team and its cross-functional Americas Management Team. His appointment is effective immediately to secure a smooth transition until Alderete retires.
Commenting on Alderete's retirement, Niegel said, "In his ALK career of 23 years, rising from National Sales Director to Senior Vice President of ALK North America, Jorge has overseen a significant expansion of our commercial setup in North America, including the repatriation of our tablets franchise from a former partner. Under his leadership, ALK North America has grown significantly, generating broad-based, double-digit compounded annual sales growth throughout his tenure, and has thereby helped a lot more people with their allergies. On a personal note, I'd like to thank Jorge for his counsel, support and leadership and wish him a happy transition into this new chapter in his life."
About ALK
ALK is a global, research-driven pharmaceutical company that focuses on the prevention, diagnosis and treatment of allergies. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,600 people worldwide and is listed on Nasdaq Copenhagen. Find more information at www.alk.net.
For further information, please contact:
Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525
Media: Dan Commerford, tel. +1 908 842 8355
View original content to download multimedia:
SOURCE ALK, INC. | https://www.kxii.com/prnewswire/2022/05/19/hans-lindeberg-appointed-lead-alk-north-america/ | 2022-05-19T12:37:30Z |
The specialized resource offers patients with small cell lung cancer (SCLC) and their caregivers access to treatment information, informative webinars, the latest scientific news, and a supportive community
WASHINGTON, Aug. 16, 2022 /PRNewswire/ -- LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit organization, has launched the Small Cell Lung Cancer Patient Gateway. This new resource completes the suite of six Patient Gateways, where lung cancer survivors can access relevant information tailored to their specific subtype. Small cell lung cancer accounts for 15% of all lung cancers and is often diagnosed in people with a history of smoking. The Gateway allows survivors to locate specialists and resources more easily. The Patient Gateway also features information on treatment options and the ability to connect with a community of fellow survivors and their caregivers.
"Due to the aggressive nature of small cell lung cancer, it is especially important that survivors have access to accurate information and breaking news regarding treatment options and new clinical trials," said Andrea Ferris, president and CEO of LUNGevity Foundation. "We hope that patients and their caregivers are empowered by the information they find on the Patient Gateway and can use what they learn to be active decision-makers in their treatment."
The Small Cell Lung Cancer Patient Gateway is a user-friendly and easily accessible information portal that offers the latest medical updates and practical resources for patients and their caregivers. The Gateway, available at sclc.lungevity.org, provides visitors with information about the disease and how it is treated. Visitors can also find a specialist, join a variety of patient and caregiver communities, explore clinical trial options, and read up-to-the-minute, curated news and trends. Each individual Gateway features expert webinars and blogs, patient and caregiver stories, and quarterly newsletters.
The Small Cell Lung Cancer Patient Gateway joins the EGFR, KRAS, ALK, Rare Mutations and Fusions, and Non-Small Cell Lung Cancer (NSCLC) platforms at gateway.lungevity.org.
The Small Cell Lung Cancer Patient Gateway is supported by generous sponsorships from AstraZeneca, EMD Serono, Genentech, and Jazz Pharmaceuticals.
About LUNGevity Foundation
LUNGevity Foundation is the nation's leading lung cancer organization focused on improving outcomes for people with lung cancer. The foundation works tirelessly to advance research into early detection and more effective treatments, and to ensure that patients have access to these advances. LUNGevity seeks to make an immediate impact on quality of life and survivorship for everyone touched by the disease—while promoting health equity by addressing disparities throughout the care continuum. LUNGevity provides information and educational tools to empower patients and their caregivers, promote impactful public policy initiatives, and amplify the patient voice through research and engagement. The organization provides an active community for patients and survivors—and those who help them live better and longer lives.
Comprehensive resources include a medically vetted and patient-centric website, a toll-free HELPLine for support, the International Lung Cancer Survivorship Conference, and an easy-to-use Clinical Trial Finder, among other tools. All of these programs are to achieve our vision—a world where no one dies of lung cancer. LUNGevity Foundation is proud to be a four-star Charity Navigator organization.
About Lung Cancer in the US
- About 1 in 17 Americans will be diagnosed with lung cancer in their lifetime.
- More than 236,000 people in the US will be diagnosed with lung cancer this year.
- About 60%-65% of all new lung cancer diagnoses are among people who have never smoked or are former smokers.
- Lung cancer takes more lives in the United States than the next two deadliest cancers (colorectal and pancreatic) combined.
- Only about 23% of all people diagnosed with lung cancer in the United States will survive 5 years or more, BUT if it is caught before it spreads, the chance of 5-year survival improves dramatically.
Please visit lungevity.org to learn more.
View original content to download multimedia:
SOURCE LUNGevity Foundation | https://www.wibw.com/prnewswire/2022/08/16/lungevity-launches-new-small-cell-lung-cancer-patient-gateway/ | 2022-08-16T17:47:28Z |
ATLANTA — A settlement in a federal class-action lawsuit against the Georgia Department of Labor reached last week is in limbo after the state agency withdrew its consent to the agreement.
The Southern Poverty Law Center announced last Thursday that it had reached a preliminary settlement with the Labor department in a suit over unemployment claims during the pandemic. A group of Georgians experiencing delays in claims processing since the pandemic began in March 2020 took the agency to court.
The settlement in U.S. District Court for the Northern District of Georgia could help jumpstart stalled unemployment determinations, payments, and appeals for Georgians still facing problems sorting out their claims.
But the Labor department withdrew its consent to the agreement last Friday, according to court filings.
The state attorney general’s office — on behalf of the Labor department — claimed that the Southern Poverty Law Center had already violated the terms of the settlement by posting a press release about the new agreement unilaterally.
The settlement agreement required a joint press release, the department claimed in its motion to withdraw its consent.
Georgia Commissioner of Labor Mark Butler confirmed that the department had filed a motion to withdraw its consent to the agreement.
Butler said the Labor department had already instituted some of the improvements mentioned in the settlement agreement prior to the lawsuit, such as a claim status tracker.
“[The Labor department] will continue to work with the plaintiffs’ attorneys to find common ground in this lawsuit, but not to the detriment of the men and women who have worked tirelessly for the past two years on issuing over $23 billion in unemployment insurance and pandemic relief benefits,” Butler said.
It’s unclear what will happen to the settlement agreement for now.
But if adopted as outlined in federal court filings, the agreement will focus on helping Georgians whose unemployment insurance cases are still stalled and on improving communication.
One focus is on clearing backlogs of claimants who still need help resolving the 2020 and 2021 delays. The SPLC will submit a list of names to the Labor department of people who are still having problems getting payment, and the agency will attempt to resolve the cases.
The settlement also outlines steps the agency will take to clear out a backlog of appeals by the end of this year, including hiring a vendor to scan documents to allow for electronic processing and setting up an “automated validity determination system.”
Another focus is on improving communication between the Labor department and Georgians applying for unemployment insurance.
One of the major complaints of Georgians facing difficulty getting unemployment insurance during the pandemic was finding someone to speak to at the agency. The Labor department has already instituted a modernized telephone answering system, according to the preliminary agreement.
Butler, who is named in the lawsuit, has decided not to run for re-election to the position.
Republican Bruce Thompson will face Democrat William Boddie in the race for Labor commissioner in November. | https://www.albanyherald.com/news/department-of-labor-class-action-lawsuit-in-limbo/article_a40d7e60-fd56-11ec-81a2-9791bf8a6059.html | 2022-07-06T20:24:33Z |
Frost Possible Saturday Morning, Windy 80s by Sunday Afternoon
Severe weather possible Monday, more likely Tuesday
It will be a cold start to your Saturday with many locations getting into the upper 30s. Patchy frost is possible for our eastern and northern quadrant, from Ada to Durant to Bonham and eastward. A light freeze may visit portions of Atoka and Pushmataha Counties.
Southerly winds return for Saturday with sunny, windy, and dry conditions. Gusts to 30 mph are expected. Sunday will be very windy with gusts to 40 mph and highs in the lower 80s, making for elevated fire danger. Rain potential creeps into the forecast at 20% for Monday as the moisture supply deepens, and a dry line takes shape.
It looks like thunderstorms and severe weather will be most likely Tuesday as the dry line presses eastward during peak afternoon heating.
Cooler air returns later next week.
Here’s your 7-Day:
Saturday: Sunny, windy afternoon, warmer
Sunday: Mostly sunny, very windy
Monday: 20% Thunderstorms
Tuesday: 50% Thunderstorms
Wednesday: 30% showers morning, decreasing clouds, windy
Thursday: Sunny
Friday: Partly cloudy
Steve LaNore
Chief Meteorologist
News 12 / KXII-TV
Copyright 2021 KXII. All rights reserved. | https://www.kxii.com/2022/04/08/frost-possible-saturday-morning-windy-80s-by-sunday-afternoon/ | 2022-04-08T22:44:18Z |
Innocence claims denied in death of Chris Paul’s grandfather
WINSTON-SALEM, N.C. (AP) — Judges have denied the innocence claims of four men who were convicted of killing the grandfather of NBA star Chris Paul when they were teens, even though a key witness has recanted her testimony. In 2020, the North Carolina Innocence Inquiry Commission found sufficient evidence of factual innocence to send their cases to a panel of three Superior Court judges. The judges rejected the claims of the four defendants Thursday after days of testimony. Paul’s 61-year-old grandfather Nathaniel Jones died from a heart attack outside his Winston-Salem home after being tied up, beaten and robbed in November 2002. Paul was a standout high school basketball player at the time. | https://localnews8.com/sports/ap-national-sports/2022/04/28/innocence-claims-denied-in-death-of-chris-pauls-grandfather/ | 2022-04-28T22:17:00Z |
Qatar says it will boost investment in Spain by $4.9 billion
MADRID (AP) — Qatar is set to boost investments in Spain by $4.9 billion in the coming years. Spain’s state news agency EFE said emir of Qatar made the announcement at a gala dinner held Tuesday by Spanish King Felipe VI at the Royal Palace in Madrid. The emir is set to “sign agreements” when he sits down Wednesday with Spanish Prime Minister Pedro Sánchez. The details of the investments have not been made public. With Europe scrambling to find alternatives to Russian energy, Qatar is positioned to help fill the gap with exports of liquefied natural gas. | https://localnews8.com/news/2022/05/18/qatar-says-it-will-boost-investment-in-spain-by-4-9-billion/ | 2022-05-18T11:51:53Z |
LOUISVILLE, Ky., Aug. 11, 2022 /PRNewswire/ -- USA Cares (usacares.org) is honored to announce it has received a $20,000 grant from the Disabled Veterans National Foundation (DVNF) to reduce factors contributing to veteran suicide. This funding will provide military families with life-changing financial assistance with housing, food, utilities, and other essential bills.
"The support we have received from DVNF over the years has provided significant relief for the veterans and military families we serve," said Trace Chesser, President/CEO of USA Cares. "DVNF's Capacity Building grants are vital to enhancing the efforts of veteran service organizations like USA Cares, and we are grateful and honored to be selected to receive this funding to further the impact of our mission."
Joseph VanFonda (USMC Sgt.Maj. Ret.), EO of the Disabled Veterans National Foundation said, "We are very excited to continue our capacity building relationship with USA Cares. Our veterans need all the resources available to them, and USA Cares provides wonderful training that will create long term stability while improving their quality of life."
USA Cares is a 501(c)(3) charitable organization whose mission is to provide post-9/11 military veterans, service members, and their families with emergency financial assistance and post-service skills training that will create a foundation for long term stability. Our services improve the quality of life of veterans and their families and reduce potential factors that contribute to veteran suicide.
Disabled Veterans National Foundation exists to provide critically needed support to disabled and at-risk veterans who leave the military wounded—physically or psychologically—after defending our safety and our freedom.
DVNF achieves this mission by:
- Offering direct financial support to veteran organizations that address the unique needs of veterans, and whose missions align with that of DVNF.
- Providing supplemental assistance to homeless and low-income veterans through the Health & Comfort program and various empowerment resources.
- Providing an online resource database that allows veterans to navigate the complex process of seeking benefits that they are entitled to because of their military service, as well as additional resources they need.
- Serving as a thought leader on critical policy issues within the veteran community and educating the public accordingly.
View original content:
SOURCE USA Cares | https://www.mysuncoast.com/prnewswire/2022/08/11/usa-cares-receives-grant-award-disabled-veterans-national-foundation/ | 2022-08-11T20:20:54Z |
66% of SAP users say the biggest hurdle is aligning business, project, and IT teams
BONN, Germany and BOSTON, July 28, 2022 /PRNewswire/ -- LeanIX, a leading platform enabling continuous transformation of corporate and product IT, today announced the findings of its SAP S/4HANA 2022 Survey. The report reveals that organizations need to view the SAP S/4HANA transformation as more than a technical upgrade — it is a business imperative. The report also found that the inherent complexity of the ERP landscape and its connection to the broader IT landscape complicates and slows down the transformation process. As a result, many organizations have barely started the transformation — and time is running out.
The survey looked at the challenges companies face in the transformation process, the primary drivers of SAP S/4HANA transformation, the phases and timing of SAP S/4HANA transformation, the levels of customization in existing ERP systems, the state of collaboration between SAP & EA teams, and the appropriate involvement of EAs in the transformation process.
Key findings from the report include:
- Over half the respondents (54%) see the move to S/4HANA as a business transformation, not a technical upgrade. Respondents also identified enterprise architect management and business process modeling as the disciplines most critical to the process.
- When it comes to ERP, companies face a lot of complexity. Over 70% of companies run more than one ERP system and more than half of the companies surveyed use ERP systems from more than one vendor.
- About half of the respondents said both identifying interdependencies between ERP and non-ERP landscapes and defining the target architecture as the top challenges faced in in their SAP S/4HANA transformation. These challenges arise in part from the fact that fewer than 20% of respondents can establish an overview of their entire software landscape in under a month.
- To complete a successful transformation, collaboration is essential. The biggest obstacle to transformation? Aligning business, project, and IT teams, say two-thirds of those surveyed. Less than half (38%) of EAs describe their involvement in the SAP S/4HANA transformation as sufficient, which represents a drop from the level of involvement reported in last year's LeanIX SAP S/4HANA survey (47%).
"Time is running out for organizations that plan on moving to SAP S/4HANA," said André Christ, CEO and Co-Founder of LeanIX. "With only a third of those surveyed saying they will complete their transformation within the planned timeframe, organizations need to focus on actions that will accelerate the process. Enabling effective collaboration between business, project, and IT teams is the critical step they need to take. This will not only speed things up, but will also ensure that the transformation delivers lasting business value."
For more information about LeanIX, visit www.leanix.net
Survey Methodology
In April and May 2022, 100 IT experts from international enterprises participated in an online survey conducted by LeanIX and focused on the transformation process, ERP systems, the importance of collaboration and the challenges faced. For readability, the results in this report are presented as rounded percentages.
About LeanIX
LeanIX's Continuous Transformation Platform® is trusted by Corporate IT and Product IT to achieve comprehensive visibility and superior governance. Global customers organize, plan and manage IT landscapes with LeanIX's automated and data-driven approach. Offering Enterprise Architecture, SaaS Management, and Value Stream Management, LeanIX helps organizations make sound decisions and accelerate transformation journeys. LeanIX has hundreds of customers globally, including Adidas, Atlassian, Bosch, Dropbox, Santander and Workday. The company is headquartered in Bonn, Germany, with offices in Boston and around the world.
View original content:
SOURCE LeanIX | https://www.mysuncoast.com/prnewswire/2022/07/28/leanix-survey-reveals-only-12-sap-users-have-finished-sap-s4hana-transformation/ | 2022-07-28T12:43:08Z |
NEW YORK and SAN JUAN, Puerto Rico, Aug. 18, 2022 /PRNewswire/ -- miR Scientific, LLC announced the launch of national event #CanDoBlue to create awareness of the need for widespread prostate cancer testing during the 2022 Prostate Cancer Awareness Month (also known as "PCAM"). On September 1, New York, New Jersey, Chicago, and Puerto Rico will simultaneously light up dozens of landmarks and buildings in blue to call attention to the urgent need for getting men tested for this aggressive type of cancer.
Across North America, September is recognized as Prostate Cancer Awareness Month by healthcare experts, advocates and organizations concerned with men's prostate health. miR Scientific's goal is to introduce #CanDoBlue into men's health conversations in Canada, Israel, Japan, the U.S., Puerto Rico, Singapore, and other global markets. For Puerto Rico, the hashtag that will highlight the event has been adapted to #VísteteDeAzul.
Last month the company announced that miR Sentinel™ Prostate Cancer Test is commercially available in the United States, Puerto Rico and select international markets. miR Sentinel™ is a novel, urine-based, molecular test that analyzes small non-coding RNA using a proprietary biostatistical algorithm. The miR Sentinel™ Test assesses the risk of aggressive prostate cancer and is intended to aid in the detection and clinical management of men >45 years of age at risk for prostate cancer.
"An estimated 268,490 men will be diagnosed with prostate cancer in 2022 according to the American Cancer Society. miR Scientific's vision is to revolutionize prostate cancer disease management by improving accessibility and accuracy of the tools used to assess each man's personal risk of this aggressive disease. To achieve this we need to create awareness of the urgency of getting tested," said Sam Salman, Chairman and CEO of miR Scientific.
"We believe that the miR Sentinel Test offers patients and providers a non-invasive means of accurately assessing a man's prostate cancer risk, which could potentially reduce unnecessary biopsies and biopsy-related complications in men with low-risk of clinically significant prostate cancer, while prioritizing diagnostic and treatment resources to those men that potentially harbor clinically significant prostate cancer," added Salman.
In Puerto Rico, where extensive testing was conducted by the company, prostate cancer is the most common cancer among men, and the leading cause of cancer deaths among men. The rate of prostate cancer on the Island is 149% higher than in the mainland United States and is 65% more likely to be diagnosed in a late stage of the disease. Since October 2019, miR Scientific has been committed to improving prostate cancer outcomes for men in Puerto Rico and created a coalition of doctors, academics, universities, and the government to create a movement that the company hopes will encourage men to get tested.
The first Prostate Cancer Awareness Month in Puerto Rico was observed in September 2021. miR Scientific worked closely with Governor Pedro Pierluisi and the Senate of Puerto Rico to bring attention to a topic that is seldom discussed by Puerto Rican men.
"#CANDOBLUE is a global movement that started in Puerto Rico and now is expanding to the US and other global markets. Our coalition's partners have signed agreements to help us educate, empower, and engage others to raise awareness about prostate cancer. Our partners include Puerto Rico Urological Group, Empresas River Siaca, Grupo Ferré Rangel, D Group Equities Management Corp., ZERO - The End of Prostate Cancer, Fans for the Cure, Puerto Rico Consortium for Clinical Investigation, Partnership for Modern Puerto Rico, Synercode, PR5G, Health Front Group, Puerto Rico Federal Affairs and Administration, and San Juan Bautista School of Medicine Clinical Research Unit," noted Arminda "Mindy" Figueroa, Chief of Staff & Country Manager for Puerto Rico.
The results of miR Scientific's recent clinical study performed at multiple sites within the US and Puerto Rico were presented at the 2022 American Urological Association's Annual Meeting. The results show that in the study cohort of ~1100 men, the miR Sentinel™ Test identified molecular evidence of prostate cancer in at-risk men with 98.5% sensitivity and distinguish clinically non-significant (nominally No Pathological Evidence of Prostate Cancer and Grade Group 1), from clinically significant prostate cancer (nominally Grade Groups 2-5) with a prognostic sensitivity of 83%.
Additional information on the miR Sentinel™ Prostate Cancer Test as well as information on how to access the test can be found by visiting miRSentinel.com or calling 855-55CALLMIR from the United States or +1 (855) 552-2556.
Join the #CanDoBlue movement! For more information visit CanDoBlue.org
About miR Scientific:
miR Scientific, LLC is a healthcare company committed to transforming global cancer management by providing early and highly accurate detection, characterization, and monitoring of disease. The Company's proprietary miR Disease Management Platform® was developed to assist providers in effectively managing targeted diseases, initially focused on urological cancers.
The platform powers the miR Sentinel™ Prostate Cancer Test, a liquid biopsy urine test that can accurately detect, classify, and monitor prostate cancer based on the interrogation of small-non-coding RNAs extracted from urinary exosomes.
Media Contact: Arminda 'Mindy' Figueroa, media@mirscientific.com
View original content:
SOURCE miR Scientific, LLC | https://www.kxii.com/prnewswire/2022/08/18/mir-scientific-launches-can-do-blue-september-1-2022-prostate-cancer-awareness-month/ | 2022-08-18T14:57:45Z |
WOODINVILLE, Wash., June 29, 2022 /PRNewswire/ -- As farmers face surging fuel and input costs, unseasonal cold weather and precipitation in Washington State throws a wrench into already complicated food pricing.
"The pathways are up to our boot tops with standing water," said Amy White of Bumblebee Farms. "Even cold-weather crops like spinach, arugula, radishes, peas, and kale are struggling because the soil is saturated with water."
Over the past decade, small local farms have been adjusting to increasing heat by switching out tried-and-true seed varietals for more heat-hardy varieties. By contrast, spring of 2022 has been unusually cold and wet—Seattle is experiencing its coldest spring since 1955.
Many farms in the Greater Seattle area--Sammamish, Snohomish, and Snoqualmie valleys—have high water tables. Seasonal flooding comes with the territory--but not usually this late in the season, when drier, heat-loving crops like tomatoes and squash are supposed to be in the ground already. Food safety rules dictate that fields cannot be planted again until 60 days after a flooding event—meaning some varieties may not have any time to come to fruition.
Plus, when the soil is saturated, tilling can create compaction and disrupt soil ecosystems. For those on tiny margins, farmers are having to choose: Wait until the weather is more stable for heat-loving crops, or till anyway, which can create problems in the future.
"We use a no-till system so we are just waiting until the soil is workable with hand tools," said Noa Kay, farmer at Songbird Haven Farms. "Still, we're planting our cucumbers a month later than what's typical."
That uncertainty is partially responsible for rising costs of food—though not entirely. "We're hearing consistent reports of everything from linen service to the price of olive oil increasing," Farmstand Local Foods shared in a recent newsletter.
An American workforce already reeling from the pandemic is struggling to afford rising costs of food. On the flip side, farmers are barely breaking even. "We are now losing money on every box we send off the farm, so it's time to raise our shipping prices, which will further limit our customer base," Micha Ide wrote in a recent article for Eat Local First.
"The soil is still so wet that we can't get spinach or carrots to germinate. We've done two failed plantings on each," said White. "Arugula is a whole saga, with half our plantings failed."
"That's quite a bit of income and time lost," she added. "It's been discouraging, but we just have to keep replanting, otherwise when the weather does improve we won't have anything."
Increasing fuel costs and inputs like animal feed, fertilizer, and equipment are also putting a strain on farmers. "The heat dome the Pacific Northwest experienced last year damaged crops and reduced the availability of local grains, which raised our feed costs by 12.5%," wrote Ide. "That was before the expected global shortage of wheat that is being predicted due to the war in Ukraine."
As the summer plays out, we're yet to see the true impacts to our food system that the extreme weather this year has caused. "With more precarious growing conditions we need a lot more resiliency and fairer resource allocation," said Kay.
Ansley Roberts, Farm Manager at 21 Acres, said that local food producers are uniquely positioned to contribute to food access initiatives, trial climate-hardy seed varietals, and grow a wide variety of crops. While industrial farms are dependent on imports from abroad, small farms are able to nimbly source their needs locally. And farms on about five acres or less grow more food crops, account for a greater percentage of crop diversity, and produce less waste than large-scale industrial agriculture.
One thing is certain: small farms are still the best-positioned to address urgent food needs.
"What I saw during the pandemic was that smaller, more localized operations were the first to pivot and feed their community," said Roberts. "It speaks to the importance of diversity in our food systems."
21 Acres Center for Local Food & Sustainable Living is a nonprofit organization committed to educating about the value of agroecology, soil health, local food systems, and green energy as solutions to climate change. Our campus in Woodinville, Washington hosts a Certified Organic regenerative farm, a LEED Platinum certified building, a distribution center for local food, and a year-round retail Farm Market.
View original content to download multimedia:
SOURCE 21 Acres Center for Local Food | https://www.wibw.com/prnewswire/2022/06/29/21-acres-extreme-precipitation-threatens-food-security-drives-up-local-food-costs/ | 2022-06-29T18:07:43Z |
ON!Track Unite is an open API single hub for construction data with proven capability to provide better insights, improved efficiencies, and greater cost savings.
PLANO, Texas, June 14, 2022 /PRNewswire/ -- Hilti North America, an innovator of tools, technology, software, and services to the commercial construction industry is leading a fundamental shift in how customers run their businesses with the launch of ON!Track Unite, a new open Application Programming Interface (API) for software integration. The platform transforms what is often complex and manual-based into a seamless digital experience, unifying data from multiple sources, increasing data quality and consistency, and automating processes involving ON!Track Tool Tracking and Asset Management and other software.
In 2015, Hilti launched construction asset management solution ON!Track to help solve problems related to managing assets, services, workers, and safety certifications. The company is building on the software with the release of ON!Track Unite, an add-on which makes using ON!Track even more efficient and unified. The open API facilitates a seamless exchange of data between ON!Track and other applications construction professionals use to run their businesses.
The platform is designed to support two main integration scenarios. Customers can use off-the-shelf integrations available on the marketplace or create their own integrations by leveraging the ON!Track Unite open API. Developers can rely on guidance and modern API documentation on the ON!Track Unite hub to easily build scalable integrations. Construction software players can offer joint customers a pre-built integration between ON!Track and the application they develop or distribute, which can be listed on the integration marketplace. The marketplace already includes many integrations, including Fieldwire, Trackunit, Procore and Viewpoint, a leading construction Enterprise Resource Planning (ERP). Hilti has plans to offer even more integrations soon.
In recent years, Hilti has made major investments to digitize the construction industry and extend its digital Internet of Things (IoT) portfolio. Today's announcement follows the brand's recent acquisition of the project management software Fieldwire, a partnership with Trackunit in the heavy equipment telematics space, and the launch of Nuron, an all-new 22-volt cordless platform with built-in connectivity.
"This API-first approach assist in enabling integrations with other applications so that ON!Track Unite can be catered to the exact needs of every customer, providing a unified experience, and unlocking new business value," said Thibaud Lefebvre, Senior Director of Tools Services at Hilti North America. "Customers who utilize the ON!Track Unite platform will experience a step change in how they operate their businesses because it avoids the duplication manual data entries, helps to correctly allocate asset and consumables costs, and opens the door to increased tool crib transparency. We believe this technology will help our partners make better data-driven decisions and take productivity to new heights."
Fleet customers of Hilti's all-new cordless tool platform, Nuron, can leverage the innovation for a fully connected experience. The tools generate data which is then stored on the Nuron batteries and sent securely to the cloud during every charge without any operator interaction. The data collected includes information on tool usage, charging location and battery state-of-health. Those insights are accessible through ON!Track and will be accessible on the ON!Track Unite open API in the near future.
"This is what customers expect from Hilti – valuable solutions to help their businesses modernize, which will lead to limitless growth and profitability," said Lefebvre. "We understand data is a critical asset that must be highly prioritized. This launch represents a key piece of the open ecosystem of integrated applications that we are expanding and affirms our commitment to the digital change journey."
Hilti will proactively discuss and offer support services to customers who decide to implement ON!Track Unite. The platform is available now for U.S. and Canadian customers. The global rollout will continue in 2023.
Hilti supplies the worldwide construction industry with technologically leading products, systems, software, and services that provide construction professionals with innovative solutions and superior added value. In North America, there are more than 3,800 team members who share Hilti's corporate culture based on integrity, teamwork, commitment, and the courage to embrace change. Hilti calls Texas its North American home since relocating its headquarters to Plano in 2015. To learn more about Hilti, visit our website at www.hilti.com.
View original content to download multimedia:
SOURCE Hilti | https://www.kxii.com/prnewswire/2022/06/14/hilti-opens-up-its-ontrack-tool-tracking-app-help-enable-contractors-manage-more-than-jobsite-assets/ | 2022-06-14T18:53:34Z |
UNITED NATIONS (AP) — The U.N. chief called for Lebanon’s parliamentary elections on May 15 to be “free, fair transparent and inclusive” in a report circulated Wednesday and urged the quick formation of a government afterward that gives priority to implementing reforms addressing the country’s multiple crises.
Secretary-General Antonio Guterres said in the report to the U.N. Security Council that political polarization in the country has deepened and the Lebanese people “are struggling daily to meet basic essential needs.” He pointed to frequent protests across the country sparked by “public frustration with the political situation and the economic and financial crisis.”
The May 15 elections for parliament are the first since Lebanon’s economic meltdown began in late 2019. The government’s factions have done virtually nothing to address the collapse, leaving Lebanese to fend for themselves as they plunge into poverty, without electricity, medicine, garbage collection or any other semblance of normal life.
The elections are also the first since the August 4, 2020, catastrophic explosion at Beirut port that killed more than 215 people and wrecked large parts of the city. The destruction sparked widespread outrage at the traditional parties’ endemic corruption and mismanagement.
Guterres, who visited Lebanon last December, said no one has yet been held accountable for the explosion and the Lebanese people are demanding “truth and justice.” He reiterated his call for “a swift, impartial, thorough and transparent investigation” and stressed that “the independence of the judiciary must be respected.”
In the May 15 election, a total of 103 lists with 1,044 candidates are vying for the 128-seat legislature, which is equally divided between Christians and Muslims.
Self-declared opposition groups remain divided along ideological lines on virtually every issue, including over how to revive the economy, and as a result, there are an average of at least three different opposition lists in each of the 15 electoral districts, a 20% increase from the 2018 elections.
Guterres noted that proposals submitted in the past two years for a women’s quota were still pending in parliament, and he urged that the new government be quickly formed “with full participation of women and young people.”
The secretary-general’s semi-annual report on implementation of a 2004 Security Council resolution reiterated that its key demands — that the Lebanese government establish its sovereignty throughout the country and that all Lebanese militias disarm and disband — have not been fulfilled.
Guterres said Hezbollah’s maintenance “of sizeable and sophisticated military capabilities outside the control of the government of Lebanon remains a matter of grave concern.” He noted Hezbollah leader Hassan Nasrallah’s February announcement that it now has the ability to transform thousands of its missiles “into precision missiles” and has been manufacturing drones “for a long time.”
The secretary-general urged the Lebanese state to “increase its efforts to achieve a monopoly over the possession of weapons and the use of force throughout its territory.”
“I continue to urge the government and the armed forces of Lebanon to take all measures necessary to prohibit Hezbollah and other armed groups from acquiring weapons and building paramilitary capacity outside the authority of the state,” the U.N. chief said, stressing that this violates Security Council resolutions.
Guterres said Hezbollah’s continued involvement in the war in neighboring Syria also risks entangling Lebanon in regional conflicts and undermining its stability.
He called on countries in the region with close ties to Hezbollah to encourage its disarmament and transformation into “a solely civilian political party.” Both Syria and Iran have close ties to Hezbollah. | https://cw33.com/news/international/ap-international/un-chief-urges-free-transparent-elections-in-lebanon-may-15/ | 2022-05-05T05:01:34Z |
- Powered by the industry's first lidar with 7 μm resolution and a dedicated Neural Processing Unit, the printer automatically fine-tunes itself for bed leveling, flow linear advance, vibration compensation, and even belt tensioning.
- Print up to 16 colors/engineering materials, with the help of a 300°C all-metal hot end, 120°C heat bed, and temperature regulated closed chamber.
- Easy support removal with dedicated support filament.
- 20,000 mm/s² acceleration and 500 mm/s speed.
- Eco-efficient design that reduces carbon footprint by up to 80% and plastic waste by 20%.
SHENZHEN, China, May 23, 2022 /PRNewswire/ -- Bambu Lab announces today that its cutting-edge X1 Series is ready for pre-order on Kickstarter on 31st May. During the past few weeks, the X1 Series has triggered vivid discussions in 3D printing community on social media platforms and has been the subject of several latest online reviews.
Bursting with industry-leading features, Bambu Lab X1 Series distinguishes itself first by its AI-powered automated capabilities. A Quad-core SoC with a dedicated 2TOPs Neural Processing Unit, matching Bambu Micro Lidar and over 40 sensors, provides a series of automated features, including spaghetti detection, first layer inspection, automated bed leveling with dual redundancy, extrusion calibration for linear advance flow control, and active vibration compensation. Bambu Lab X1 Series allows users to print multiple colors and materials at high speed and with incredible smoothness, raising the bar on consumer-grade 3D printing technology.
"There has been a difference between the public imagination of 3D printers fed by pop culture, which gives the idea of a magic box that satisfies every need in the blink of an eye, and the actual experience of using a 3D printer. Our goal is to create a state-of-the-art 3D printer which narrows that gap and makes 3D printing a true work of creativity." Founder and CEO of Bambu Lab, Dr. Ye Tao.
Limitless Creativity with More Colors and Materials
Printing in multiple colors and materials presents a challenge for consumer-grade 3D printers. Countless creative ideas and projects are either restrained by the limited choices of colors and textures or undermined by the lack of seamless filament management. That's where Bambu Lab's Automatic Material System (AMS) comes in.
Bambu Lab AMS is an intelligent system that communicates with the toolhead to guarantee smooth feeding and automatic mid-print filament switching. It can detect the tension on filament and actively adjust the feeding pace. With RFID technology, Bambu Lab AMS identifies filament loaded inside and automatically configures the most appropriate print settings. Equipped with humidity sensors and with an airtight enclosure, Bambu Lab AMS keeps the filament dry and ready to use, which is especially helpful for engineering grade materials such as nylon and polycarbonate, which are hydroscopic. Each Bambu Lab AMS is composed of 4 filament slots, and up to 4 AMS can be installed in parallel. With multiple filament slots at disposal, it's now possible to use snap-away support material or dissolvable filament to minimize the pain of removing supports.
Bambu Lab X1 Series unlocks more demanding materials than PLA and PETG by using advanced parts and thermal control. It is equipped with a 300°C all-metal hot end with a steel nozzle. The resilient steel drive gear provides steady filament feeding with maximum abrasion resistance. The X1 Series opens the door to a wider selection of materials, including PA, PC, PET, HIPS, PVA, and TPU. The X1-Carbon, which is equipped with extra cooling and a hardened nozzle and carburized drive gear, specializes in carbon fiber and glass fiber reinforced polymers.
High Speed Printing at 20,000 mm/s² Acceleration
The breathtaking speed of Bambu Lab X1 Series is made possible by strong mechanical parts, rigid and ultra-lightweight components, a high-flow hot end, and a powerful cooling system. The welded steel chassis provides a more solid platform than the bolted structure in most consumer-grade 3D printers. The CoreXY motion system and featherlight full-carbon X rail allow the ultra-lightweight toolhead to accelerate at 20,000 mm/s² with very little compromise in printing quality.
Ultra-Smoothness with Active Vibration Compensation
One of the unwanted side effects of high-speed printing is ringing. The mechanical vibrations coming from the 3D printer leave marks on the print surface in the shape of "echoes". Bambu Lab X1 minimizes ringing by automatically detecting vibration frequency and providing subtle motion compensation.
Another challenge for high-speed printing is that the extrusion needs to catch up with the sudden acceleration in X and Y movement. In the X and Y axes, it is simply Newton's law and a=F/m. For the extrusion, it is hydrodynamic and extremely difficult because the molten plastic is viscous, just imagine that you want to dynamically control the flow of honey being squeezed out of a plastic bottle at a fast pace. The X1 Series utilize a hydrodynamic model to predict flow behavior, which is sensitive to fluid properties. Bambu Micro Lidar then automatically performs calibrations to measure the hydrodynamic properties of each filament and temperature setting.
Lower Carbon Footprint
- Energy-saving: Bambu Lab X1 Series' Isothermal hotbed and shortened print time save up to 80% carbon emission in the printing process.
- Eco-friendly packaging: as a result of our eco-friendly filament packaging, 250 g of plastic is saved for every 1 kg filament used when compared with traditional methods, in addition to less transportation-related emissions for each roll of filament.
- Space saving: Bambu Lab X1 Series has the most effective build-volume-to-printer-dimension ratio, giving you room to print large projects in a small space.
- Noise reduction: Bambu Lab X1 series reduces noise pollution, thanks to its advanced motor controller, enclosed structure, and high quality-parts.
Price and Availability
Bambu Lab X1 series will be launched on Kickstarter on the 31st May, followed by Bambu Lab's official store as well as selected e-commerce platforms.
Shipment will start immediately upon the completion of the Kickstarter campaign in July.
Official web: www.bambulab.com
Facebook official user group: https://www.facebook.com/groups/bambulabofficialusers
Youtube: www.youtube.com/bambulab
Twitter: https://twitter.com/BambulabGlobal
About Bambu Lab
Bambu Lab is a consumer tech company focusing on desktop 3D printers. Starting with the X1 Series, Bambu Lab builds state-of-the-art 3D printers that break the barriers between the digital and physical worlds, bringing creativity to a whole new level.
Email us: contact@bambulab.com
Our Team
Our story started with the gathering of a team of 3D printing fans, who are also expert engineers in robotics, artificial intelligence, materials science, and internet industries. Our team is experienced in building high-tech products that bring positive impacts to the world. From the start, we have been dedicated to making cutting-edge technology affordable with advanced know-how and high production quality. We see ourselves as part of the ecosystem and are delighted to learn from and share knowledge with the 3D printing community. Our team's passion lies also in the commitment to creating the next generation of eco-friendly 3D printers - pushing the industry toward a future with a much lower carbon-footprint.
Remarks:
1. Build-volume-to-printer-dimension ratio comparison sheet
2. Discussions and reviews
- https://www.youtube.com/watch?v=6HE2ik46SFk
- https://www.youtube.com/watch?v=yvFznQa9miI
- https://www.youtube.com/watch?v=lRA-MO2fUTk
- https://twitter.com/search?q=bambu%20lab&src=typed_query
View original content to download multimedia:
SOURCE Bambu Lab | https://www.mysuncoast.com/prnewswire/2022/05/24/bambu-lab-launches-x1-series-prosumer-grade-corexy-printer-that-brings-3d-printing-technology-into-ai-powered-era/ | 2022-05-24T08:05:53Z |
NEW ORLEANS, Sept. 16, 2022 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 17, 2022 to file lead plaintiff applications in a securities class action lawsuit against MINISO Group Holding Limited (NYSE: MNSO), if they purchased or acquired the Company's securities pursuant and/or traceable to the Company's October 2020 initial public offering (the "IPO"). This action is pending in the United States District Court for the Central District of California.
What You May Do
If you purchased or acquired securities of MINISO as above and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nyse-mnso/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by October 17, 2022.
About the Lawsuit
MINISO and certain of its executives are charged with failing to disclose material information in its IPO Registration Statement, violating federal securities laws.
On July 26, 2022, market researcher Blue Orca Capital reported on a myriad of issues involving the China-based company, including that "there is overwhelming evidence that MINISO misleads the market about its core business" and that "Chinese corporate filings also indicate, in our view, that the chairman siphoned hundreds of millions from the public company through opaque Caribbean jurisdictions as the middleman in a crooked headquarters deal," among other things.
On this news, the price of MINISO's American Depositary Shares fell $1.08, or 14.98%, to close at $6.13, on unusually heavy trading volume.
The case is Ashraf v. MINISO Group Holding Limited, No. 22-cv-05815.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, California, Louisiana and New Jersey.
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850
1100 Poydras St., Suite 3200
New Orleans, LA 70163
View original content to download multimedia:
SOURCE Kahn Swick & Foti, LLC | https://www.mysuncoast.com/prnewswire/2022/09/17/miniso-group-shareholder-alert-by-former-louisiana-attorney-general-kahn-swick-amp-foti-llc-reminds-investors-with-losses-excess-100000-lead-plaintiff-deadline-class-action-lawsuit-against-miniso-group-holding-limited-mnso/ | 2022-09-17T13:46:59Z |
Senate readies final congressional OK of $40B Ukraine aid
WASHINGTON (AP) — A $40 billion infusion of military and economic aid for Ukraine and its allies was on the cusp of Senate passage Thursday as both parties rallied behind America’s latest, and quite possibly not last, financial salvo against Russia’s invasion.
Thursday’s planned vote would give final congressional approval to the package, three weeks after President Joe Biden requested a smaller $33 billion version. The House approved it last week after beefing up its defense and humanitarian expenditures, and Senate passage was not in doubt, though a modest group of America First-minded Republicans was expected to vote “no.”
Biden’s quick signature was certain as Russia’s attack, which has mauled Ukraine’s forces and cities, slogs into a fourth month with no obvious end ahead. That means more casualties and destruction in Ukraine, which has relied heavily on U.S. and Western assistance for its survival, especially advanced arms, with requests for more aid potentially looming.
Senate Majority Leader Chuck Schumer, D-N.Y., said Wednesday he was not confident this would be the final measure to help Ukraine. “They’re doing the fighting, they’re the ones getting killed, they’re the ones struggling and suffering. The least we can do is give them the weaponry they need,” he said.
Senate Minority Leader Mitch McConnell, R-Ky., said Russian President Vladimir Putin’s invasion is “a dangerous spark to be stamped out” before it succeeds or encourages other countries like China to launch attacks in their regions. Though he did not specifically address future aid for Ukraine, McConnell said countries should “stand shoulder to shoulder against authoritarian aggression” and said the U.S. must continue helping other allies upgrade their militaries.
Sen. Rand Paul, R-Ky., who’s long had non-interventionist views, used procedural tactics to thwart Schumer and McConnell, who’d planned for Senate approval a week ago.
In a personal criticism seen seldom on the Senate floor, Schumer on Wednesday called Paul’s move “repugnant” and said the delay, with passage inevitable, would “strengthen Putin’s hand.” McConnell, who last Saturday met with Ukrainian President Volodymyr Zelenskyy during a surprise visit to Kyiv, did not speak up in his fellow Kentucky Republican’s defense.
In a brief interview, Paul responded that it would be “repugnant” to disparage “the democratic process” as embodied in Senate rules that he was using. He called Schumer’s comments “callous and careless.”
The legislation contains around $24 billion for weapons, equipment and military financing for Ukraine, restoring Pentagon stocks of arms sent to the region and paying for U.S. reinforcements sent there. The rest includes economic aid to keep Zelenskyy’s government functioning, food programs for countries that rely on Ukraine’s diminished crop production, refugee assistance and funds for Kyiv to investigate Russian war crimes.
With the November elections for control of Congress in full swing, former President Donald Trump has criticized the $40 billion plan. He’s contrasted it with the current shortage of infant formula — over which the Biden administration has little control — and complained European allies are not contributing enough.
Such arguments have found traction with some — but not all — Trump-friendly Republicans in Congress.
“It’s, you know, the world’s going to end if you don’t do anything here,” said Sen. Mike Braun, R-Ind., who said he would oppose the Ukraine measure. “I’m more worried about the trust fund going broke” that finances Medicare and another that pays for Social Security.
Braun said he’s long pushed for bills that pay for themselves. Asked why saving $40 billion in this instance outweighed stopping Russia, he said, “Number one, it’s going to pass.”
Another conservative, Sen. Ted Cruz, R-Texas, said that as costly as the measure is, the aid will protect U.S. national security and said, “If Putin wins, the consequences for America and American taxpayers will be hundreds of billions of dollars.”
Sen. Mitt Romney, R-Utah, a moderate who has clashed with Trump, said in an interview that helping Ukraine defend itself “is about as smart an investment as we could possibly make.” He added, “What does America First mean? It means that we should first be concerned about the interests of America. I totally agree.”
The House approved the new bill last week by 368-57, with all “no” votes from Republicans. The Senate gave it preliminary approval Monday by 88-11, with all 11 opponents from the GOP, and Thursday’s final passage was expected to largely replicate that.
Congress approved an initial $13.6 billion measure in March. The combined price tag of nearly $54 billion exceeds what the U.S. spent on all its foreign and military aid in 2019, according to the nonpartisan Congressional Research Service.
Copyright 2022 The Associated Press. All rights reserved. | https://www.kxii.com/2022/05/19/senate-readies-final-congressional-ok-40b-ukraine-aid/ | 2022-05-19T14:04:54Z |
SEOUL, South Korea (AP) — North Korea has become one of the few nations in the world to recognize the independence of two Russian-backed separatist regions in eastern Ukraine in support of Russia’s war against its neighbor.
Ukraine’s Foreign Ministry cut off diplomatic ties with North Korea in response and condemned Pyongyang’s decision as undermining Ukraine’s sovereignty and territorial integrity.
North Korea has repeatedly blamed the United States for the crisis in Ukraine, claiming the West’s “hegemonic policy” justified Russia’s offensive in Ukraine to protect itself.
North Korea’s state media said Thursday that the country’s foreign minister, Choe Sun Hui, sent letters to leaders in the breakaway regions of Donetsk and Luhansk a day earlier to convey the North’s decision to recognize their independence and its willingness to develop diplomatic relations with both.
Donetsk separatist leader Denis Pushilin acknowledged North Korea’s decision Wednesday.
Luhansk and Donetsk together make up the Donbas region, a mostly Russian-speaking region of steel factories, mines and other industries in Ukraine’s east. Separatists have controlled parts of both provinces since 2014, but Russian President Vladimir Putin recognized their independence only shortly before the invasion began in February. Syria has since recognized their independence as well.
Ukrainian Foreign Minster Dmytro Kuleba said Russia’s appeal to North Korea for support shows Moscow has “no more allies in the world, except for countries that depend on it financially and politically.” Ukraine had already suspended its political and economic contacts with North Korea because of international sanctions imposed on the North over its nuclear weapons and ballistic missiles program.
“The level of isolation of the Russian Federation will soon reach the level of isolation of the DPRK,” Kuleba said in a statement, using the initials of North Korea’s formal name, the Democratic People’s Republic of Korea.
Russia’s invasion of Ukraine has effectively paralyzed the U.N. Security Council, where Russia is a veto-wielding permanent member, leaving an opening for North Korean leader Kim Jong Un to push forward his weapons development as he tries to cement the North’s status as a nuclear power and negotiate a removal of crippling U.S.-led sanctions from a position of strength.
North Korea has test-fired more than 30 missiles in 2022 alone, including its first flight test of an intercontinental ballistic missile in nearly five years. There are also indications the North is restoring tunnels at a nuclear testing site that was last active in 2017 in possible preparations to resume nuclear explosive tests. | https://cw33.com/news/international/ap-international/n-korea-backs-independence-of-breakaway-regions-in-ukraine/ | 2022-07-14T12:12:17Z |
ROME (AP) — Five European Union nations on the Mediterranean who fear possible waves of refugees driven by hunger out of Africa called Saturday for an end to the EU’s “voluntary” solidarity on migrants and a better way to redistribute the burden of caring for them.
The Interior ministers from Italy, Cyprus, Greece, Malta and Spain wrapped up two days of talks in Venice amid worries that the blockade of Ukraine grain exports due to Russia’s invasion could see huge numbers of refugees from Africa flooding southern Europe.
Cypriot Interior Minister Nicos Nouris told reporters that robust, common EU policy is needed on migration. “Solidarity is not a slogan, nor can it be void of substance,” Nouris said.
Past EU policies in which member countries could offer to receive some of the hundreds of thousands of migrants landing in Italy, Greece and other southern shores proved grossly inadequate.
Many EU countries didn’t step forward. Others, even with they did pledge to receive modest numbers of some of the hundreds of thousands of migrants rescued from smugglers’ unseaworthy boats, didn’t follow through.
“Solidarity in our mind cannot be voluntary,” Nouris said.
He noted that after several years of Cyprus taking in migrants, now 5% of the eastern Mediterranean island nation’s population consists of asylum-seekers.
The meeting did not address the millions of Ukrainian refugees who recently flooded into northern EU nations like Poland, Hungary and Romania.
How Europe handles large numbers of migrants takes on particular urgency now, amid fears that drought in Africa and surging food prices even before the war made shipping Ukrainian grain to Somalia, Egypt and other poor nations impossible could drive up the already alarmingly numbers of hungry people.
In the Sahel, the part of Africa just below the Sahara desert, an estimated 18 million people are facing severe hunger as farmers endure their worst production season in more than a decade.
Italian Interior Minister Luciana Lamorgese cited the blocking of grain in Ukraine as just another reason for the EU to develop a “adequate mechanism of distributing migrants” among its members.
She also pressed for more repatriation agreements with countries whose people are seeking a better life in Europe but had their asylum bids rejected since they are fleeing poverty, not war or persecution.
Italy has an effective repatriation agreement with Tunisia, but not with most other countries in Africa or in Asia whose citizens take to smugglers’ boats to try to reach southern European shores. As a result, even though their asylum applications fail, many migrants remain in Italy, often taking illegal jobs or resorting to begging.
Greece’s interior minister expressed support for more legal paths for migration.
“We cannot let smugglers decide who comes to live in Europe,” minister Notis Mitarachi told reporters.
___
Follow all AP developments on global migration at https://apnews.com/migration. | https://cw33.com/news/international/ap-international/mediterranean-nations-criticize-eu-solidarity-on-migrants/ | 2022-06-04T19:48:21Z |
Did you lose money on investments in Pegasystems? If so, please visit Pegasystems Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights.
NEW YORK, May 20, 2022 /PRNewswire/ -- Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the common stock of Pegasystems Inc. ("Pegasystems" or the "Company") (NASDAQ: PEGA) between May 29, 2020 and May 9, 2022, inclusive (the "Class Period"). The lawsuit was filed in the United States District Court for the Eastern District of Virginia and alleges violations of the Securities Exchange Act of 1934.
Pegasystems develops customer relationship management ("CRM") software, which has a very competitive market. Pegasystems repeatedly stated that the "market for our offerings is intensely competitive, rapidly changing, and highly fragmented" and that Pegasystems was subject to "significant competition" from other technology vendors. In addition, the Company assured investors that it had internally developed its products. Pegasystems also stated that the Company faced a risk that competitors may "appropriate our intellectual property."
Plaintiff alleges that unbeknownst to investors, however, Pegasystems' products and, thus, the revenue generated from those products were, in large part, the result of theft of trade secrets from one of the Company's competitors. On May 29, 2020, Pegasystems was sued by one of its principal competitors, Appian Corporation ("Appian") in Virginia circuit court for stealing its trade secrets and violating the commonwealth's computer crime law (the "Appian Litigation"). The lawsuit alleged that Pegasystems retained an employee of a government contractor from 2012 to 2014 to secretly access and learn about Appian's software and pass the information on to Pegasystems in order to improve the Company's products and better train its sales force.
Plaintiff alleges that in violation of SEC reporting requirements, for nearly two full years, Pegasystems never publicly disclosed Appian's lawsuit in its SEC filings. Pegasystems did not even disclose the existence of this lawsuit until it filed its 2021 Annual Report on February 16, 2022 – i.e., just one month before a jury trial was scheduled to begin on March 21, 2022.
After the close of the markets on May 9, 2022, Pegasystems revealed that the Virginia circuit court jury awarded Appian more than $2 billion for Pegasystems' trade secret misappropriation. On this news, the price of Pegasystems common stock fell almost 21% to close at $52.25 per share on May 10, 2022. According to press reports, during the seven-week trial, the jury was presented with substantial evidence supporting Appian's claims, including videos, emails, and text messages, and evidence that Alan Trefler ("Trefler"), Pegasystems' Founder and Chief Executive Officer ("CEO"), personally attended a meeting with the "spy" and received Appian trade secrets supplied by the "spy." During the trial, CEO Trefler admitted that it was "inappropriate" for Pegasystems to have hired the contractor and that the Pegasystems employees who gained access to Appian trial software "shouldn't have done it." The jury found that Pegasystems engaged in "willful and malicious" misappropriation of Appian's trade secrets.
Plaintiff alleges that Defendants made materially false and misleading statements throughout the Class Period, including by failing to disclose that: (1) Pegasystems had misappropriated trade secrets to better compete against Appian, a principal competitor; (2) Defendants' product development and associated success was, in significant part, not the result of its own research and product testing but rather the result of corporate espionage and trade secret theft; and (3) Defendants had engaged in a scheme to steal Appian trade secrets, which was not only known to, but carried out through, the personal involvement of the Company's CEO.
If you wish to serve as lead plaintiff, you must move the Court no later than July 18, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery does not require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.
If you purchased PEGA common stock, and/or would like to discuss your legal rights and options please visit Pegasystems Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com.
Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for ten consecutive years.
ATTORNEY ADVERTISING. © 2022 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact Information:
Peter Allocco
Bernstein Liebhard LLP
https://www.bernlieb.com
(212) 951-2030
pallocco@bernlieb.com
View original content to download multimedia:
SOURCE Bernstein Liebhard LLP | https://www.mysuncoast.com/prnewswire/2022/05/20/pegasystems-inc-nasdaq-pega-shareholder-class-action-alert-bernstein-liebhard-llp-announces-that-securities-class-action-lawsuit-has-been-filed-against-pegasystems-inc-nasdaq-pega/ | 2022-05-20T20:23:11Z |
Relatives worry, mourn in wake of elementary school shooting
(AP) - Relatives turned to social media and waited in a desperate attempt to find their missing children as the death toll in a gruesome school shooting at a Texas elementary school rose to at least 19 students. Authorities said the gunman also killed two adults.
Adolfo Cruz, a 69-year-old air conditioning repairman, was still outside Robb Elementary School in the town of Uvalde Tuesday night as the sun set, waiting for word on his 10-year-old great-granddaughter, Elijah Cruz Torres, whose whereabouts remained unknown to family.
Cruz drove to the scene after receiving a tearful and terrifying call from his daughter shortly after the first reports that an 18-year-old gunman had opened fire. While he waited outside the school Tuesday night, his family was at the hospital and civic center waiting for any potential word on her condition.
Çruz called the waiting the heaviest moment of his life.
“I hope she is alive,” Cruz said. “They are waiting for an update.”
“It’s a shock for me. I also feel for all the other families. This is a small community. Uvalde has always been real friendly. People are real friendly,” Cruz said.
WARNING: Videos used may contain graphic content.
On social media, pictures of smiling children were posted, their families begging for information. Classes were winding down for the year and each school day had a theme. Tuesday’s was Footloose and Fancy. Students were supposed to wear a nice outfit with fun or fancy shoes.
By nightfall, names of those killed during the attack were beginning to emerge. Fourth-grade teacher Eva Mireles was remembered as a loving mother and wife.
“She was adventurous. I would definitely say those wonderful things about her. She is definitely going to be very missed,” said 44-year-old relative Amber Ybarra, of San Antonio.
Ybarra was preparing to give blood for the wounded and was pondering how no one was able to spot possible problems in the shooter in time to stop him.
“To me, it’s more about raising mental health awareness,” said Ybarra, a wellness coach who attended the elementary school where the shooting happened. “Someone could possibly have seen a dramatic change before something like this happened.”
Hillcrest Memorial Funeral Home, which is located across the street from Robb Elementary School, said in a Facebook post on Tuesday evening that it would be assisting families of the shooting victims with no cost for funerals.
Copyright 2022 The Associated Press. All rights reserved. | https://www.mysuncoast.com/2022/05/25/relatives-worry-mourn-wake-elementary-school-shooting/ | 2022-05-25T05:23:40Z |
Statement Pursuant to Section 19(a) of the Investment Company Act of 1940
DENVER, July 29, 2022 /PRNewswire/ -- On July 29, 2022, the Reaves Utility Income Fund (NYSE American: UTG) (the "Fund"), a closed-end sector fund, paid a monthly distribution on its common stock of $0.19 per share to shareholders of record at the close of business on July 22, 2022.
The following table sets forth the estimated amount of the sources of distribution for purposes of Section 19 of the Investment Company Act of 1940, as amended, and the related rules adopted thereunder. In accordance with generally accepted accounting principles ("GAAP"), the Fund estimates the following percentages, of the total distribution amount per share, attributable to (i) current and prior fiscal year net investment income, (ii) net realized short-term capital gain, (iii) net realized long-term capital gain and (iv) return of capital or other capital source as a percentage of the total distribution amount. These percentages are disclosed for the current distribution as well as the fiscal year-to-date cumulative distribution amount per share for the Fund.
The timing and character of distributions for federal income tax purposes are determined in accordance with income tax regulations which may differ from GAAP. As such, all or a portion of this distribution may be reportable as taxable income on your 2022 federal income tax return. The final tax character of any distribution declared in 2022 will be determined in January 2023 and reported to you on IRS Form 1099-DIV.
The amounts and sources of distributions reported in this 19(a) Notice are only estimates and not for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund's investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.
Presented below are return figures, based on the change in the Fund's Net Asset Value per share ("NAV"), compared to the annualized distribution rate for this current distribution as a percentage of the NAV on the last day of the month prior to distribution record date.
Fund Performance & Distribution Information
^ Based on the Fund's NAV as of June 30, 2022.
*Cumulative fiscal year-to-date return is based on the change in NAV including distributions paid and assuming reinvestment of these distributions for the period November 1, 2021 through June 30, 2022.
**The 5 year average annual total return is based on change in NAV including distributions paid and assuming reinvestment of these distributions and is through the last business day of the month prior to the month of the current distribution record date.
While the NAV performance may be indicative of the Fund's investment performance, it does not measure the value of a shareholder's investment in the Fund. The value of a shareholder's investment in the Fund is determined by the Fund's market price, which is based on the supply and demand for the Fund's shares in the open market. Past performance does not guarantee future results. Shareholders should not draw any conclusions about the Fund's investment performance from the amount of this distribution or from the terms of the Fund's Managed Distribution Plan.
Furthermore, the Board of Trustees reviews the amount of any potential distribution and the income, capital gain or capital available. The Board of Trustees will continue to monitor the Fund's distribution level, taking into consideration the Fund's net asset value and the financial market environment. The Fund's distribution policy is subject to modification by the Board of Trustees at any time. The distribution rate should not be considered the dividend yield or total return on an investment in the Fund.
ALPS Portfolio Solutions Distributor, Inc., FINRA Member Firm.
View original content to download multimedia:
SOURCE Reaves Utility Income Fund | https://www.wibw.com/prnewswire/2022/07/29/reaves-utility-income-fund-section-19a-notice/ | 2022-07-29T15:01:20Z |
Special Weather Statement issued April 13 at 8:54PM MDT by NWS Pocatello ID
At 850 PM MDT, an area of snow was located along a line extending
from 6 miles west of Northwest Inl to 7 miles east of Atomic City to
14 miles south of Southwest Inl. Movement was east at 45 mph.
Travelers out tonight in the northern Snake River plain can expect
heavy but brief snow showers that can suddenly reduce visibility to
near zero. This includes portions of Interstate 15, U S Routes 20
and 26.
Locations impacted include…
Idaho Falls, Rexburg, Rigby, Swan Valley, Ririe Reservoir, Terreton,
Lorenzo, Goshen, Ammon, Shelley, Victor, Iona, Sugar City, Ucon,
Menan, Teton, Ririe, Roberts, Firth and Lewisville.
The snow can accumulate at a rate of one inch per hour or more in
this area of heavy snow. Be prepared for hazardous driving
conditions. Consider delaying travel if you will be going through
this area of heavy snow.
Conditions can deteriorate rapidly in winter weather situations. Be
prepared for snow or ice covered roads. Slow down and allow extra
time when traveling. | https://localnews8.com/weather/alerts-weather/2022/04/13/special-weather-statement-issued-april-13-at-854pm-mdt-by-nws-pocatello-id/ | 2022-04-14T04:01:31Z |
POTOMAC, Md., April 13, 2022 /PRNewswire/ -- Curbio, the leading fix now, pay-at-closing pre-listing home improvement solution for real estate agents and their clients, today announced the addition of LoKation® Real Estate to its brokerage partnerships program. LoKation® Real Estate is a tech-forward brokerage that is at the forefront of providing more opportunity, profitability, and support for real estate agents so they can maximize their potential. Recent Industry Rankings put them at #23 in the Nation of all non-franchised brokerages.
"At our core, Curbio is a completely turnkey solution that exists to help agents succeed. LoKation's dedication to the success of their agents made this partnership an obvious choice for us," said Olivia Mariani, VP of Marketing at Curbio. "We're excited to formally welcome them to our brokerage partnerships program, and to begin providing their agents with a powerful solution to help get all of their listings on the market quickly and sold for top dollar."
Through this partnership, LoKation® has created it's new REvitalize Program, a concierge service powered by Curbio. With this new program, LoKation's agents have gained access to a comprehensive pre-listing home improvement service with fix now, pay later terms for their clients, positioning them to win more listings in a competitive market. Homeowners who work with LoKation® agents to sell their home will now be able to complete pre-listing updates that will allow them to unlock the true value of their home quickly, without paying any cash up front.
"We are so excited to announce our partnership with Curbio, and to begin offering our new REvitalize Program to all our agents and clients. Curbio's turnkey, pay-at-closing model, combined with their innovative technology and world-class team, made this partnership a no-brainer for us. We're proud to now be able to offer a concierge solution to our agents, as yet another tool available to them through LoKation® to help them thrive," says Jeremy Beard, Director of Business Development at LoKation® Real Estate.
To learn more about Curbio's brokerage partnerships program, visit https://curbio.com/brokers/.
About Curbio
Curbio is the nation's leading pay-at-closing home improvement solution for real estate agents and their clients. Founded in 2017, the company has set out to transform the process of getting homes move-in ready with its streamlined approach to home improvement. Powered by technology, Curbio has created a one-stop solution for pre-listing home improvements, handling the entire process from start to finish. Curbio is a completely turnkey solution, taking care of all sourcing, project management and communication, and acting as the licensed, insured general contractor on all projects. Curbio makes home improvement accessible and stress-free so that every real estate agent and contractor can grow their business, and every seller can unlock the value in their home. From simple repairs to whole home makeovers, Curbio gets every listing on the market faster and sold for top dollar.
About LoKation Real Estate
LoKation® Real Estate is a tech-forward brokerage that is at the forefront providing more opportunity, profitability, and support for Agents so they can maximize their potential. Cloud-based technology and SmartSpaces for Agents, LoKation covers all aspects of buying and selling – Real Estate, Mortgage, Title & Insurance services. LoKation is an Independent Brokerage ranking #23 per in the U.S. per Real Trends 2022 Top 500 report and has produced over $3b in sales per year. We arm our REALTORS® with the best technology and all the resources needed under one roof including the most efficient online platform for agents to operate from, allowing them to be free to conduct transactions from anywhere. LoKation gives back via our LoKation® Care's philanthropy initiatives in multiple states. Our commitment to our community, agents, and industry is evident through our actions.
View original content to download multimedia:
SOURCE Curbio | https://www.kxii.com/prnewswire/2022/04/13/curbio-announces-brokerage-partnership-with-lokation-real-estate/ | 2022-04-13T13:58:55Z |
Founded by Aleksandr, Maksim, and Valentin Chmerkovskiy, non-profit Baranova27 has spearheaded large-scale product donation drives in New Jersey to support humanitarian relief efforts in Ukraine
SECAUCUS, N.J., June 6, 2022 /PRNewswire/ -- The Vitamin Shoppe, an omni-channel specialty retailer of nutritional products, is pleased to partner with Baranova27, a grassroots charitable organization, to donate over two tons of protein bars and healthy snacks to communities in Ukraine impacted by the ongoing war.
Sharon Leite, CEO of The Vitamin Shoppe, commented: "Our teams at The Vitamin Shoppe are honored to be able to contribute to the refugees, frontline heroes, and extraordinary citizens of Ukraine in the way we know best – with nutritional support that we hope will give a boost to the everyday health and energy of the courageous people there. Just as importantly, we are proud to help shine a light on the incredible work of Baranova27 in mobilizing much-needed humanitarian aid and supplies, and getting it directly into the hands of those in need in Ukraine. We are happy to be able to partner with a fellow New Jersey-based organization and want to thank Mayor Mike Gonnelli of Secaucus for first connecting us."
Over 4,600 pounds of nutritious, on-the-go snacks and protein bars were shipped to Baranova27's facility in Fort Lee, New Jersey from The Vitamin Shoppe's distribution centers in Virginia and Arizona. The Vitamin Shoppe's freight logistics partner, Transplace, generously donated transportation costs. Volunteers from The Vitamin Shoppe's corporate support center in Secaucus, New Jersey, unloaded the donated product on June 1 into the Baranova27 warehouse, destined for Ukraine.
Since the outset of the Ukraine conflict, Baranova27 has collected, organized, and transported over 280,000 pounds (140 tons) of first aid supplies, non-perishable food, clothing, front-line equipment, hygiene items, and children's care products to on-the-ground relief and humanitarian organizations in Ukraine and Poland. The 501(c)(3) non-profit was founded by Aleksandr Chmerkovskiy and his sons, Maksim and Valentin Chmerkovskiy, both former Dancing with the Stars champions. The Chmerkovskiy family emigrated to the United States from Odessa, Ukraine in the mid-nineties and previously lived at the address Baranova 27 in Odessa.
"I want to thank The Vitamin Shoppe and all the caring teams there that came together to make this meaningful and useful donation to the people of Ukraine. Nutritious, easily shared food and snack items are highly appreciated donations in Ukraine. With my work at Baranova27, I've tried to turn my pain about the war into a purpose. The contributions of companies like The Vitamin Shoppe reminds me that so much of the world is united in supporting the people of Ukraine and working towards peace," said Aleksandr Chmerkovskiy.
For more information about donation and volunteer opportunities, please visit www.baranova27.org.
Lifelong Wellness Starts Here™. The Vitamin Shoppe®, a subsidiary of Franchise Group Inc. (NASDAQ: FRG), is a global, omnichannel specialty retailer and wellness lifestyle Company with the mission of providing customers with the most trusted products, guidance, and services to support them on their journeys of lifelong wellness. Based in Secaucus, New Jersey, the Company offers a comprehensive assortment of nutritional solutions, including vitamins, minerals, specialty supplements, herbs, sports nutrition, homeopathic remedies, green living products, and natural beauty products. In addition to carrying products from approximately 700 national brands, The Vitamin Shoppe offers products from its proprietary brands within its owned and wholesale channels, including: The Vitamin Shoppe®, Vthrive The Vitamin Shoppe™, BodyTech®, BodyTech® Elite, fitfactor™, fitfactor KETO™, plnt®, ProBioCare®, True Athlete®, and TrueYou™. In the U.S., the Company conducts business through over 700 company-operated retail stores under The Vitamin Shoppe and Super Supplements™ banners, and via its website, www.vitaminshoppe.com. The company is expanding its retail footprint via an innovative, omnichannel franchising model and opened its first franchise store in 2022. Globally, The Vitamin Shoppe serves customers in select Asia, South America, and Central America markets through local retail and e-commerce partners.
Baranova27 is a charitable organization dedicated to bringing direct aid and humanitarian relief to the people of Ukraine. The organization is operating out of Fort Lee, NJ, and is 100% volunteer-based. To contribute to our cause, please visit our linktree to purchase items for Ukrainian civilians. To donate monetary aid, please visit our GoFundMe. For more information, please visit www.baranova27.org or follow us on Facebook or Instagram at @Baranova27 for regular updates on events and opportunities to help.
View original content to download multimedia:
SOURCE The Vitamin Shoppe | https://www.mysuncoast.com/prnewswire/2022/06/06/vitamin-shoppe-partners-with-baranova27-donate-over-two-tons-protein-bars-nutritious-snacks-communities-impacted-by-war-ukraine/ | 2022-06-06T14:20:17Z |
Stephen Ayres was drawn to Washington, D.C., on Jan. 6, 2021 by Donald Trump’s outrageously false claims that the presidential election had been stolen.
“I felt like I had horse blinders on,” the soft-spoken cabinetmaker from Ohio told the Congressional committee investigating the events of that day. “Take the blinders off, make sure you step back and see what’s going on before it’s too late.”
Jason Van Tatenhove, a former spokesman for the far-right group Oath Keepers, echoed Ayres’ warning: “I do fear for this next election cycle because who knows what that might bring.”
This is the most important lesson taught by the Jan. 6 panel. The real issue is the future, not the past. It’s 2024, not 2020. The country has to “take the blinders off” and realize that the Stop the Steal movement Trump instigated after the last election is morphing into a Start the Steal conspiracy that threatens to undermine democracy itself.
As Trump moves closer to announcing his candidacy for a second term, election expert and law professor Richard Hasen warns in the Washington Post: “Any attempt to subvert the next presidential election is likely to be far more efficient and ruthlessly targeted than the last effort.”
“The truth is that as bad as 2020 was, it could be worse next time around,” insists Michael Waldman, who heads the Brennan Center at NYU School of Law, which closely tracks threats to election integrity. “Trump’s coup try was clownish, incompetent, chaotic. ... Since then, the professionals have taken over,” Waldman wrote in a post for the center’s website.
Trump failed to overturn the 2020 results in large part because a cadre of officials, many of them Republicans, bravely resisted his tantrums and rejected his lies. Those resisters ranged from Vice President Mike Pence and Attorney General Bill Barr to governors and secretaries of states, local legislators and election officials, federal and state judges.
The system worked. The firewalls held. Democracy survived.
But now that system is under assault. Those firewalls are deliberately being weakened. The website FiveThirtyEight is tracking the views of every Republican candidate for statewide office and concludes, “We can say definitively that at least 120 election-deniers have won their party’s nomination and will be on the ballot in the fall.”
This campaign of chaos continues. Take Arizona, a critical battleground in 2020 and likely to be one again. GOP Gov. Doug Ducey, who stood valiantly against Trump’s lies, is term-limited, and a leading candidate to replace him is Kari Lake, a former TV anchor who is endorsed by Trump and totally embraces his falsehoods and fantasies.
“Kari Lake is misleading voters with no evidence,” Ducey, who has endorsed Lake’s opponent in the Aug. 2 primary, said on CNN. “She’s been tagged by her opponents with a nickname, ‘Fake Lake,’ which seems to be sticking and actually doing some damage.”
If Start the Stealers like Lake take office, predicts Waldman, “they would not hesitate” to use their power to try “to block certification” of election results that go against Trump.
Republican-controlled legislatures are joining the plot. “New laws in Arkansas and Georgia recently gave state authorities the power to remove and temporarily replace local election officials,” reports Waldman. “They could, for example, remove election officials in Fulton County, Georgia, on a pretext, install their own candidate, and throw out ballots in the Atlanta area.”
This threat only begins with public officials. Other conspirators are seeking jobs as election overseers, and many of those slots are opening because Start the Stealers are making life miserable for local administrators who refuse to swallow Trump’s lies.
“The harassment and death threats haven’t stopped against those who have pushed back against the false claims,” PBS reported. “The threats have contributed to an exodus of election officials across the country, particularly at the local level, and made recruiting poll workers even harder — adding to the challenges of conducting smooth elections in the fall.”
Yet another threat to “smooth elections” comes from the conservative majority on the Supreme Court, which has agreed to hear a case next term from North Carolina that challenges the authority of state courts — which often stood firm against Trump’s tirades in 2020 — to oversee election disputes. Yet one more firewall could be in jeopardy.
A bipartisan group of lawmakers is preparing legislation to clarify and strengthen protections against some of these threats to ballot integrity, and that would certainly be an important advance. But it’s primarily the voters who have to “take the blinders off” and thwart Trump and his Start the Steal movement.
Steven Roberts teaches politics and journalism at George Washington University. He can be contacted by email at stevecokie@gmail.com.
Keep it Clean. Please avoid obscene, vulgar, lewd,
racist or sexually-oriented language. PLEASE TURN OFF YOUR CAPS LOCK. Don't Threaten. Threats of harming another
person will not be tolerated. Be Truthful. Don't knowingly lie about anyone
or anything. Be Nice. No racism, sexism or any sort of -ism
that is degrading to another person. Be Proactive. Use the 'Report' link on
each comment to let us know of abusive posts. Share with Us. We'd love to hear eyewitness
accounts, the history behind an article. | https://www.albanyherald.com/opinion/steve-roberts-take-the-blinders-off/article_e87980d6-0c0f-11ed-8f66-531e2eb8e887.html | 2022-07-25T23:32:58Z |
New Role Supports Flack Metal Bank Business Development
CHICAGO, May 4, 2022 /PRNewswire/ -- Flack Global Metals deepens its bench and continues to attract top talent in the metals space with the addition of Jennifer Betts as Sr. Vice President of Business Development. Flack Global Metals (FGM) is an innovative domestic flat-rolled metals distributor and supply chain manager, international commodities trader, and a global hedge fund – purpose-built to deliver certainty. In 2021 FGM launched Flack Metal Bank (FMB), the world's premier ferrous metals trading desk, to allow buyers of flat-rolled metal products to take advantage of pricing on the forward curve regardless of whether they secure physical inventory from FGM or maintain existing supply relationships.
In her role, Betts will be responsible for implementing the company's business and development strategy to fuel growth for FGM and FMB by opening new channels for physical sales growth and educating the market on the broad range of price risk management services offered by the company.
Betts brings over a decade of experience working with ferrous, non-ferrous and ferro-alloy metals including movement via scrap yards, steel mills and trading companies.
Prior to joining FMB, Betts was Vice President of Business Development, Metals, Americas for Argus Media where she broadly enhanced industry knowledge through her impact on reporting, pricing, and online tools for the ferrous and non-ferrous worlds. Prior to her time at Argus, Betts served as Director of Ferrous Marketing for Becker Iron & Metal and as AK Steel's Raw Materials Manager. She got her start in the metals business as a Brokerage Representative for the Nucor Steel subsidiary The David J. Joseph Company, where she traded non-ferrous and ferrous scrap metal for numerous U.S. regional and international markets. Betts holds an MBA from Xavier University and a B.A. in Finance from Indiana University.
"Jen brings a wealth of knowledge and experience to the FGM team," said Jeremy Flack, Founder and Chief Executive Officer. "She will play an integral role in expanding our educational efforts around hedging and supporting our growth strategy including the launch of Flack Metal Bank."
Flack Metal Bank (FMB), separates metal supply from metal pricing for OEMs, allowing them to take advantage of pricing on the forward curve for flat rolled products without disrupting their existing supply relationships. The process involves converting fixed price arrangements into floating and vice versa. FMB creates a relatively easy method for entering into risk management when compared to other methodologies, as all transactions are backed by FGM's balance sheet, trading group, and sophisticated research arm.
ABOUT FLACK GLOBAL METALS
In 2010, Flack Global Metals (FGM) was founded with the mission to reinvent how metal is bought and sold. Twelve years later, the company has evolved into a hybrid organization with three distinct lines of business. FGM is an innovative domestic flat-rolled metals distributor and supply chain manager, an international commodities trader, and a global hedge fund, purpose-built to deliver certainty.
CONTACT:
Patty Rioux
ODEA Group, LLC
312.893.5163
patty@teamodea.com
View original content to download multimedia:
SOURCE Flack Global Metals | https://www.mysuncoast.com/prnewswire/2022/05/04/flack-global-metals-adds-jennifer-betts-growing-team/ | 2022-05-04T22:04:25Z |
IRVINE, Calif., June 2, 2022 /PRNewswire/ -- Sunstone Hotel Investors, Inc. (the "Company" or "Sunstone") (NYSE: SHO), the owner of Long-Term Relevant Real Estate® in the lodging industry, today announced that it has completed the previously announced acquisition of the 339-room The Confidante Miami Beach (the "Hotel") for a purchase price of $232 million, or $684,000 per key. The Company will invest approximately $60 million to reposition the Hotel into a premiere beachfront resort under Hyatt's luxury, lifestyle Andaz brand. Upon completion of the renovation, Sunstone will own a well-located, fully renovated, beachfront resort at a highly attractive all-in basis. The Company expects the Hotel will generate an 8% to 9% stabilized net operating income yield on the total investment in the Hotel, including the planned repositioning. The renovation program will begin in phases, starting in the fourth quarter of 2022 with completion expected to occur in the first half of 2024 when the Hotel will debut as Andaz Miami Beach.
The Company expects the Hotel will generate $3.5 to $4.0 million of EBITDA during its ownership period in 2022. The acquisition was funded from available cash and with $140 million of proceeds received from the Company's previously undrawn revolving credit facility. Together with the expected funding for the previously announced acquisition of the remaining 25% joint venture interest in the Hilton San Diego Bayfront which is expected to close by the end of June, the Company anticipates having an outstanding credit facility balance at the end of the second quarter of approximately $240 million. Based on the Company's anticipated leverage ratio as of the end of the second quarter, borrowings on the credit facility are expected to bear interest at the rate of one-month LIBOR plus 1.50%.
Operations Update
The Company's operations for April and May 2022 reflect accelerating hotel demand as compared to the first quarter of 2022. While leisure travel continues to be robust, the greatest demand growth is occurring at the Company's urban and group-oriented hotels which are experiencing an increase in near-term booking activity, higher than expected attendance at group events, and increased business transient volume.
- Occupancy at the comparable 12 hotels the Company owned during both 2022 and 2019 (the "12 Hotel Comparable Portfolio") has improved from down more than 2,800 bps as compared to 2019 in the first quarter of 2022 to down only 1,240 bps in Q2 2022 QTD.
- Average Daily Rate at the 12 Hotel Comparable Portfolio has exceeded 2019 levels in each month of 2022 and is higher by 11.3% so far in Q2 2022 QTD.
- As of April 30, 2022, group revenue pace for the 12 Hotel Comparable Portfolio for Q2 through Q4 2022 was down only 15% as compared to the same time in 2019, with average rates approximately 5% higher than in 2019.
- As of mid-May, the 12 Hotel Comparable Portfolio had 87% of the total transient room nights on-the-books for June to December as compared to the same time in 2019, with average rates approximately 31% higher than in 2019.
- In the second quarter 2019, the 12 Hotel Comparable Portfolio generated RevPAR of $229.50. Based on stronger demand acceleration in April and May, the Company currently anticipates that RevPAR at the 12 Hotel Comparable Portfolio for the second quarter 2022 will be down only 6% to 8% as compared to the second quarter of 2019.
Share Repurchase Update
Since the beginning of April through June 1, 2022, the Company has repurchased 1.9 million shares of its common stock at an average price of $11.01 per share for a total purchase price of $21.2 million. Year to date, the Company has repurchased 5.8 million shares of its common stock at an average price of $11.13 per share for a total purchase price of $64.6 million. The Company has $435.4 million remaining under its existing share repurchase authorization. The authorization has no stated expiration date and future repurchases will depend on various factors, including the Company's capital availability and the price of the Company's common stock. The Company will provide the details of future stock repurchase activity, if any, as part of its quarterly financial reporting.
About Sunstone Hotel Investors
Sunstone Hotel Investors, Inc. is a lodging real estate investment trust ("REIT"). Sunstone's strategy is to create long-term stakeholder value through the acquisition, active ownership, and disposition of hotels considered to be Long-Term Relevant Real Estate®. For further information, please visit Sunstone's website at www.sunstonehotels.com.
For Additional Information
Aaron Reyes
Chief Financial Officer
Sunstone Hotel Investors, Inc.
(949) 382-3018
Forward Looking Statements
This press release contains forward-looking statements within the meaning of federal securities laws and regulations. These forward-looking statements are identified by their use of terms and phrases such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "predict," "project," "should," "will" and other similar terms and phrases, including opinions, references to assumptions and forecasts of future results. Forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that may cause the actual results to differ materially from those anticipated at the time the forward-looking statements are made. These risks include, but are not limited to: the impact the COVID-19 pandemic has on the Company's business and the economy, as well as the response of governments and the Company to the pandemic, and how quickly and successfully effective vaccines and therapies are distributed and administered; increased risks related to employee matters, including increased employment litigation and claims for severance or other benefits tied to termination or furloughs as a result of temporary hotel suspensions or reduced hotel operations due to COVID-19; general economic and business conditions, including a U.S. recession or increased inflation, trade conflicts and tariffs, regional or global economic slowdowns and any type of flu or disease-related pandemic that impacts travel or the ability to travel, including COVID-19; the need for business-related travel, including the increased use of business-related technology; rising hotel operating costs due to labor costs, workers' compensation and health-care related costs, utility costs, property and liability insurance costs, unanticipated costs such as acts of nature and their consequences and other costs that may not be offset by increased room rates; the ground or airspace leases for two of the hotels the Company has interests in as of the date of this release; the need for renovations, repositionings and other capital expenditures for the Company's hotels; the impact, including any delays, of renovations and repositionings on hotel operations; new hotel supply, or alternative lodging options such as timeshare, vacation rentals or sharing services such as Airbnb, in the Company's markets, which could harm its occupancy levels and revenue at its hotels; competition from hotels not owned by the Company; relationships with, and the requirements, performance and reputation of, the managers of the Company's hotels; relationships with, and the requirements and reputation of, the Company's franchisors and hotel brands; the Company's hotels may become impaired, or its hotels which have previously become impaired may become further impaired in the future, which may adversely affect its financial condition and results of operations; competition for the acquisition of hotels, and the Company's ability to complete acquisitions and dispositions; performance of hotels after they are acquired; changes in the Company's business strategy or acquisition or disposition plans; the Company's level of debt, including secured, unsecured, fixed and variable rate debt; financial and other covenants in the Company's debt and preferred stock; the impact on the Company's business of potential defaults by the Company on its debt agreements or leases; volatility in the capital markets and the effect on lodging demand or the Company's ability to obtain capital on favorable terms or at all; the Company's need to operate as a REIT and comply with other applicable laws and regulations, including new laws, interpretations or court decisions that may change the federal or state tax laws or the federal or state income tax consequences of the Company's qualification as a REIT; potential adverse tax consequences in the event that the Company's operating leases with its taxable REIT subsidiaries are not held to have been made on an arm's-length basis; system security risks, data protection breaches, cyber-attacks and systems integration issues, including those impacting the Company's suppliers, hotel managers or franchisors; other events beyond the Company's control, including climate change, natural disasters, terrorist attacks or civil unrest; and other risks and uncertainties associated with the Company's business described in its filings with the Securities and Exchange Commission. Although the Company believes the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that the expectations will be attained or that any deviation will not be material. All forward-looking information provided herein is as of the date of this release, and the Company undertakes no obligation to update any forward-looking statement to conform the statement to actual results or changes in the Company's expectations.
This release should be read together with the consolidated financial statements and notes thereto included in our most recent reports on Form 10-K and Form 10-Q. Copies of these reports are available on our website at www.sunstonehotels.com and through the SEC's Electronic Data Gathering Analysis and Retrieval System ("EDGAR") at www.sec.gov.
View original content:
SOURCE Sunstone Hotel Investors, Inc. | https://www.kxii.com/prnewswire/2022/06/02/sunstone-hotel-investors-completes-acquisition-confidante-miami-beach-provides-business-update/ | 2022-06-02T20:35:47Z |
NEW YORK, Aug. 10, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Carvana Co..
Shareholders who purchased shares of CVNA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.
CONTACT US HERE:
CLASS PERIOD: May 6, 2020 to June 24, 2022
ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Carvana faced serious, ongoing issues with documentation, registration, and title with many of its vehicles; (2) as a result, Carvana was issuing unusually frequent temporary plates; (3) as a result of the foregoing, Carvana was violating laws and regulations in many existing markets; (4) as a result of the foregoing, Carvana risked its ability to continue business and/or expand its business in existing markets; (5) as a result of the foregoing, Carvana was at an increased risk of governmental investigation and action; (6) Carvana was in discussion with state and local authorities regarding the above-stated business tactics and issues; (7) Carvana was facing imminent and ongoing regulatory actions including license suspensions, business cessation, and probation in several states and counties including in Arizona, Illinois, Pennsylvania, Michigan, and North Carolina; and (8) as a result, Defendants' statements about Carvana's business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
DEADLINE: October 3, 2022 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/carvana-co-loss-submission-form/?id=30702&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of CVNA during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is October 3, 2022. There is no cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original content:
SOURCE The Gross Law Firm | https://www.wibw.com/prnewswire/2022/08/10/shareholder-alert-gross-law-firm-notifies-shareholders-carvana-co-class-action-lawsuit-lead-plaintiff-deadline-october-3-2022-nyse-cvna/ | 2022-08-10T10:13:29Z |
PHILADELPHIA (AP) — Joel Embiid made his closing argument for MVP votes and all but wrapped up the NBA scoring title, scoring 41 points while adding 20 rebounds and four assists to lead the Philadelphia 76ers to a 133-120 victory Saturday over the Indiana Pacers.
Embiid shot 14 for 17 from the floor, went 11 of 15 from the foul line and made both his 3-point attempts in a game that Philadelphia (50-31) needed to win to remain alive in the hunt for the third seed in the Eastern Conference playoffs. It was the first time this season that an NBA player scored 40 or more points and had 20 or more rebounds in a game. It was the third time in Embiid’s career it has happened — with all three times coming against the Pacers.
“I’ve always said that every single night, I want to dominate,” Embiid said. “If you are dominating, things can show up in a lot of different ways — whether it is offensively or defensively. Sometimes, the numbers don’t show it. But it’s good, I guess.”
Philadelphia coach Doc Rivers said: “It’s methodical and historical. Whatever the calls you want to put on it, it’s what’s he’s been.”
James Harden had 22 points and 14 assists for Philadelphia, who also got double-digit point performances from Tobias Harris (18), Tyrese Maxey (18) and Danny Green (15).
“We’re getting better,” Rivers said.
Oshae Brissett scored 20 points and Tyrese Haliburton had 19 for Indiana (25-56), which lost its ninth straight game. The Pacers fell behind by 21 points in the first half, then cut the deficit to five late in the third quarter before Embiid and Harden began to take control of the game.
“We haven’t seen a guy like this in the history of the league who has this kind of power and skill,” Indiana coach Rick Carlisle said of Embiid. “He’s able to score on all three levels effortlessly. He’s an amazing player and it will be interesting to see what teams do in the playoffs to try to slow him down.”
Embiid is now averaging 30.6 points for the season, which is just ahead of LeBron James’ 30.3-point-per-game clip for the Los Angeles Lakers and Kevin Durant’s 30.1 average for the Brooklyn Nets.
But neither James nor Durant will play enough games to qualify for the statistical title; in an 82-game season, 58 games played is the minimum. That means the scoring race comes down to Embiid and Milwaukee’s Giannis Antetokounmpo, who would need a miracle finish to grab the scoring crown. The last center to win a scoring title with a more than 30 ppg average was Bob McAdoo, who averaged 31.1 points in 1976-77.
Embiid also has been considered one of main contenders for league MVP, along with Antetokounmpo and Denver’s Nikola Jokic. Saturday’s game was Embiid’s 13th scoring 40 or more points.
The Sixers can move up to the third seed in the East and a first-round matchup with Chicago with a victory over Detroit on Sunday and a Boston loss at Memphis. Otherwise, Philadelphia will face Toronto in the 4-5 matchup in the first round of the postseason tournament.
Embiid said no decision was made about his playing status for Sunday night’s game, which takes place at the same time Boston faces Memphis.
“I want to, but at the same time it’s a back to back and we have to get ready for the playoffs,” Embiid said. “I want to play because we still need to work on my spacing and chemistry. Whatever we can get out of this last game, it will be good.”
TIP-INS
Pacers: Indiana guard Malcolm Brogdon was ruled out with lower back soreness while Jalen Smith sat because of left groin soreness. Reserve forward Nate Hinton was ruled out for the final two games because of the NBA’s health and safety protocols. “He’s in a van heading home,” coach Rick Carlisle said.
76ers: For the second straight game, Philadelphia inserted veteran guard Danny Green into the starting lineup in the spot normally held by top defender Matisse Thybulle. Thybulle may not be able to play in a possible first-round series in Toronto because of his COVID-19 vaccination status. Canadian rules forbid cross-border travel to anyone not vaccinated; Thybulle has not said publicly whether he is vaccinated. He missed Thursday night’s 119-114 road loss to the Raptors and was listed as “ineligible to play.” … Guard Georges Niang missed Saturday’s game with left knee soreness. Rivers said the move was precautionary. “If this was a playoff game, he would be in there,” the coach said in his pre-game meeting with the media.
UP NEXT
Pacers: Play at Brooklyn on Sunday to finish their season.
76ers: Host Detroit on Sunday night in regular-season finale.
___
More AP NBA: https://apnews.com/hub/NBA and https://twitter.com/AP_Sports | https://cw33.com/sports/ap-sports/embiid-has-41-points-20-rebounds-as-sixers-down-pacers/ | 2022-04-10T19:06:09Z |
Loss of Union Jobs is an Attack on Essential Service Workers
SPRINGFIELD, Ill., June 30, 2022 /PRNewswire/ -- Teamsters Local 916 is condemning the planned closure of Decatur Ambulance Service (DAS) by Hospital Sisters Health System (HSHS), a not-for-profit religious hospital. The closure, which is scheduled for September 1, will result in 40 workers losing their jobs and five retirees losing their health care benefits.
"This is an attack on working families and the communities where they live and serve," said JP Fyans, Local 916 President. "These brave men and women are out there every day saving people's lives, and HSHS is rewarding them for their service by hanging them out to dry."
"We expect that HSHS will replace this ambulance service with a non-union carrier to cut costs," said Jerrime Hiser, Local 916 Vice President. "This organization claims to care about essential service workers, but all they really care about is the profit margin of a not-for-profit. We're demanding that HSHS either halt the shutdown or guarantee in writing that whoever replaces DAS assume the obligations set forth in these members' collective bargaining agreement."
HSHS refuses to disclose agreements reached with potential new EMS companies to the union. DAS has proudly served the communities of Decatur, Pana and Shelbyville since 1978. Four years ago, HSHS bought out the private ambulance service. Since 1978 these men and women have proudly worked and retired as Teamsters.
Teamsters Local 916 represents over 4,500 hard working men and women throughout central Illinois. For more information, go to https://teamsters916.org/.
Contact:
JP Fyans, (217) 522-7932
View original content to download multimedia:
SOURCE Teamsters Local 916 | https://www.wibw.com/prnewswire/2022/06/30/teamsters-local-916-condemns-planned-closure-decatur-ambulance-service/ | 2022-06-30T21:45:52Z |
Accelerated Capital Investments Driven by EV Thermal Barrier Demand; Updated 2022 Financial Outlook
NORTHBOROUGH, Mass., June 6, 2022 /PRNewswire/ -- Aspen Aerogels, Inc. (NYSE: ASPN) ("Aspen" or the "Company"), a technology leader in sustainability and electrification solutions, today provided an update on recent developments with its business, as well as an update on its financial outlook for fiscal year 2022 as a result of these developments.
Recent Developments
- Increased visibility to expected order volume for 2022 from General Motors and Toyota is driving an updated outlook in thermal barrier revenues from $18.0 million to a range of $52.0 million to $62.0 million, a potential threefold increase in demand versus original expectations.
- The energy industrial demand book is also strong and accelerating; Aspen's recent investments and productivity improvements position it to deliver 2022 revenues in this segment in the range of $128.0 million to $138.0 million.
- To prepare for anticipated continued revenue growth, Aspen is advancing progress on the construction of its second aerogel manufacturing facility in Statesboro, Georgia ("Plant II"), with over half of the site work completed and commissioning of Phase I of the facility expected in Q4 2023.
- Aspen has also leased, and is in the process of equipping, its planned high-volume thermal barrier facility in Mexico to assemble its thermal barrier products for various EV OEM customers. This facility, which is intended to enable the growth in thermal barrier volumes in the second half of 2022 and beyond, has started training personnel and assembling parts.
- Aspen has also accelerated capital expenditures to execute its growth plans through 2025. These capital expenditures include productivity improvements to its aerogel manufacturing facility in Rhode Island, Phase I of Plant II, and all related thermal barrier assembly facilities and equipment. Aspen believes that the anticipated cost of these capital projects will be in the range of $650.0 million to $750.0 million. However, further cost inflation and/or supply chain disruptions, as well as potential changes in the scope of the facilities, could lead to increases in that range. Engineering changes and other factors could also decrease the amount of capital expenditures incurred by Aspen.
Commenting on today's announcement, Donald R. Young, President and CEO, stated, "Our updated outlook for the year reflects an acceleration in demand and penetration in the EV market, coupled with solid energy industrial growth. We are increasing our investment levels for the year in advance of the significant expected growth within our PyroThin® thermal barrier business. These investments are focusing on Phase 1 of Plant II; a high-volume thermal barrier assembly operation in Mexico; and enhancing the technical, commercial and operational teams that support our thermal barrier business. Leveraging higher volumes, coupled with the impact of these investments, advances our path to profitability and sets the stage for reaching our revenue and profitability goals over the next several years."
As a result of these recent developments, Aspen is today also providing the following update on its financial outlook for 2022:
2022 Financial Outlook
Aspen's 2022 full year outlook has been updated to reflect the following.
- Total revenue is expected to range between $180.0 million and $200.0 million, as compared to the previous range of $145.0 million and $155.0 million; $34.0 million to $44.0 million of the increase in the revenue outlook is driven by additional thermal barrier volumes.
- Net loss is expected to range between $79.8 million and $86.8 million, as compared to the previous range of $66.7 million and $70.7 million, driven by increased materials costs and increased manufacturing and operating expenses necessary to support the additional thermal barrier volumes.
- Adjusted EBITDA is expected to range between $(55.0) million and $(62.0) million, as compared to the previous range of $(42.0) million and $(46.0) million driven by the increase in expected net loss.
- Net loss per share is expected to range between $2.20 and $2.40, as compared to the previous range of $1.88 and $1.99.
- Capital expenditures in 2022 are expected to range between $250.0 million and $300.0 million, as compared to the previous range of $250.0 million and $275.0 million. These expectations reflect the advancing progress of Phase I of Plant II and the acceleration of investments for high-volume thermal barrier assembly in Mexico.
The Company's 2022 outlook assumes depreciation and amortization of $9.7 million, stock-based compensation expense of $8.2 million, interest expense of $6.8 million and weighted average shares outstanding of 36.2 million for the full year. Aspen may incur, among other items, additional charges, realize gains or losses, incur financing costs or interest expense, or experience other events in 2022, including those related to the planned capacity expansion, supply chain disruptions or further cost inflation, that could cause actual results to vary materially from this outlook.
Ricardo C. Rodriguez, Senior Vice President and CFO, added, "The higher than expected demand for thermal barriers from General Motors and Toyota is enabling us to accelerate planned transitions in our operating plan and pave our path to profitability. Our target gross profit margins are coming into focus as the absorption of fixed costs improves and our conversion costs decrease as a percentage of sales." Mr. Rodriguez concluded, "In many ways our plans for 2022 now look very much like our original plans for 2023 coming into this year."
A reconciliation of non-GAAP Adjusted EBITDA to net loss for the 2022 financial outlook is provided in the financial schedules that are part of this press release. An explanation of this non-GAAP financial measure is also included below under the heading "Non-GAAP Financial Measures."
Non-GAAP Financial Measures
In addition to providing financial measurements based on generally accepted accounting principles in the United States of America ("GAAP"), Aspen provides additional financial metrics that are not prepared in accordance with GAAP ("non-GAAP"). The non-GAAP financial measure included in this press release is Adjusted EBITDA. Management uses non-GAAP financial measures, in addition to GAAP financial measures, as a measure of operating performance because the non-GAAP financial measures do not include the impact of items that management does not consider indicative of Aspen's core operating performance. In addition, management uses Adjusted EBITDA (i) for planning purposes, including the preparation of Aspen's annual operating budget, (ii) to allocate resources to enhance the financial performance of its business, and (iii) as a performance measure under its bonus plan.
Management believes that these non-GAAP financial measures reflect Aspen's ongoing business in a manner that allows for meaningful comparisons and analysis of trends in its business, as they exclude expenses and gains not reflective of Aspen's ongoing operating results or that may be infrequent and/or unusual in nature. Management also believes that these non-GAAP financial measures provide useful information to investors in understanding and evaluating Aspen's operating results and future prospects in the same manner as management and in comparing financial results across accounting periods and to those of peer companies. These non-GAAP measures may not be comparable to similarly titled measures presented by other companies.
The non-GAAP financial measures do not replace the presentation of Aspen's GAAP financial results and should only be used as a supplement to, not as a substitute for, Aspen's financial results presented in accordance with GAAP. In this press release, Aspen has provided a reconciliation of Adjusted EBITDA to net loss, the most directly comparable GAAP financial measure. Management strongly encourages investors to review Aspen's financial statements and publicly-filed reports in their entirety and not rely on any single financial measure.
About Aspen Aerogels, Inc.
Aspen is a technology leader in sustainability. The company's aerogel technology enables its customers and partners to achieve their own objectives around the global megatrends of resource efficiency, e-mobility and clean energy. Aspen's PyroThin® products enable solutions to thermal runaway challenges within the electric vehicle market. The company's carbon aerogel program seeks to increase the performance of lithium-ion battery cells to enable EV manufacturers to extend the driving range and reduce the cost of electric vehicles. Aspen's Spaceloft® products provide building owners with industry-leading energy efficiency and fire safety. The company's Cryogel® and Pyrogel® products are valued by the world's largest energy infrastructure companies. Aspen's strategy is to partner with world-class industry leaders to leverage its Aerogel Technology Platform™ into additional high-value markets. Headquartered in Northborough, Mass., Aspen manufactures its products at its East Providence, R.I. facilities.
Special Note Regarding Forward-Looking and Cautionary Statements
This press release and any related discussion contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements, including statements relating to Aspen's 2022 financial outlook. These statements are not historical facts but rather are based on Aspen's current expectations, estimates and projections regarding Aspen's business, operations and other factors relating thereto, including with respect to Aspen's 2022 financial outlook. Words such as "may," "will," "could," "would," "should," "anticipate," "predict," "potential," "continue," "expects," "intends," "plans," "projects," "believes," "estimates," "outlook," "assumes," "targets," "opportunity," and similar expressions are used to identify these forward-looking statements. Such forward-looking statements include statements regarding, among other things, Aspen's expectations about capacity, revenue, backlog, costs, expenses, profitability, cash flow, gross profit, gross margin, operating margin, net loss, Adjusted EBITDA, Adjusted EBITDA margin and related decreases, improvements, timing, variability or trends; beliefs about higher than expected demand from General Motors and Toyota and how they may enable path to profitability, expectations about improvement in ability to absorb fixed costs and reduction of conversion costs as a percentage of sales and the same leading to target gross margins; beliefs about the general strength, weakness or health of Aspen's business; acceleration in demand; demand increase from General Motors and Toyota for 2022, energy industrial demand book acceleration in 2022, level of penetration in EV market, growth in energy industrial markets; beliefs about current or future trends in the energy, energy infrastructure, chemical and refinery, LNG, sustainable building materials, EV thermal barrier, EV battery materials or other markets and the impact of these trends on Aspen's business; beliefs about the strength, effectiveness, productivity, costs, profitability or other fundamentals of Aspen's business; beliefs about the role of Aspen's technology and opportunities in the electric vehicle market; beliefs about Aspen's ability to provide and deliver products and services to electric vehicle customers; beliefs about content per vehicle, revenue, costs, expenses, profitability, investments or cash flow associated with Aspen's electric vehicle opportunities, including the EV thermal barrier business; beliefs about revenue growth and profitability; beliefs about the performance of PyroThin® including its ability to mitigate the propagation of thermal runaway in electric vehicles; beliefs about Aspen's ability to expand the market for PyroThin, to achieve design wins, to commence shipments of production parts, and to become an industry standard solution for thermal runaway management; beliefs about Aspen's thermal barrier design, prototype, quoting and assembly activities; expectations about the cost of the capital projects, including Plant II, expectations about the commissioning of Phase I of Plant II in Q4 2023; beliefs about our planned Mexico assembly facility and its timely operations, its ability to meet the demand, the growth in thermal barrier demand to match the assembly operation and vice versa; ability to shift assembly operations from East Providence to Mexico in a timely manner. All such forward-looking statements are based on management's present expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, the following: inability to execute the growth plan through 2025, inability to complete construction and commissioning the Phase I of Plant II by Q4 2023 and reasonably within budget, inability to manage supply chain disruptions to avoid undue delay or impact on operations or construction of Plant II and Mexico assembly facility, inability to create new product, partnership and market opportunities; any sustained downturn in the industry or energy prices; any sustained downturn in the energy, energy infrastructure, chemical and refinery, LNG, sustainable building materials, EV thermal barrier, EV battery materials or other markets due to the coronavirus pandemic, COVID-19 or any other factor; any failure to sustain project-based demand in the subsea, LNG, on-shore or other markets; the right of EV thermal barrier customers to cancel contracts with Aspen at any time and without penalty; any costs, expenses, or investments incurred by Aspen in excess of projections used to develop pricing under the contracts with EV thermal barrier customers; any failure of Aspen or PyroThin to meet contractual specifications and requirements under contracts with EV thermal barrier customers; Aspen's inability to create customer or market opportunities for, including PyroThin; any other battery performance and safety products, battery materials or for other new products developed from Aspen's aerogel technology; any disruption or inability to achieve expected capacity levels in any of our three existing production lines in East Providence, RI or the Mexico assembly facility, including due to the coronavirus pandemic, COVID-19 or any other factor; any inability to expand manufacturing capacity in a second manufacturing facility in Bulloch County, Georgia or at any other location; any inability to establish or timely establish thermal barrier assembly operations in Mexico or any other location; the failure to receive all regulatory or other approvals required to operate, maintain or expand any of Aspen's facilities; any failure to achieve demand for Aspen's products; any failure to achieve expected price increases or average selling prices for Aspen's products; any significant increase in the cost of raw materials, utilities or any other manufacturing consumable; shortages of raw materials, utilities or any other manufacturing consumable due to the coronavirus pandemic, COVID-19 or any other factor; the failure to generate sufficient operating cash flow or to obtain significant additional capital to pursue Aspen's strategy; any failure to timely raise sufficient capital to fund various capital projects; the failure of Aspen's products to become widely adopted; the competition Aspen faces in its business; any failure to enforce any of Aspen's patents; any failure to protect or expand Aspen's Aerogel Technology Platform™; any future finding of invalidity of any of Aspen's patents in any jurisdiction; any failure to generate sufficient operating cash flow or to obtain sufficient additional capital to continue to pursue Aspen's new business, technology, patent enforcement, or patent defense strategy; any failure of Aspen's products to meet applicable specifications and other performance, safety, technical and delivery requirements; the general economic conditions and cyclical demands in the markets that Aspen serves; the economic, operational and political risks associated with sales and expansion of operations in foreign countries including Mexico; the loss of any direct customer, including distributors, contractors and OEMs; compliance with health and safety laws and regulations; the maintenance and development of distribution channels; and the other risk factors discussed under the heading "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2021 and filed with the Securities and Exchange Commission ("SEC") on March 1, 2022, as well as any updates to those risk factors filed from time to time in our subsequent periodic and current reports filed with the SEC. All statements contained in this press release are made only as of the date of this press release. Aspen does not intend to update this information unless required by law.
Reconciliation of Non-GAAP Financial Measures
The following table presents a reconciliation of the non-GAAP financial measure included in this press release to the most directly comparable GAAP measure:
Reconciliation of Adjusted EBITDA to Net Income (Loss)
We define Adjusted EBITDA as net income (loss) before interest expense, taxes, depreciation, amortization, stock-based compensation expense and other items, which occur from time to time and which we do not believe are indicative of our core operating performance.
For the 2022 full year financial outlook:
View original content to download multimedia:
SOURCE Aspen Aerogels, Inc. | https://www.mysuncoast.com/prnewswire/2022/06/06/aspen-aerogels-inc-provides-business-update/ | 2022-06-06T11:03:46Z |
Significant Milestone Brings Sustainable Transportation of Lifesaving Organs One Step Closer
EVERETT, Wash., June 7, 2022 /PRNewswire/ -- magniX, the company powering the electric aviation revolution, today announced that Tier 1 Engineering, specialists in the design and development of electric aircraft, achieved a successful first flight of an all-electric Robinson 44 helicopter with a magniX electric propulsion unit (EPU). The helicopter flew on Saturday, June 4 at 8:00 am Pacific Time for over three minutes at Los Alamitos Army Airfield, California.
Tier 1 is developing the all-electric Robinson R44 for Lung Biotechnology PBC, a biotech company on a mission to address the severe shortage of transplantable organs in the U.S. Tier 1 Engineering integrated its battery system and the magniX EPU on the helicopter, and has started its flight testing program.
"magniX has been powering all-electric aircraft since December of 2019, and this flight represents another first for the company as we have now electrified a rotary aircraft," said Nuno Taborda, magniX's CEO. "This landmark event demonstrates yet again magniX's commitment to lead the electrification of aviation by designing and delivering industry-leading products through smart innovation and customer centricity. This is a significant achievement that will lead to the sustainable delivery of life saving organs."
Tier 1 Engineering is currently working with the FAA Aircraft Certification Office in Los Angeles on the e-R44 project to obtain a Supplemental Type Certificate (STC). Lung Biotechnology PBC plans to acquire a fleet of aircraft to fly transplant organs.
"This historic flight, of an all-electric helicopter with a certifiable electric engine, was an important step towards obtaining aircraft certification. We are excited to expand the flight tests to greater distances and demonstrate safe, reliable all-electric flight," said Glen Dromgoole, President of Tier 1 Engineering.
Headquartered in Everett WA, magniX is dedicated to enabling an era of clean and affordable commercial air travel with all-electric propulsion. magniX offers a range of revolutionary solutions including all-electric motors – which produce zero emissions and increased efficiency for various aviation applications. For more information, please visit www.magnix.aero.
Tier 1 Engineering, is an innovative design and development company, serving the aviation industry, based in Southern California. In 2015, Tier 1 Engineering developed one of the world's largest battery-powered helicopters, a modified Robinson R44 helicopter. The 2500lb aircraft achieved its first flight in 2016 and currently holds four Guinness World Record titles including, firsts in electric flight, farthest distance and longest duration.
Contact:
FINN Partners for magniX
magniX@finnpartners.com
View original content to download multimedia:
SOURCE magniX | https://www.wibw.com/prnewswire/2022/06/07/tier-1-engineering-achieves-successful-first-flight-robinson-44-helicopter-with-magnix-electric-propulsion-unit/ | 2022-06-07T20:15:43Z |
- Record net sales of $492.4 million increased 13% compared to Q2'21 driven by higher selling prices
- Reported net income of $14.3 million and earnings per diluted share of $0.80
- Delivered $58.5 million of adjusted EBITDA and $1.32 of non-GAAP earnings per diluted share
- Successfully amended our credit agreement and extended our maturity profile to June 2027
CONSHOHOCKEN, Pa., Aug. 4, 2022 /PRNewswire/ -- Quaker Houghton ("the Company") (NYSE: KWR), the global leader in industrial process fluids, today announced its second quarter 2022 results.
Second Quarter 2022 Consolidated Results
Second quarter 2022 net sales were a record of $492.4 million, an increase of 13% compared to $435.3 million in the prior year quarter primarily due to an increase in selling price and product mix of approximately 22% and additional net sales from acquisitions of 1%, partially offset by a 6% unfavorable impact from foreign currency translation and a 4% decrease in organic sales volumes. The increase in selling price and product mix was primarily attributable to double-digit price increases in all segments in response to ongoing and unprecedented raw material and supply chain-related inflationary pressures. The decline in organic sales volumes was primarily attributable to COVID-19 related disruptions in China, the wind-down of the tolling agreement for products previously divested related to the Quaker Houghton combination, the impact of the war in Ukraine and the Company's ongoing value based pricing initiatives, partially offset by net new business wins.
The Company generated net income in the second quarter of 2022 of $14.3 million or $0.80 per diluted share, compared to the prior year quarter net income of $33.6 million or $1.88 per diluted share. Excluding non-recurring and non-core items in each period, the Company's second quarter of 2022 non-GAAP earnings per diluted share was $1.32 compared to $1.82 in the prior year quarter. The Company's second quarter of 2022 adjusted EBITDA of $58.5 million declined compared to $70.1 million in the second quarter of 2021, as the increase in net sales was more than offset by lower gross margins primarily attributable to significant increases in raw material and other costs, compared to the prior year period.
Andy Tometich, Chief Executive Officer and President, commented, "We delivered another quarter of record net sales in the second quarter, driven by strong price realization and above market volume growth. As expected our earnings declined primarily due to ongoing inflationary pressures, COVID-19 disruptions in China, unfavorable foreign currency translation, geopolitical issues and other disruptions that impacted our customers and end markets. Notwithstanding, we delivered significant price increases which offset the raw material inflation and helped to stabilize our gross margins on a sequential basis. I am energized by the commitment and focus of our people who continually demonstrate their dedication to delivering on our objectives and the value proposition of our products and services to our customers.
Looking ahead, our focus remains on executing on items within our control. We are actively working with our customers to get the needed pricing to offset the persistent inflationary pressures on our margins while remaining vigilant on our costs. Therefore, despite significant uncertainty caused by several macroeconomic factors, we continue to expect to deliver sequential gross margin expansion and earnings growth in the second half of 2022."
Second Quarter 2022 Segment Results
The Company's second quarter 2022 operating performance of each of its four reportable operating segments: (i) Americas; (ii) Europe, Middle East and Africa ("EMEA"); (iii) Asia/Pacific; and (iv) Global Specialty Businesses, are further described below.
* Refer to the Segment Measures and Reconciliations section below for additional information
All four segments benefitted from double-digit increases in selling price and product mix in the second quarter of 2022 compared to the prior year quarter. Organic sales volumes increased approximately 10% in Global Specialty Businesses compared to the prior year quarter, while the other segments declined due to the impacts on sales volumes mentioned above. The EMEA and Asia/Pacific segments were also significantly impacted by unfavorable foreign currency translation. Operating earnings from the Global Specialty Businesses and Americas segments increased compared to the prior year quarter whereas the other segments declined due to continued raw material and other inflationary cost pressures, the impact of the COVID-19 disruptions in China on our Asia/Pacific segment, and the unfavorable impact from foreign currency translation.
All four segments benefitted from increases in selling price and product mix compared to the first quarter of 2022, as we continued our strategic pricing initiatives. Organic sales volumes increased compared to the first quarter of 2022 in the Global Specialty Businesses and the Americas but declined in Asia/Pacific and EMEA, primarily due to COVID-19 disruptions in China, which impacted our Asia/Pacific segment, as well as lower sales volumes attributable to the war in Ukraine, and the Company's ongoing value based pricing initiatives, partially offset by net new business wins. Asia/Pacific and EMEA were also unfavorably impacted by foreign currency translation.
Cash Flow and Liquidity Highlights
The Company had a net operating cash outflow of $2.1 million during the second quarter of 2022, bringing the year-to-date net operating cash outflow to $8.4 million, compared to a net operating cash outflow of $9.6 million during the six months ended June 30, 2021. The net operating cash outflow in both periods reflects working capital investment primarily related to higher accounts receivable due to increases in net sales and higher inventory due primarily to rising raw material costs and to a lesser extent an increase in certain inventory stocks in response to global supply chain and logistics challenges.
During the second quarter of 2022, the Company successfully amended its credit agreement and extended the maturity from August 2024 to June 2027. As of June 30, 2022, the Company's total gross debt was $989.1 million and its cash and cash equivalents was $202.3 million. The Company's net debt was approximately $786.8 million, and its net debt divided by its trailing twelve months adjusted EBITDA was approximately 3.2x.
Non-GAAP Measures and Reconciliations
The information included in this press release includes non-GAAP (unaudited) financial information that includes EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income and non-GAAP earnings per diluted share. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader's understanding of the financial performance of the Company, are indicative of future operating performance of the Company, and facilitate a comparison among fiscal periods, as the non-GAAP financial measures exclude items that are not indicative of future operating performance or not considered core to the Company's operations. Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP.
The Company presents EBITDA which is calculated as net income attributable to the Company before depreciation and amortization, interest expense, net, and taxes on income before equity in net (loss) income of associated companies. The Company also presents adjusted EBITDA which is calculated as EBITDA plus or minus certain items that are not indicative of future operating performance or not considered core to the Company's operations. In addition, the Company presents non-GAAP operating income which is calculated as operating income plus or minus certain items that are not indicative of future operating performance or not considered core to the Company's operations. Adjusted EBITDA margin and non-GAAP operating margin are calculated as the percentage of adjusted EBITDA and non-GAAP operating income to consolidated net sales, respectively. The Company believes these non-GAAP measures provide transparent and useful information and are widely used by investors, analysts, and peers in our industry as well as by management in assessing the operating performance of the Company on a consistent basis.
Additionally, the Company presents non-GAAP net income and non-GAAP earnings per diluted share as additional performance measures. Non-GAAP net income is calculated as adjusted EBITDA, defined above, less depreciation and amortization, interest expense, net, and taxes on income before equity in net (loss) income of associated companies, in each case adjusted, as applicable, for any depreciation, amortization, interest or tax impacts resulting from the non-core items identified in the reconciliation of net income attributable to the Company to adjusted EBITDA. Non-GAAP earnings per diluted share is calculated as non-GAAP net income per diluted share as accounted for under the "two-class share method." The Company believes that non-GAAP net income and non-GAAP earnings per diluted share provide transparent and useful information and are widely used by investors, analysts, and peers in our industry as well as by management in assessing the operating performance of the Company on a consistent basis.
As it relates to 2022 projections for the Company as well as other forward-looking information described further above, the Company has not provided guidance for comparable GAAP measures or a quantitative reconciliation of forward-looking non-GAAP financial measures to the most directly comparable U.S. GAAP measure because it is unable to determine with reasonable certainty the ultimate outcome of certain significant items necessary to calculate such measures without unreasonable effort. These items include, but are not limited to, certain non-recurring or non-core items the Company may record that could materially impact net income, as well as the impact of COVID-19. These items are uncertain, depend on various factors, and could have a material impact on the U.S. GAAP reported results for the guidance period.
The Company's reference to trailing twelve months adjusted EBITDA within this press release refers to the twelve month period ended June 30, 2022 adjusted EBITDA of $245.8 million, which includes (i) the six months ended June 30, 2022 adjusted EBITDA of $118.9 million, as presented in the non-GAAP reconciliations below, and (ii) the twelve months ended December 31, 2021 adjusted EBITDA of $274.1 million, as presented in the non-GAAP reconciliations included in the Company's fourth quarter and full year 2021 results press release dated February 24, 2022, less (iii) the six months ended June 30, 2021 adjusted EBITDA of $147.2 million, as presented in the non-GAAP reconciliations below.
Certain of the prior period non-GAAP financial measures presented in the following tables have been adjusted to conform with current period presentation. The following tables reconcile the Company's non-GAAP financial measures (unaudited) to their most directly comparable GAAP (unaudited) financial measures (dollars in thousands unless otherwise noted, except per share amounts):
Non-GAAP Operating Income and Margin Reconciliations
Segment Measures and Reconciliations
The Company's operating segments, which are consistent with its reportable segments, reflect the structure of the Company's internal organization, the method by which the Company's resources are allocated and the manner by which the chief operating decision maker assesses the Company's performance. The Company has four reportable segments: (i) Americas; (ii) EMEA; (iii) Asia/Pacific; and (iv) Global Specialty Businesses. The three geographic segments are composed of the net sales and operations in each respective region, excluding net sales and operations managed globally by the Global Specialty Businesses segment, which includes the Company's container, metal finishing, mining, offshore, specialty coatings, specialty grease and Norman Hay businesses. Segment operating earnings for each of the Company's reportable segments are comprised of the segment's net sales less directly related COGS and selling, general and administrative expenses. Operating expenses not directly attributable to the net sales of each respective segment, such as certain corporate and administrative costs, Combination, integration and other acquisition-related expenses, and Restructuring and related charges, are not included in segment operating earnings. Other items not specifically identified with the Company's reportable segments include interest expense, net and other (expense) income, net.
The following tables reconcile the Company's reportable operating segments performance to that of the Company (dollars in thousands):
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements can be identified by the fact that they do not relate strictly to historical or current facts. We have based these forward-looking statements, including statements regarding the potential effects of the COVID-19 pandemic, the Russia and Ukraine conflict, inflation and global supply chain constraints on the Company's business, results of operations, and financial condition, our expectations that we will maintain sufficient liquidity and remain in compliance with the terms of the Company's credit facility, expectations about future demand and raw material costs, and statements regarding the impact of increased raw material costs and pricing initiatives, on our current expectations about future events. These forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, intentions, financial condition, results of operations, future performance, and business, including but not limited to the potential benefits of the Combination and other acquisitions, the impacts on our business as a result of the COVID-19 pandemic and global supply chain constraints, and our current and future results and plans and statements that include the words "may," "could," "should," "would," "believe," "expect," "anticipate," "estimate," "intend," "plan" or similar expressions. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected in such statements. A major risk is that demand for the Company's products and services is largely derived from the demand for its customers' products, which subjects the Company to uncertainties related to downturns in a customer's business and unanticipated customer production slowdowns and shutdowns, including as is currently being experienced by many automotive industry companies as a result of supply chain disruptions. Other major risks and uncertainties include, but are not limited to, the primary and secondary impacts of the COVID-19 pandemic, including actions taken in response to the pandemic by various governments, which could exacerbate some or all of the other risks and uncertainties faced by the Company, as well as inflationary pressures, including the potential for significant increases in raw material costs, supply chain disruptions, customer financial instability, rising interest rates and the potential of economic recession, worldwide economic and political disruptions, including the impacts of the military conflict between Russia and Ukraine, the economic and other sanctions imposed by other nations on Russia, suspensions of activities in Russia by many multinational companies and the potential expansion of military activity, foreign currency fluctuations, significant changes in applicable tax rates and regulations, future terrorist attacks and other acts of violence. Furthermore, the Company is subject to the same business cycles as those experienced by our customers in the steel, automobile, aircraft, industrial equipment, and durable goods industries. The ultimate impact of COVID-19 on our business will depend on, among other things, the extent and duration of the pandemic, the severity of the disease and the number of people infected with the virus including new variants, the continued uncertainty regarding global availability, administration, acceptance and long-term efficacy of vaccines, or other treatments for COVID-19 or its variants, the longer-term effects on the economy of the pandemic, including the resulting market volatility, and by the measures taken by governmental authorities and other third parties restricting day-to-day life and business operations and the length of time that such measures remain in place, as well as laws and other governmental programs implemented to address the pandemic or assist impacted businesses, such as fiscal stimulus and other legislation designed to deliver monetary aid and other relief. Other factors could also adversely affect us, including those related to the Combination and other acquisitions and the integration of acquired businesses. Our forward-looking statements are subject to risks, uncertainties and assumptions about the Company and its operations that are subject to change based on various important factors, some of which are beyond our control. These risks, uncertainties, and possible inaccurate assumptions relevant to our business could cause our actual results to differ materially from expected and historical results. All forward-looking statements included in this press release, including expectations about business conditions during 2022 and future periods, are based upon information available to the Company as of the date of this press release, which may change. Therefore, we caution you not to place undue reliance on our forward-looking statements. For more information regarding these risks and uncertainties as well as certain additional risks that we face, refer to the Risk Factors section, which appears in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2021, and in subsequent reports filed from time to time with the Securities and Exchange Commission. We do not intend to, and we disclaim any duty or obligation to, update or revise any forward-looking statements to reflect new information or future events or for any other reason. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.
Conference Call
As previously announced, the Company's investor conference call to discuss its second quarter 2022 performance is scheduled for August 5, 2022 at 8:30 a.m. ET. A live webcast of the conference call, together with supplemental information, can be accessed through the Company's Investor Relations website at investors.quakerhoughton.com. You can also access the conference call by dialing 877-269-7756.
About Quaker Houghton
Quaker Houghton is the global leader in industrial process fluids. With a presence around the world, including operations in over 25 countries, our customers include thousands of the world's most advanced and specialized steel, aluminum, automotive, aerospace, offshore, can, mining, and metalworking companies. Our high-performing, innovative and sustainable solutions are backed by best-in-class technology, deep process knowledge and customized services. With approximately 4,700 employees, including chemists, engineers and industry experts, we partner with our customers to improve their operations so they can run even more efficiently, even more effectively, whatever comes next. Quaker Houghton is headquartered in Conshohocken, Pennsylvania, located near Philadelphia in the United States. Visit quakerhoughton.com to learn more.
View original content to download multimedia:
SOURCE Quaker Houghton | https://www.kxii.com/prnewswire/2022/08/04/quaker-houghton-announces-second-quarter-2022-results/ | 2022-08-04T21:50:00Z |
MAUMEE, Ohio, June 16, 2022 /PRNewswire/ -- The Andersons, Inc. (Nasdaq: ANDE) announces a third quarter 2022 cash dividend of 18 cents ($0.18) per share payable on July 22, 2022, to shareholders of record as of July 1, 2022. This is The Andersons 103rd consecutive quarterly cash dividend since listing on the Nasdaq in February 1996.
About The Andersons, Inc.
The Andersons, Inc., celebrating 75 years of service and named to Forbes® lists of America's Best Employers for 2022 and Best Employers for Diversity 2022 as well as America's Most Trusted Companies 2022 by Newsweek®, is a diversified company rooted in agriculture that conducts business in the commodity merchandising, renewables, and plant nutrient sectors. Guided by its Statement of Principles, The Andersons is committed to providing extraordinary service to its customers, helping its employees improve, supporting its communities, and increasing the value of the company. For more information, please visit www.andersonsinc.com.
View original content to download multimedia:
SOURCE The Andersons, Inc. | https://www.wibw.com/prnewswire/2022/06/16/andersons-inc-declares-cash-dividend-third-quarter-2022/ | 2022-06-16T20:26:50Z |
NEW YORK, June 1, 2022 /PRNewswire/ -- Brixmor Property Group Inc. (NYSE: BRX) today announced that it will release its 2022 second quarter earnings on Monday, August 1, 2022 after the market close. Brixmor will host a teleconference on Tuesday, August 2, 2022 at 10:00 AM ET.
Event: Brixmor Property Group's Second Quarter Earnings Results
When: 10:00 AM ET, Tuesday, August 2, 2022
Live Webcast: Brixmor 2Q 2022 Earnings Call under the Investors tab at https://www.brixmor.com
Dial #: 1.877.704.4453 (International: 1.201.389.0920)
A replay of the webcast will be available on the Brixmor website at https://www.brixmor.com. A replay of the call can be accessed until midnight ET on Tuesday, August 16, 2022 by dialing 844.512.2921 (International: 412.317.6671); Passcode: 13730173.
- For additional information, please visit https://www.brixmor.com;
- Follow Brixmor on:
- Find Brixmor on LinkedIn at https://www.linkedin.com/company/brixmor.
Brixmor (NYSE: BRX) is a real estate investment trust (REIT) that owns and operates a high-quality, national portfolio of open-air shopping centers. Its 380 retail centers comprise approximately 67 million square feet of prime retail space in established trade areas. The Company strives to own and operate shopping centers that reflect Brixmor's vision "to be the center of the communities we serve" and are home to a diverse mix of thriving national, regional and local retailers. Brixmor is a proud real estate partner to over 5,000 retailers including The TJX Companies, The Kroger Co., Publix Super Markets and Ross Stores.
View original content to download multimedia:
SOURCE Brixmor Property Group Inc. | https://www.kxii.com/prnewswire/2022/06/01/brixmor-property-group-announces-second-quarter-2022-earnings-release-teleconference-dates/ | 2022-06-01T21:41:17Z |
̶ Clinical, Epidemiology and Health Economics and Outcomes Research to Advance Understanding of Treatment Patterns and Patient Experiences ̶
DUBLIN, May 2, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced plans to present research related to its psychiatry portfolio at four scientific conferences during Mental Health Awareness Month in May. The meetings include:
- American Telemedicine Association (ATA) Annual Conference, May 1-3, Boston
- International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, May 15-18, National Harbor, Md.
- American Psychiatric Association (APA) Annual Meeting, May 21-25, New Orleans
- American Society of Clinical Psychopharmacology (ASCP) Annual Conference, May 31-June 3, Scottsdale, Ariz.
"This year, we're excited to once again take part in scientific discourse and engage with leaders and members of the medical, mental health and health economics communities," said Craig Hopkinson, M.D., Chief Medical Officer and Executive Vice President of Research & Development at Alkermes. "May is Mental Health Awareness Month, and it's an important reminder of the tremendous unmet need that still exists for people living with mental health conditions. We are committed to conducting and sharing research that contributes to the understanding of these diseases, and that may help inform future study into new treatment options."
Highlights of the upcoming presentations include:
- Methodology and qualitative data from LATITUDE, a noninterventional study designed to assess knowledge of, attitudes toward and perceived barriers to utilizing long-acting injectable (LAI) antipsychotics for schizophrenia in telepsychiatry;
- Findings from post-hoc analyses evaluating daily and social functioning in adults with schizophrenia who were switched from a prior LAI antipsychotic to ARISTADA® (aripiprazole lauroxil);
- Findings from a budget impact model estimating the cost of adding LYBALVI® (olanzapine and samidorphan) to formulary from Commercial, Medicaid and Medicare perspectives in the United States;
- Detailed results from ENLIGHTEN-Early, a phase 3b study that evaluated the effect of LYBALVI compared to olanzapine on body weight in young adult patients (ages 16 to 39; mean age: 26 years) with schizophrenia, schizophreniform disorder or bipolar I disorder who were early in their illness.
The full list of Alkermes' presentations by meeting includes:
ATA
- Use of Long-Acting Antipsychotic Treatments in Community Telepsychiatry: Study to Assess Knowledge, Attitudes, and Perceived Barriers from Patients', Caregivers', and Providers' Perspectives in South Carolina (LATITUDE Study)
ISPOR
- Poster EE158: Budget Impact of LYBALVI for the Treatment of Schizophrenia and Bipolar I Disorder from a US Payer Perspective
- Poster CO58: Long-term Health Outcomes in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Aripiprazole Lauroxil for 1 Year
- Poster CO122: Patient Versus Caregiver and Clinician Reports of Cognitive Difficulties in Patients with Schizophrenia Switching to Long-Acting Injectable Antipsychotic Aripiprazole Lauroxil: A Post Hoc Analysis
- Poster HPR1: Does Specialty Drug Coverage Vary Between Health Plans' Medical and Pharmacy Benefit Policies?
APA
- Poster P8-090: Clinical Management of Patients with Schizophrenia Treated with Long-Acting Injectable Antipsychotics Since COVID-19 Pandemic Onset, Including the Role of Telepsychiatry
- Poster P6-082: Opioid Prescription Dispensing Patterns Among Patients with Schizophrenia or Bipolar Disorder
ASCP
Oral Presentation:
- Title: Olanzapine/Samidorphan in Young Adults with Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder Who Are Early in Their Illness: Results of the ENLIGHTEN-Early Study
- Presenter: John Kane, M.D., Chairman of the Department of Psychiatry at The Zucker Hillside Hospital and Professor and Chairman of Psychiatry at Hofstra Northwell School of Medicine
- Presentation Date: The oral presentation will take place during the Individual Research Report session on Tuesday, May 31, 2022 at 5:05 p.m. MT.
Posters:
- W37: Opioid Prescription Dispensing Patterns Among Patients with Schizophrenia or Bipolar Disorder
- W38: Patient Versus Caregiver and Clinician Reports of Cognitive Difficulties in Patients with Schizophrenia Switching to Long-Acting Injectable Antipsychotic Aripiprazole Lauroxil: A Post Hoc Analysis
- Th36: Metabolic Parameters, Vital Signs, and Weight Change in Patients with Schizophrenia Switched to Treatment with Aripiprazole Lauroxil
- Th53: Daily and Social Functioning in Patients with Schizophrenia After Switching to Treatment with Aripiprazole Lauroxil
About LYBALVI® (olanzapine and samidorphan)
LYBALVI® (olanzapine and samidorphan) is a once-daily, oral atypical antipsychotic drug approved in the U.S. for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. LYBALVI is composed of olanzapine, an established antipsychotic agent, co-formulated with samidorphan, a new chemical entity, in a single bilayer tablet. LYBALVI is available in fixed dosage strengths composed of 10 mg of samidorphan and 5 mg, 10 mg, 15 mg or 20 mg of olanzapine.
INDICATIONS and IMPORTANT SAFETY INFORMATION FOR LYBALVI® (olanzapine and samidorphan)
INDICATIONS
LYBALVI is indicated for the treatment of:
- Schizophrenia in adults
- Bipolar I disorder in adults
- Acute treatment of manic or mixed episodes as monotherapy and as adjunct to lithium or valproate
- Maintenance monotherapy treatment
IMPORTANT SAFETY INFORMATION
Contraindications: LYBALVI is contraindicated in patients who are using opioids or are undergoing acute opioid withdrawal. If LYBALVI is administered with lithium or valproate, refer to the lithium or valproate Prescribing Information for the contraindications for these products.
Cerebrovascular Adverse Reactions in Elderly Patients with Dementia-Related Psychosis, including stroke, transient ischemia attack, and fatalities. See Boxed Warning above.
Precipitation of Severe Opioid Withdrawal in Patients who are Physiologically Dependent on Opioids: LYBALVI can precipitate opioid withdrawal in patients who are dependent on opioids, which can lead to an opioid withdrawal syndrome, sometimes requiring hospitalization. LYBALVI is contraindicated in patients who are using opioids or undergoing acute opioid withdrawal. Prior to initiating LYBALVI, there should be at least a 7-day opioid-free interval from last use of short-acting opioids, and at least a 14-day opioid-free interval from the last use of long-acting opioids. Explain the risks associated with precipitated withdrawal and the importance of giving an accurate account of last opioid use to patients and caregivers.
Vulnerability to Life-Threatening Opioid Overdose: Attempting to overcome opioid blockade with high or repeated doses of exogenous opioids could lead to life-threatening or fatal opioid intoxication, particularly if LYBALVI therapy is interrupted or discontinued subjecting the patient to high levels of unopposed opioid agonist as the samidorphan blockade wanes. Inform patients of the potential consequences of trying to overcome the opioid blockade and the serious risks of taking opioids concurrently with LYBALVI or while transitioning off LYBALVI. In emergency situations, if a LYBALVI-treated patient requires opioid treatment as part of anesthesia or analgesia, discontinue LYBALVI. Opioids should be administered by properly trained individual(s) and patient should be continuously monitored in a setting equipped and staffed for cardiopulmonary resuscitation. Patients with a history of chronic opioid use prior to treatment with LYBALVI may have decreased opioid tolerance if LYBALVI therapy is interrupted or discontinued. Advise patients that this decreased tolerance may increase the risk of opioid overdose if opioids are resumed at the previously tolerated dosage.
Neuroleptic Malignant Syndrome, a potentially fatal reaction. Signs and symptoms include hyperpyrexia, muscle rigidity, delirium, autonomic instability, elevated creatinine phosphokinase, myoglobinuria (and/or rhabdomyolysis), and acute renal failure. Manage with immediate discontinuation, intensive symptomatic treatment, and close monitoring.
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), a potentially fatal condition reported with exposure to olanzapine, a component of LYBALVI. Symptoms include a cutaneous reaction (such as rash or exfoliative dermatitis), eosinophilia, fever, and/or lymphadenopathy with systemic complications such as hepatitis, nephritis, pneumonitis, myocarditis, and/or pericarditis. Discontinue if DRESS is suspected.
Metabolic Changes, including hyperglycemia, diabetes mellitus, dyslipidemia, and weight gain. Hyperglycemia, in some cases extreme and associated with ketoacidosis or hyperosmolar coma or death, has been reported in patients treated with atypical antipsychotics. Any patient treated with LYBALVI should be monitored for symptoms of hyperglycemia including polydipsia, polyuria, polyphagia, and weakness. In some cases, hyperglycemia has resolved when the atypical antipsychotic was discontinued; however, some patients required anti-diabetic treatment despite discontinuation of the suspect drug. Measure weight and assess fasting glucose and lipids when initiating LYBALVI and monitor periodically.
Tardive Dyskinesia (TD): Risk of developing TD (a syndrome of potentially irreversible, involuntary, dyskinetic movements) and the likelihood it will become irreversible increases with the duration of treatment and the cumulative dose. The syndrome can develop after a relatively brief treatment period, even at low doses, or after discontinuation. Given these considerations, LYBALVI should be prescribed in a manner that is most likely to reduce the risk of tardive dyskinesia. If signs and symptoms of TD appear, drug discontinuation should be considered.
Orthostatic Hypotension and Syncope: Monitor orthostatic vital signs in patients who are vulnerable to hypotension, patients with known cardiovascular disease, and patients with cerebrovascular disease.
Falls: LYBALVI may cause somnolence, postural hypotension, and motor and sensory instability, which may lead to falls, and consequently, fractures or other injuries. Assess patients for risk when using LYBALVI.
Leukopenia, Neutropenia, and Agranulocytosis (including fatal cases): Perform complete blood counts in patients with a history of a clinically significant low white blood cell (WBC) count or history of leukopenia or neutropenia. Discontinue LYBALVI if clinically significant decline in WBC occurs in the absence of other causative factors.
Dysphagia: Use LYBALVI with caution in patients at risk for aspiration.
Seizures: Use LYBALVI with caution in patients with a history of seizures or with conditions that lower the seizure threshold.
Potential for Cognitive and Motor Impairment: Because LYBALVI may cause somnolence, impair judgment, thinking, or motor skills, caution patients about operating hazardous machinery, including motor vehicles, until they are certain that LYBALVI does not affect them adversely.
Body Temperature Dysregulation: Use LYBALVI with caution in patients who may experience conditions that increase core body temperature (e.g., strenuous exercise, extreme heat, dehydration, or concomitant use with anticholinergics).
Anticholinergic (Antimuscarinic) Effects: Olanzapine, a component of LYBALVI, was associated with constipation, dry mouth, and tachycardia. Use LYBALVI with caution with other anticholinergic medications and in patients with urinary retention, prostatic hypertrophy, constipation, paralytic ileus or related conditions. In postmarketing experience, the risk for severe adverse reactions (including fatalities) was increased with concomitant use of anticholinergic medications.
Hyperprolactinemia: LYBALVI elevates prolactin levels. Galactorrhea, amenorrhea, gynecomastia, and impotence have been reported in patients receiving prolactin-elevating compounds.
Risks Associated with Combination Treatment with Lithium or Valproate: If LYBALVI is administered with lithium or valproate, refer to the lithium or valproate Prescribing Information for a description of the risks for these products.
Most common adverse reactions observed in clinical trials were:
- Schizophrenia (LYBALVI): weight increased, somnolence, dry mouth, and headache
- Bipolar I Disorder, Manic or Mixed Episodes (olanzapine): asthenia, dry mouth, constipation, increased appetite, somnolence, dizziness, tremor
- Bipolar I Disorder, Manic or Mixed Episodes, adjunct to Lithium or Valproate (olanzapine): dry mouth, dyspepsia, weight gain, increased appetite, dizziness, back pain, constipation, speech disorder, increased salivation, amnesia, paresthesia
Concomitant Medication: LYBALVI is contraindicated in patients who are using opioids or undergoing acute opioid withdrawal. Concomitant use of LYBALVI is not recommended with strong CYP3A4 inducers, levodopa and dopamine agonists. Reduce dosage of LYBALVI when using with strong CYP1A2 inhibitors. Increase dosage of LYBALVI with CYP1A2 inducers. Use caution with diazepam, alcohol, other CNS acting drugs, or in patients receiving anticholinergic (antimuscarinic) medications. Monitor blood pressure and reduce dosage of antihypertensive drug in accordance with its approved product labeling.
Pregnancy: May cause extrapyramidal and/or withdrawal symptoms in neonates with third trimester exposure. Advise patients to notify their healthcare provider if they become pregnant or intend to become pregnant during treatment with LYBALVI. Inform patients that there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to LYBALVI during pregnancy.
Renal Impairment: LYBALVI is not recommended for patients with end-stage renal disease (eGFR of <15 mL/minute/1.73 m2).
To report SUSPECTED ADVERSE REACTIONS, contact Alkermes at 1-888-235-8008 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please see accompanying full Prescribing Information, including Boxed Warning, for LYBALVI.
About ARISTADA®
ARISTADA is an injectable atypical antipsychotic approved in four dose strengths and three dosing durations for the treatment of schizophrenia (441 mg, 662 mg or 882 mg monthly, 882 mg once every six weeks and 1064 mg once every two months). Once in the body, ARISTADA converts to aripiprazole.
About ARISTADA INITIO®
ARISTADA INITIO, in combination with a single 30 mg dose of oral aripiprazole, can be used to initiate onto any dose of ARISTADA. The first ARISTADA dose may be administered on the same day as the ARISTADA INITIO regimen or up to 10 days thereafter.
INDICATION and IMPORTANT SAFETY INFORMATION for ARISTADA INITIO® (aripiprazole lauroxil) and ARISTADA® (aripiprazole lauroxil) extended-release injectable suspension, for intramuscular use
INDICATION
ARISTADA INITIO, in combination with oral aripiprazole, is indicated for the initiation of ARISTADA when used for the treatment of schizophrenia in adults.
ARISTADA is indicated for the treatment of schizophrenia in adults.
IMPORTANT SAFETY INFORMATION
Contraindication: Known hypersensitivity reaction to aripiprazole. Reactions have ranged from pruritus/urticaria to anaphylaxis.
Cerebrovascular Adverse Reactions, Including Stroke: Increased incidence of cerebrovascular adverse reactions (e.g., stroke, transient ischemic attack), including fatalities, have been reported in placebo-controlled trials of elderly patients with dementia-related psychosis treated with risperidone, aripiprazole, and olanzapine. ARISTADA INITIO and ARISTADA are not approved for the treatment of patients with dementia-related psychosis.
Potential for Dosing and Medication Errors: Medication errors, including substitution and dispensing errors, between ARISTADA INITIO and ARISTADA could occur. ARISTADA INITIO is intended for single administration in contrast to ARISTADA which is administered monthly, every 6 weeks, or every 8 weeks. Do not substitute ARISTADA INITIO for ARISTADA because of differing pharmacokinetic profiles.
Neuroleptic Malignant Syndrome (NMS): A potentially fatal symptom complex may occur with administration of antipsychotic drugs, including ARISTADA INITIO and ARISTADA. Clinical manifestations of NMS include hyperpyrexia, muscle rigidity, altered mental status, and evidence of autonomic instability (irregular pulse or blood pressure, tachycardia, diaphoresis, and cardiac dysrhythmia). Additional signs may include elevated creatine phosphokinase, myoglobinuria (rhabdomyolysis), and acute renal failure. The management of NMS should include: 1) immediate discontinuation of antipsychotic drugs and other drugs not essential to concurrent therapy; 2) intensive symptomatic treatment and medical monitoring; and 3) treatment of any concomitant serious medical problems for which specific treatments are available.
Tardive Dyskinesia (TD): The risk of developing TD (a syndrome of abnormal, involuntary movements) and the potential for it to become irreversible are believed to increase as the duration of treatment and the total cumulative dose of antipsychotic increase. The syndrome can develop, although much less commonly, after relatively brief treatment periods at low doses. Prescribing antipsychotics should be consistent with the need to minimize TD. Discontinue ARISTADA if clinically appropriate. TD may remit, partially or completely, if antipsychotic treatment is withdrawn.
Metabolic Changes: Atypical antipsychotic drugs have been associated with metabolic changes that include:
- Hyperglycemia/Diabetes Mellitus: Hyperglycemia, in some cases extreme and associated with ketoacidosis, coma, or death, has been reported in patients treated with atypical antipsychotics. There have been reports of hyperglycemia in patients treated with oral aripiprazole. Patients with diabetes should be regularly monitored for worsening of glucose control; those with risk factors for diabetes should undergo baseline and periodic fasting blood glucose testing. Any patient treated with atypical antipsychotics should be monitored for symptoms of hyperglycemia, including polydipsia, polyuria, polyphagia, and weakness. Patients who develop symptoms of hyperglycemia should also undergo fasting blood glucose testing. In some cases, hyperglycemia has resolved when the atypical antipsychotic was discontinued; however, some patients require continuation of antidiabetic treatment despite discontinuation of the suspect drug.
- Dyslipidemia: Undesirable alterations in lipids have been observed in patients treated with atypical antipsychotics.
- Weight Gain: Weight gain has been observed with atypical antipsychotic use. Clinical monitoring of weight is recommended.
Pathological Gambling and Other Compulsive Behaviors: Compulsive or uncontrollable urges to gamble have been reported with use of aripiprazole. Other compulsive urges less frequently reported include sexual urges, shopping, binge eating and other impulsive or compulsive behaviors which may result in harm for the patient and others if not recognized. Closely monitor patients and consider dose reduction or stopping aripiprazole if a patient develops such urges.
Orthostatic Hypotension: Aripiprazole may cause orthostatic hypotension which can be associated with dizziness, lightheadedness, and tachycardia. Monitor heart rate and blood pressure, and warn patients with known cardiovascular or cerebrovascular disease and risk of dehydration and syncope.
Falls: Antipsychotics including ARISTADA INITIO and ARISTADA may cause somnolence, postural hypotension or motor and sensory instability which may lead to falls and subsequent injury. Upon initiating treatment and recurrently, complete fall risk assessments as appropriate.
Leukopenia, Neutropenia, and Agranulocytosis: Leukopenia, neutropenia and agranulocytosis have been reported with antipsychotics. Monitor complete blood count in patients with pre-existing low white blood cell count (WBC)/absolute neutrophil count or history of drug-induced leukopenia/neutropenia. Discontinue ARISTADA INITIO and/or ARISTADA at the first sign of a clinically significant decline in WBC and in severely neutropenic patients.
Seizures: Use with caution in patients with a history of seizures or with conditions that lower the seizure threshold.
Potential for Cognitive and Motor Impairment: ARISTADA INITIO and ARISTADA may impair judgment, thinking, or motor skills. Patients should be cautioned about operating hazardous machinery, including automobiles, until they are certain therapy with ARISTADA INITIO and/or ARISTADA does not affect them adversely.
Body Temperature Regulation: Disruption of the body's ability to reduce core body temperature has been attributed to antipsychotic agents. Advise patients regarding appropriate care in avoiding overheating and dehydration. Appropriate care is advised for patients who may exercise strenuously, may be exposed to extreme heat, receive concomitant medication with anticholinergic activity, or are subject to dehydration.
Dysphagia: Esophageal dysmotility and aspiration have been associated with antipsychotic drug use; use caution in patients at risk for aspiration pneumonia.
Concomitant Medication: ARISTADA INITIO is only available at a single strength as a single-dose pre-filled syringe, so dosage adjustments are not possible. Avoid use in patients who are known CYP2D6 poor metabolizers or taking strong CYP3A4 inhibitors, strong CYP2D6 inhibitors, or strong CYP3A4 inducers, antihypertensive drugs or benzodiazepines.
Depending on the ARISTADA dose, adjustments may be recommended if patients are 1) known as CYP2D6 poor metabolizers and/or 2) taking strong CYP3A4 inhibitors, strong CYP2D6 inhibitors, or strong CYP3A4 inducers for greater than 2 weeks. Avoid use of ARISTADA 662 mg, 882 mg, or 1064 mg for patients taking both strong CYP3A4 inhibitors and strong CYP2D6 inhibitors. (See Table 4 in the ARISTADA full Prescribing Information.)
Commonly Observed Adverse Reactions: In pharmacokinetic studies the safety profile of ARISTADA INITIO was generally consistent with that observed for ARISTADA. The most common adverse reaction (≥5% incidence and at least twice the rate of placebo reported by patients treated with ARISTADA 441 mg and 882 mg monthly) was akathisia.
Injection-Site Reactions: In pharmacokinetic studies evaluating ARISTADA INITIO, the incidences of injection site reactions with ARISTADA INITIO were similar to the incidence observed with ARISTADA. Injection-site reactions were reported by 4%, 5%, and 2% of patients treated with 441 mg ARISTADA (monthly), 882 mg ARISTADA (monthly), and placebo, respectively. Most of these were injection-site pain and associated with the first injection and decreased with each subsequent injection. Other injection-site reactions (induration, swelling, and redness) occurred at less than 1%.
Dystonia: Symptoms of dystonia, prolonged abnormal contractions of muscle groups, may occur in susceptible individuals during the first days of treatment and at low doses.
Pregnancy/Nursing: May cause extrapyramidal and/or withdrawal symptoms in neonates with third trimester exposure. Advise patients to notify their healthcare provider of a known or suspected pregnancy. Inform patients that there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to ARISTADA INITIO and/or ARISTADA during pregnancy. Aripiprazole is present in human breast milk. The benefits of breastfeeding should be considered along with the mother's clinical need for ARISTADA INITIO and/or ARISTADA and any potential adverse effects on the infant from ARISTADA INITIO and/or ARISTADA or from the underlying maternal condition.
Please see full Prescribing Information, including Boxed Warning for ARISTADA INITIO and ARISTADA.
About Alkermes
Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.
LYBALVI®, ARISTADA® and ARISTADA INITIO® are registered trademarks of Alkermes Pharma Ireland Limited, used by Alkermes, Inc. under license.
Alkermes Contacts:
For Investors: Alex Braun +1 781 296 8493
For Media: Marisa Borgasano +1 781 609 6659
View original content to download multimedia:
SOURCE Alkermes plc | https://www.wibw.com/prnewswire/2022/05/02/alkermes-highlight-data-related-psychiatry-portfolio-upcoming-scientific-conferences-during-mental-health-awareness-month/ | 2022-05-02T11:43:17Z |
SEATTLE (AP) — An inquest jury found Wednesday that two Seattle police officers were justified in fatally shooting a mentally unstable, pregnant, Black mother of four children inside her apartment when she menaced them with knives in 2017.
The six King County coroner’s inquest jurors unanimously determined that officers Jason Anderson and Steven McNew, who are white, had no reasonable alternative to using deadly force. The findings drew an angry outburst from Lyles’ father, who shouted profanities and yelled, “You killed my daughter!”
The officers testified that Lyles, who had threatened other officers with shears two weeks earlier and spoke of morphing into a wolf, had been calmly speaking with them after calling to report a purported burglary when she suddenly lunged at one with a knife.
As the officers drew their weapons, Lyles yelled “Do it!” and cursed at them. The officers repeatedly yelled for her to get back before firing, hitting her seven times. The jury found that even if the officers had a Taser, it would not have been an effective or appropriate option as she advanced on them in the close confines of the apartment, The Seattle Times reported.
Her crying baby crawled over and climbed on top of her as she died, and a boy came out of a bedroom and said, in tears, “You shot my mother,” the officers recalled in emotional testimony.
Lyles was 15 weeks pregnant.
King County Prosecutor Dan Satterberg issued a statement saying he would review the evidence presented at the inquest as well as the findings in deciding whether to press charges against the officers.
“Charleena Lyles’ death is a tragedy,” Satterberg said. “Details of the incident shared at the inquest are heartbreaking.”
Her death unleashed a storm of public protest and has been held up by advocates of police reforms as demonstrating unnecessary police violence and institutional racism by law enforcement.
Family members questioned why the officers, who had been trained to deal with people showing signs of mental illness or other behavior crises, didn’t use nonlethal methods to subdue her. Anderson did not have his Taser with him — the battery was dead — and he was later suspended for two days without pay for violating department policy.
Under questioning from the family’s lawyer, Karen Koehler, a Seattle police detective who helped review the shooting acknowledged that the officers had made no plan for dealing with Lyles aside from not allowing her to get behind them.
The family last year settled a civil lawsuit against the officers and the Seattle Police Department for $3.5 million.
The inquest began after a years-long delay prompted by revisions to the coroner’s inquest process. It included six days of testimony. The jurors were asked to consider Lyles’ death in light of the police deadly force law that was in effect in 2017, which requires a finding of “actual malice” by the officer — a standard that was changed in 2018 by voter approval of Initiative 940, after prosecutors and lawmakers concluded it was virtually impossible to meet that standard to charge an officer with murder.
An inquest jury can determine if law enforcement violated any policies and potentially any criminal laws. But any decision to charge a police officer is made by the King County prosecutor. | https://cw33.com/news/u-s-news/ap-us-headlines/inquest-seattle-police-shooting-of-pregnant-woman-justified/ | 2022-07-07T17:32:45Z |
LUDLOW, Ma., Aug. 2, 2022 /PRNewswire/ -- PosiGen, the nation's leading provider of renewable energy and energy efficiency solutions for low-to-moderate (LMI) income homeowners is excited to announce our expansion into Massachusetts. The Bay State becomes PosiGen's sixth operational state, joining Connecticut, New Jersey, Pennsylvania, Mississippi, and the company's home base of Louisiana. The initial launch focuses on Western Massachusetts, with plans to expand PosiGen's footprint across the Commonwealth over the next six to eight months.
"We are very excited to be entering the Massachusetts market," says Tom Neyhart, PosiGen CEO. "Massachusetts has been committed to solar and renewables for decades and is recognized as one of the states leading the charge to decarbonization. We look forward to helping families who traditionally haven't had access to rooftop solar, lowering their energy burden and putting real money back in their pockets through our No Credit Needed, Solar for All program. We are committed to our mission to provide meaningful savings to every family we serve."
Since 2011, PosiGen has worked to close the clean energy affordability gap by delivering lower utility bills and the benefits of clean energy through solar panels and energy efficiency upgrades to low-to-moderate homeowners. To date, the company has served over 22,000 residential customers. PosiGen's lease program covers the full cost of installing, maintaining, and ensuring the rooftop solar system, and also provides energy efficiency upgrades with no minimum credit score or minimum income requirement.
In addition to delivering the low-cost benefits of rooftop solar and energy efficiency, the arrival of PosiGen in Massachusetts brings a boost to the state's economy. PosiGen has already created 16 competitive-paying sales positions in Western Massachusetts, with the anticipation of hiring approximately 40 more sales representatives by early 2023. In addition, the company will open two operations warehouses with the need to hire an additional 30 employees within the next year. PosiGen also works with Massachusetts solar installation companies and energy efficiency providers, supporting local small businesses and their employees as well as creating new clean energy jobs.
PosiGen is proud of its mission to make solar available to everyone. The team in Massachusetts has already started working with local leaders and renewable energy groups to plan the launch of "Solar for All Mass," which uses community partnerships to let lower income homeowners know they can now afford rooftop solar and energy efficiency. PosiGen truly makes Solar for All.
The first PosiGen sales office is in Ludlow. The company is currently hiring. You can learn more about PosiGen, including career opportunities, by visiting www.posigen.com or calling 866-767-4436.
Headquartered in New Orleans, LA, PosiGen is the nation's leading residential solar, energy efficiency and energy education provider for low-to-moderate income families. PosiGen has more than 22,000 resident customers, over 460 direct employees and also supports more than 150 employees through its contractors in Louisiana, Mississippi, Connecticut, New Jersey, Pennsylvania and Massachusetts. PosiGen's unique services and products makes solar energy affordable to homeowners of all income levels, and offers individuals, families and businesses the opportunity to achieve greater fiscal autonomy and energy independence by lowering utility bills. To learn more about PosiGen, please visit www.PosiGen.com
Contact:
Amy Barrios, amy@mmsnola.com
View original content to download multimedia:
SOURCE PosiGen Solar Energy and Energy Efficiency | https://www.kxii.com/prnewswire/2022/08/02/posigen-brings-rooftop-solar-energy-efficiency-bay-state/ | 2022-08-02T14:57:23Z |
As the Midwest region's largest Web3 event, Global VC Firm Decasonic Convenes Top Institutional Investors and Innovators to Chicago
CHICAGO, July 28, 2022 /PRNewswire/ -- Decasonic, a global venture and digital assets fund, today welcomed over 300 registered participants for their inaugural Web3 Investor Day in Chicago. The single day conference on July 28, 2022 includes a series of panels with industry thought leaders from both web3 native and traditional institutions. The full day's agenda including speaker bios can be found at https://linktr.ee/web3id.
"There should be no doubt that Chicago is a top-tier Web3 innovation hub," said Paul Hsu, Founder and CEO of Decasonic, the organizer of the Web3 Investor Day. "And our sold-out inaugural summit includes the best founders, innovators, and investors to explore the next frontier of innovation which will be transformational for the future of our economy and global startup ecosystem."
Speakers include Deputy Mayor for Economic & Neighborhood Development Samir Mayekar of the City of Chicago, Sam Yagan of Corazon Capital, Rumi Morales of Digital Currency Group, Jason Pritzker of The Pritzker Organization, Ben Weiss of CoinFlip, Brett Harrison of FTX U.S., Paul Hsu of Decasonic, and others who are headlining the inaugural Web3 flagship event in an effort to bring together institutional investors and web3 founders to learn about this technology's constant innovations, as well as to promote mainstream web3 adoption.
There are over 300 registered participants, over 160 of which are institutional investors, and over 50 are founders of web3 companies. The day's scheduled content includes 33 speakers, 10 of which are female leaders in web3.
Top technology talent is choosing to build in the city of Chicago. Currently many top tier innovators are headquartered in the technology centers around Fulton Market and River North. City developers are working on creating and defining a fresh epicenter of excellence surrounding this new wave of technology innovation.
Coming in summer of 2024, the Sterling Bay-developed Lincoln Yards is set to be the city's most metaverse-ready neighborhood. This innovation will cater to the use cases among the diverse set of industries that call Chicago their world headquarters, including healthcare, biotech, quantum technology, logistics, food and beverage, and financial services.
Web3 Investor Day is honored by the strong and diverse demand for attendance, as well as the support of our sponsors who made the conference possible. Presenting sponsors include Decasonic, Bridge Alternatives, Sterling Bay, and World Business Chicago.
You can follow the latest from the inaugural event via Twitter: @Web3InvestorDay or #Web3InvestorDay
Decasonic is the venture and digital assets fund building blockchain and web3 innovation. They draw on decades of experience as tech investors and operators to help founders in blockchain accelerate product-market fit and scale growth. As believers, builders, and investors in blockchain since 2013, they've engineered a systematic approach to iconic growth – with people, data, and relationships as the north stars of the fund. Visit
www.decasonic.com to learn more.
Bridge Alternative Investment Solutions continues to provide virtually every function that an in-house CFO, COO and/or Controller would provide, including books and records management, cash movements and controls, fee calculations and billing, audit management and coordination, tax compliance and coordination and service provider oversight and relationship management. For further information, please visit www.bridgealternatives.com.
Sterling Bay is a national real estate company that boldly transforms spaces, industries, and communities across the country, sparking growth and opportunity at every turn. Known for creating innovative urban headquarters for world-class companies such as Google, McDonald's, WPP, Pinterest, Dyson and Tyson Foods, Sterling Bay is consistently recognized for award-winning projects that strengthen a company's culture and brand. Sterling Bay's team of more than 185 professionals is responsible for a portfolio of creative office, multifamily, life sciences and industrial assets exceeding $20 billion. For more information, visit www.sterlingbay.com.
World Business Chicago serves a critical role in driving inclusive and equitable recovery throughout the city's 77 neighborhoods, focused on high growth sectors: transportation, distribution, & logistics; manufacturing; healthcare & life sciences, and our local innovation, startup, & venture ecosystem. As the City of Chicago's economic development agency, World Business Chicago leads corporate attraction & retention, workforce & talent, community impact, and promotion of Chicago as a leading global city. Supported by a council of 300+ local leaders, World Business Chicago's portfolio of innovation & venture programs include: the Chicago Venture Summit series, Startup Chicago, ThinkChicago, and Venture Engine with the Illinois Science and Technology Coalition (ISTC). Follow World Business Chicago on LinkedIn and Twitter for daily news and announcements on company relocation and expansion; industry and ecosystem growth, U.S. and world rankings, and more about Chicago's economic progress. More information can be found at www.worldbusinesschicago.com
View original content to download multimedia:
SOURCE World Business Chicago | https://www.kxii.com/prnewswire/2022/07/28/inaugural-web3-investor-day-launches-chicago/ | 2022-07-28T11:29:22Z |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.